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ABBREVIATIONS 
[a] specific rotation 
Ac acetyl 
ADP adenosine diphosphate 
AIBN 2,2'-azobisisobutyronitrile 
Ar aiyl 
Bu butyl 
6 chemical shift in parts per million downfield shift from 
tetramethylsilane 
dba dibenzylideneacetone 
DME dimethoxyethane 
DMSO dimethyl sulfoxide 
dppe l^-bis(diphenylphosphino)ethane 
DMF NJ^-dimethylformamide 
ED50 dose that is effective in 50 % of test subjects 
ee enantiomeric excess 
Et ethyl 
h hour(s) 
HRMS high resolution mass spectrum 
IR inftared 
KHMDS potassium hexamethyldisUazide 
IDA lithium diisopropylamide 
Ms methyl 
MOM methoxymethyl 
nVz mass to charge ratio 
NES N-bromosuccininiide 
NMR nuclear magnetic resonance 
PDC pyridinium dichioroate 
Ph phenyl 
PPTS pyridinium p-toluenesulfonate 
rt room tenq)erature 
TBDMS fé/î-butyldimethylsilyl 
•rap tetrahydrofuran 
THP tetrahydropyran 
TLC thin layer chromatography 
IMS trimethylsilyl 
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GENERAL INTRODUCTION 
Ever since its discovery in the mid-1960s, the family of compounds known as 
prostaglandins has been the target of organic synthesis, because of its important biological 
activity. Recently, organopalladium chemistry has evolved as a powerful technique in 
organic synthesis. Thus, the development of efficient synthetic routes to prostaglandins 
utilizing organopalladium chemistry is an attractive subject in organic synthesis. 
This dissertation is devided into four chapters. The first chapter discusses the 
synthesis of the prostaglandins PGF2a and 12-epi-PGF2a- The second chapter deals with 
the synthesis of the prostacyclin analogues, benzoprostacyclins, which are known to have 
potent biological activity. The third chapter deals with the synthesis of 12-epi-carbacyclin. 
Finally, the last chapter discusses a new Pd(0)-mediated approach to allylic aryl ethers, which 
was developed during the work on prostaglandin synthesis. 
2 
CHAPTER 1. ORGANOPALLADIUM APPROACHES TO 
PROSTAGLANDIN Fia AND 12-EPI-PGF2a 
3 
INTRODUCTION 
Prostaglandins control a wide range of physiological responses in the human body. 
Several prostaglandins and their modified synthetic analogues are being used as drugs. Many 
attempts have been made to synthesize prostaglandins with high efficiency. The most 
attractive strategy to constract prostaglandins seems to be a three-component coupling 
process! utilizing organometallic mediated Michael addition, followed by trapping of the 
resulting enolate by an allylic iodide (Scheme I). 
Scheme I. 
u 
6  
TBDMSO 
M 
OTBDMS 
OM 
TBDMSO OTBDMS 
COoCH 
. Prostaglandins 
TBDMSO OTBDMS 
M = metallic species such as Cu and Zn 
Recently, radical chemistry also has proven useful for construction of the 
prostaglandin framework. Stork and co-woikers^a first reported a radical-promoted 
cyclization-trapping method for the synthesis of PGF2a- Later, Keck and Burnett improved 
this method using an organotin compound as a trapping agent^b (Scheme H). 
4 
Scheme H. 
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As a continuing effort to synthesize prostaglandins using organopalladium chemistry, 
we decided to develop an efficient synthetic route to PGF2a and 12-epi-PGF2a by a 
palladium-mediated three-component coupling reaction. We invisioned that three different 
alkenes could be coupled by a palladium-promoted cyclization-coupling procedure. Thus, we 
decided to explore this exciting possibility. 
Fugami and co-workers reported in 1987 that the reaction of acyclic allylic alcohols, 
vinyl ethers and palladium acetate afforded good yields of 2-alkoxy-4-
alkenyltetrahydrofurans (eq 1)^. Larock and Stinn later extended this chemistry to the 
preparation of bicyclic acetals (eq 2)^. 
'OH + tf^OBu Pd(0Ac)2 
94% 
OBu 
( 1 )  
5 
OH 
6  Pd(0Ac)2 V''^ '''PdOAc^ 
H 
-HPdOAc 
-OEt 
h 
56% 
( 2 )  
A close look at the reaction mechanism in equation 2 suggests that the molecular 
skeleton of prostaglandins can be obtained using this methodology. The reaction of cis-4-t-
butyldimethylsilyloxy-2-cyclopenten-l-ol (1), ethyl vinyl ether and palladium acetate should 
give organopalladium intermediate 2, which might be trapped by l-octen-3-one to afford 
compound 2 (eq 3). Therefore, the in^ortant intermediate 1 for the synthesis of PGF2a 
o 
'OEt 
Pd(OAc)2 
TBDMSO 
1 
.OEt 
<1-% 
a 
TBDMSO 
2 
TdOAc 
O 
-OEt 
0,-<s 
a  
( 3 )  
TBDMSO o 
might be prepared by a very efficient three-component coupling process from readily 
available compound 1. 
The synthesis of PGF2a requires the natural beta stereochemistry at carbon 12. 
Fortunately, the required epimeiization and the subsequent reactions to PGF2a have already 
been reported^ (eq 4). Moreover, the intermediate 3 should be readily converted 
VVyw 
O O OH 
4 ^ 6 
80-85% 
diastereoselectively to the corresponding alcohol 7 and upon subsequent hydrolysis and 
Wittig reaction to 12-epi-PGF2a (8). The prostaglandin 8 is litde known and has not been 
biologically tested yet 
.OCH2CH3 
0-<^ HO 
[H] 1. It >-^ A=/^C02H 
( 5 )  o o 2. Wittig 
TBDMSO-
OH OH 
7 8 
There are two references to compound 8 in the chemical literature. One is a German 
patent^ stating that confound 8 has "prostaglandin-like pharmacological properties". In that 
patent, compound & was prepared via the modified procedure of Corey's PGF2a synthesis 
(eq6). 
CHOAc .. O O 
ho^ 
^Cl 
CN CN OH ^ 
7 
The other report^ of compound 8 appears in a paper describing the synthesis of 
natural prostaglandin F20C. A Wittig reaction of aldehyde 10 led to a mixture of compounds 
11 and 12, where confound 12 was converted into compound £ (eq 7). 
OH OH OH 
' " ' r. ° 
H 
& 
Compound 2 should also afford a facile route to C prostaglandins^ by elimination of 
the silyloxy group (eq 8). A synthesis of PGC2 was accomplished by Corey and Moinet^ 
from the lactol 15 by a double bond migration in the key step (eq 9). 
PCH2OH3 J O 
ir  ^ ^>\=A c^o2H ( 8 )  
2 - < I - .CsH,, 
12 O 14 OH 
PGC2 
8 
Fe(C0)3 
C5H11 
ÔTHP 
14 ( 9 )  
15 
Fû' >Î^C5Hii 
' t. âTHP 16 
We might also hope to introduce different functionality into the lower side chain by 
en^loying different alkenes in place of l-octen-3-one. One example might be a simple alkene 
like 1-octene (eq 10). 
6^   ^o'' 
COoH (10) 
17 ^ 
Above all, a very attractive feature of this palladium process is that allylic alcohol 1 is 
readily available in enantiomerically pure fcom. It is known that enzymatic hydrolysis of 
cw-l,4-diacetoxy-2-cyclopentene (19) affords enantiomerically pure monoester 20. 
Subsequent protective group manipulations provide optically pure (eq 11). 
OAc OAc QAc OH 
O —  O —  
OAc OH OTBDMS OTBDMS 
12 2Q 2i 1 
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RESULTS AND DISCUSSION 
An efficient, one-pot procediae for three-component coupling to prepare cortçound 3 
was conducted under various conditions. The results are summarized in Table 1. 
Table 1. Reaction conditions for the synthesis of compound 3 
PCH2CH3 
STBDMS ° • TBDMSCF g 
1 Ï 
Entry X y z Base Additive % Isolated Yield 
1 3 5 1.2 none none 27 
2 10 40 
3 2.5 2.4 EtgN <10 
4 2.7 5 NaOAc 44 
5 13 1.2 none 44 
6 16 55 
7 20 57 
8 6 57 
9 3 0.2 Nal 58a 
10 4 1.5 72 
11 2 NaOAc 72 
^16% of the starting material i was recovered. 
10 
The best results are presented in entries 10 and 11. In entries 2 - 4, the effect of a base 
on the reaction was examined. With triethylamine as the base, less than 10% of the desired 
product 3 was obtained. This reaction also gave a 41% yield of compound 22, which was 
probably generated by 1,4-addition of acetate to l-octen-3-one (entry 3). The addition of 
o 
22 
sodium acetate, however, provided slightly better results (entry 4). As seen in Table 1, the 
product yield is dependent on the amount of l-octen-3-one employed (entries 1,2 and 5 - 7); 
the yield ioqjroved from 27% to 57% as the amount of l-octen-3-one was increased from 5 to 
20 equivalents. This observation indicates that the cracial step in the three-component 
coupling is the Heck-type addition of l-octen-3-one to the organopalladium intermediate 2. 
Six equivalents of ethyl vinyl ether was tried, instead of three equivalents, figuring that the 
acetic add generated might destroy the vinyl ether initially added (entry 8). 
During work on the synthesis of a carbacyclin in Chapter m of this dissertation, it 
was observed that the addition of sodium iodide to the reaction system increased the yield of 
the desired product This observation led me to investigate the reaction using a catalytic 
amount of sodium iodide (entries 9-11). When 0.2 equivalents of sodium iodide was added 
to the reaction conditions shown in entry 8, the desired product was obtained in a 58% yield, 
along with recovery of 16% of the starting material It was assumed that Pd(II) was being 
destroyed for some unknown reason. Hence, the reaction was conducted with 1.5 
equivalents of Pd(OAc)2. The product 1 was then obtained in a 72% yield (entry 10). When 
11 
the reaction was carried out with sodium acetate as a base in entry 11, the same result was 
obtained. 
The reason for the improvement in product yield when using sodium iodide in this 
reaction is not clear. One might think that the reactive species is an organopalladium iodide, 
rather than an organopalladium acetate. 
Product 3 was obtained as a mixture of exo and endo diastereomers, whose ratio 
ranges from 1:1 to 5:1, depending on the experimental conditions. The diastereomers exo 24 
and endo 23 are separable by flash chromatography. Moreover, the endo isomer 23 can be 
cleanly isomerized to the exo isomer 24 with a catalytic amount of pyridinium p-
toluenesulfonic acid in ethanol (eq 12). 
^CHgCHg .OCH2CH3 
9 \ 0.3 ppTs 9"^ 
EtOH ^ 
rt, 1 d 
TBDMSd ^ TBDMSO q 
23 24 
98% 
( 1 2 )  
The reaction mechanism for the formation of the product 3 is proposed in Scheme TTT. 
Electrophilic alkoxypaUadation of ethyl vinyl ether by conipound 1 produces the intermediate 
25, which undergoes cyclic carbopalladation, followed by Heck-type insertion of l-octen-3-
one. Accordingly, a remarkably simple one-step process for the synthesis of 3 is 
accomplished via a series of three alkene couplings. 
12 
Scheme m. 
OH à l-octen-3-one 
OTBDMS Pd(0Ac)2 
Nal 
1 
- OEt 
oA^PdX 
9 
OTBDMS 
25 
îf V^-'^ PdX 
TBDMSÔ 
2Â 
a  
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X = O Ac or I 
With the knowledge that ds-4-acetoxy-2-cyclopenten-l-ol (28) is more readily 
available in optically pure fonn^ 1, we examined the use of racemic 28 as the starting material 
(eq 13). The reaction gave only a trace amount of the desired product 29. Compound 30 or 
OH 
+3/^0^ +2oyY^ 
.C5H11 Pd(OAc)2 
rt 
OAc 
28 
.OCH2CH3 
o-  ^
( 13 ) 
OAc o 
22 ^ 
<5% 
31. as judged solely by NMR spectral analysis, was obtained as a major product in 
approximately a 10% yield. 
13 
.OEî 9 
•rtOAc 
OEt 9 
o 
ÔÀc 20 2i 
The interesting feature of this approach to prostaglandins lies in the versatility for 
introducing a variety of co-side chains. A number of different olefins were examined 
extensively in this reaction. These results are summarized in Table 2. 
The following comments are noteworthy. First, the reaction was governed by the 
electronic and steric environment present in the olefin. Electron-deficient olefins, such as 
a,j3-imsaturated ketones, gave better yields than simple olefins. Steric effects can be 
compared in entries 12 to 17. While the sterically unhindered olefin 1-octene gave the 
product in fair yield, only low yields were obtained using sterically hindered acetyl- and silyl-
protected l-octen-3-ol derivatives (entries 13,14 and 16). Secondly, the product yield is 
usually improved with addition of a catalytic amount of sodium iodide. A big increase in the 
product yield was observed in the reaction of 1-heptene and 1-octene when adding sodium 
iodide (entries 15-17). Thirdly, when the reactivity of the olefin towards organopalladium 
addition is low, the reaction sometimes gave compound 22- Compound 22. can be produced 
possibly via the protonolysis of the intermediate 26 (eq 14). Efforts to reduce the amount 
PCH2CH3 PCH2CH3 
TBDIVISCf '^ PdOAc 
HOAc 
+ Pd(0Ac)2 
TBDMSO* 33 26 
14 
Table 2. The synthesis of compound 22 using different olefins 
OH 1.2Pd(OAc)2 
<P + 3 + 20 H2C=CHR ^ ^ ^ ^ 
ÔTBDMS TBDMSC? ^ OTBDMS 
1 
O 
o 
0CH3 
 ^ 22. 
% Isolated Yield 
Entry H2C=CHR Time (h) Additive 32 33. 1 
3a 5 0.2 Nal 39 - 40 
65 
35 - 26 
26 
17 5 
0.5 - 13 7 
•^SOzPh 2 - 10 -
^The reaction was conducted with 2 NaOAc and 1.5 Pd(0Ac)2 
15 
Table 2. Continued 
% Isolated Yield 
Entry H2C=CHR Time (h) Additive 22 33 1 
8 4 - 10 - 30 
9a 4 0.2 Nal 15 - 20 
10 
0 
5 min - 0 
11 HgCzCHz 2 - 0 
12 
OAc 
2 - 4 
13a 
OAc 
2 0.2 Nal 15 -
14a 
OTBDMS 
2 0.2 Nal <5 
15 2 - 13 4 4 
16a 2 0.2 Nal 58 
17a ^CeHia 2 0.2 Nal 54 
16 
of compound 33 by adding a base, such as sodium acetate, were not successful. 
In terms of the synthesis of a prostaglandin analogue, we needed to further explore 
the reaction of 1-octene (entry 17). The product was obtained as an inseparable mixture of 
exo and endo cyclic acetals, which was isomeiized to the clean exo compound using PPTS in 
ethanol. From NMR spectral analysis, however, it was not clear whether the product 
was compound 35 or 3^. Therefore, ozonolysis was conducted to identify the product. The 
result is illustrated in Scheme IV. Ozonolysis of the product afforded two products, 35 and 
36. present in a ratio of 6 to 1. The product ratio was calculated by integration of the formyl 
hydrogens by proton NMR spectroscopy. Furthermore, aldehydes 22 and 38 are separable 
by flash chromatography. 
Scheme IV. 
2 NaOAc OTBDMS 
1.5 Pd(OAc)2 35 
OTBDMS 
36 
54% 
O^/CHctOH CH3SCH3 
-78 X: -78 °C tort 
TBDMSC TBDMSO 
37 
47% 
38 
37:M = 6:1 (by NMR) 
17 
This simple three-component coupling process would appear to be quite useful for the 
synthesis of other natural products. Possible target molecules include the compounds 39^ ,^ 
4013 and 41H 
O O 
22 40 41 
12-oxophytodienoic acid (-) preclavulone A (+)-Z-methylepijasmonate 
^th the important intermediate 3 at hand, we tried to epimerize the lower side chain 
in compound 1 to the corresponding natural P-configuradon present in compound ^ (eq 
15). In 1984, Corey and co-workers^ reported a successful epimerization of compound 4 to 
.OCHgCHs PCH2CH3 
^ epimerization J— > e i enz n  
!! -rDrMk*e>/^  H 
_ (15) 
TBDMSO^ O TBDMSd" 
compound 5 in high yield (eq 16). Since the structures of compounds 2 and 4 are very 
similiar, we decided to apply Corey's reaction conditions to the epimerization of compound 
2- Attempts to epimerize compound 2 to compound ^ however, were unsuccessful (eqs 17 
and 18). When the reaction was conducted at 70 ^C, only starting material was recovered 
after 2 days of stirring. With a higher temperature, up to 100 ®C, the lactol was obtained 
18 
OCH, 
HO o 
4 
25 O NH 
\__V 
75 HOAc 
2:1DME/Hp 
70 °C, 2d 
.OCH, 
Ovyv  ^( 1 6 )  
80-85% 
.OCHgCHg 
hf  ' 
TBDMSO o 
3 
25 O NH 
75 HOAc 
2:1 DME/Hp 
70*^, 2d 
3 
90% 
( 1 7 )  
25 O NH 
75 HOAc 
5-S°" 
2:1 DME/Hp 
100Id TBDMSO 
+ 2 other spots 
r? ¥ 
25% 
( 1 8 )  
in a 25% yield, along with two unidentified products, which are not the desired products as 
determined by 1h NMR spectral analysis (eq 18). 
The synthesis of compound 4 from compound 2. was desirable to accomplish the 
formal total synthesis of PGF2a (eq 19)^. Various reagents, including aqueous Hpl^, 
BF3*OEt2^^, n-Bu4NFl7, acetic acidic, NaH/HMPAl^, NBSl^ and PPTS20 were 
examined to deprotect the silyl groiq) in compound 2. The most promising reagents to obtain 
enone 4 in one step seemed to be BF3*OEt2l6 or aqueous HCl in methanol. With 
BF3*OEt2, we need to keep the reaction temperature at about -20 ^C, but the reaction is very 
19 
PCHs PCH3 
" OvV^ V^ 
HÔ 4 Ô HÔ , Ô 
HO ^ (19) 
CO9H 
HO A OH 
slow at this temperature (eqs 20 and 21). The best reagent actually turned out to be 0.5N 
aqueous HQ in methanol at room temperature (eq 22). With a catalytic amount of 0.5N 
PCH2CH3 PCHs PCH3 
? > 50 BF3»OEt2 ? ^ ^ 
CH3OH 
TBDMsè o -20 HO Q TBDMSO Q (20) 
12 h 4 41 
34% 51% 
100 BF3«OEt2, CH3OH 4  + 4 2  
-20't, 12 h 11% 11% 
( 2 1 )  
0.5N HQ 
CH3OH 
4 + 41 + . (22) 
^ ^ ^ 53% 
20 
aqueous HCl in methanol, enone 4 was obtained in a 53% yield, along with only a small 
amount of compounds 41 and 44 (eg 22). 
Interestingly, compound 44 might provide a convenient route to Corey's intermediate 
16 used previously in the synthesis of PGC2^ (eq 23). The compound 44 was obtained 
iA=AAcooH 
CcH 5" 11 (23) 
(CO)3 
16°™'' 
14 OH 
PGCz 
cleanly and in good yield using 2N aqueous HCl in methanol solvent (eq 24). 
2N HCl 
CH3OH  ^ J  ^
rt, 3 d 
Enone 4 was also subjected to epimerization following the reported Corey reaction 
conditions^. Surprisingly, all atten^ts to epimerize compound 4 failed (eqs 25 - 27). 
When the reaction was carried out using the literature procedure^, only the eliminated product 
44 was obtained (eq 25). Upon variation of the reaction temperature, no evidence was found 
to support the presence of the epimerized product (eqs 26 and 27). 
21 
.OCHs 
V^w,^^î^Nv^5Hii 2:1DME/HP 
HO 4 o 70^, 72h 
25 morpholine 
75HOAC 
>90% 
( 2 5 )  
25 morpholine 
75HOAC 
^ 2:1DMHHP "" -
60 °C, 24 h 49% 
25 morpholine 
75HOAC 4 (27) 
2:1 DME/Hp 90% 
40 °C, 48 h 
Since the epimerization of conq)ounds 2 and 4 proved to be troublesome, we decided 
to introduce a formyl group as the lower side chain by ozonolysis of compound 45 and to 
examine its epimerization. When ozone was bubbled through the substance 45 in methanol at 
PCH2CH3 
20 
TBDMSC5" , O TBDMSd 45 n 
1 1.2Pd(OAc)2,rt,2h ^ 
-OCH2CH3 
1. O3/ CH3QH/-78 °C 
\^% 
( 2 8 )  
2. Œ3SCH3 c^ '^ CHO 
TBDMS(5' 38 
75% 
22 
-78 OC, followed by reductive decomposition of the ozonide by dimethyl sulfide, the product 
38 was obtained in 75% yield (eq 28). Unlike literature reports '^22,23 of the instability of 
similar aldehydes (no spectral data could apparently be obtained), compound M was quite 
stable. 
There are reports of the epimerization of the a-isomer of similar aldehydes to the 
more stable P-configuration during a Wittig reaction (eqs 29^, 30^2 and 3123). With the 
32% 8% 
O P p O 
2 : 1 
(30) 
55% 
AoO^CHO R Acd^" 
30% 10% 
( 3 1 )  
R= 
O 
23 
information above, cornpound ^ was subjected to the Wittig reaction using 1.5 equivalents 
of the ylide 46 (eq 32). To our surprise, enone 1 was obtained as the sole product. No 
9-  9  
38 + 1.5 (MeO)^CHC(CH2)3Œ3 
Na+ 
46 
DME 
rt 
30min 
.OCH2CH3 
TBDMSO 3 O 
90% 
( 3 2 )  
epimerized or eliminated product was observed. The relative stability of compound 38. 
contrary to literature reports,^»22,23 might be the e)q)lanation for this result. 
As an alternative path to the natural prostaglandin configuration, we decided to 
examine the epimerization of compound Functional groups such as esters and nitriles 
have been reported to undergo analogous epimerization (eqs 33^2,3422 and 35^^). 
Acq 
• •'CO2CH3 CH3OH V^COaCHa AcO 
85% 
P P 
Qr^  
10% K2CO3 
\Jv CH3OH \JL 
HC^ ''CO2CH3 20^^,24 h H(f 
( 3 4 )  
65% 
24 
.OCHzCHg -OCHoCHo 
n rS 
O" ÔL 
EVE(? EWEé^^'' 
13% 
A number of reagents were examined for the epimerization of aldehyde 38. The 
results are summarized in Table 3. 
Table 3. Attempted epimerization of compound 38 
^OCHgCHg OCH2CH3 OCH2CH3. 
R -- 0 îJ 
is 47 48 
Product Ratio 
Entry Reagent Temperature Time 38 : 47 : 48 
1 1.5 K2CO3 rt lOmin 30 24 46 
2 1.5 Na2C03 lOmin 25 20 55 
3 6.0Et3N 440c 24 h 100 0 0 
4 1.5 KOAc rt 5h 91 0 9 
5 L5HOAC 24 h 100 0 0 
6 basic alumina 14-19 OC 2d 50 40 10 
7 acidic alumina rt Id 67 13 20 
8 silica gel 2d 40 48 12 
25 
The product ratio of compounds 38,47 and 4^ was determined by NMR spectral 
analysis, because these products show characteristic aldehyde peaks. In addition, they are 
clearly separable by flash chromatography; the Rf values of 38,47 and 48 are 0.40,0.53 and 
0.26 respectively using 4:1 hexane/ethyl acetate. Among the reagents tested in Table 3, basic 
alumina and silica gel turned out to be better than general bases or acetic acid. Generation of 
the elimination product 4^, however, proved troublesome. The most discouraging 
observation was that the desired p-epimer ^ also eliminated to give enal 48 (eq 36). 
.OCHgCHg OCH2CH3 
^  h i -  9 " %  
a basic alumina 
42 48 
Corey's epimerization conditions^ were also examined. The results are presented in 
Table 4. The results was quite comparable to those using silica gel or basic alumina. The 
major problem was stiU that the epimerized product 47 was apparently slowly converted to 
enal ^ (compare entries 1 and 2). The reaction was dqjendent on the amount of morpholine 
and acetic acid employed (entries 2,5,6 and 7). Also, the reaction temperature was 
important (entries 2 - 4). It was found that morpholine was a better base than piperidine 
(entry 8). 
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Table 4. Attempted epimerization of compound 38 using Corey's procedure^. 
38 + morpholine + HOAc + 2:1DME/H;P 47 + 48 
Entry 
Equivalents 
morpholine HOAc Temperature Time M 
Product Ratio 
: 47 : 48 
1 25 75 rt Id 1.0 51 48 
2 5h 34 48 18 
3 140c 15 h 48 24 28 
4 440c 3h 21 54 25 
5 25 It 7h 32 39 29 
6 5 75 5h 100 0 0 
7 15 7h 56 0 44 
8 25a 12 h 36 0 64 
%5 equivalents of pipeiidine was used instead of morpholine. 
As an alternative procedure for the epimerization of 38, the silyl enol ether 49 was 
prepared and subjected to hydrolysis (eq 37). Surprisingly, none of the desire product £7 
was observed. The hydrolysis of 49 led to aldehydes 38 and 48, thereby showing that 
electrophilic addition of the proton occurred exclusively on the exo face. 
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OCHgCHs 
1  ^  o: 
TBDMSO 
'^ CHO 
38 
5HOAC 
2:1 DME/Hp 
It 
1.2 MesSiOTf 
1.5 EtgN 
ether, 02 h & .OCH2CH3 
^ CHOSiMes 
TBDMSd 42 
25% 
.0CH2CH3 
o: 
TBDMSd 
'^ CHO 
2& 
<s 
OCH2CH3 
CHO 
4& 
1 : 10 
(by NMR spectral analysis) 
(37) 
Although all attempts at the clean epimerization of compounds 3,4 and 38 turned out 
to be unsuccessful, compound 3 should be readily converted to 12-epi-PGF2a (2)- The 
diastereoselective reduction of the C15 carbonyl group was achieved using Noyori's (S)-
BINAH-H25 (eq gg). The reaction was veiy clean. No spots other than alcohol 7 were 
-OCHgCHa 3LiAlH4 OCH2CH3 
O-A 3 CH3CH2OH O-^ 
Vvvv^  3 
TBDMSO I TBDMSO 4 
o 1:1: Ij OH 
I 
70% 
- THF,-100 to-78" 
observed by TLC analysis. Since the reagent, (S)-BINAL-H, has been known to reduce a 
variety of unsaturated compounds in a predictable manner^^, it is quite reasonable to assign 
the stereochemistry at C15 to the (S)-configuration. 
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Deprotection of the silyl group and hydrogenolysis of the cyclic acetal in compound 7 
were effected in one step by aqueous HCl to give confound 50 in 77% yield (eq 39). 
.OCHgCHg -OH 
0< Q-< 
T > 0 (39) 
TBDMSO HO ^ 
2 77% 
A subsequent Wittig reaction on compound 5Q should give 12-epi-PGF20c (7). A 
literature survey26»27 revealed that PGF2a was obtained from lactol 51 by treatment of the 
appropriate phosphonium salt with methylsulfinyl carbanion in DMSO^ô or potassium t-
butoxide in THF^^ (eq 40). Subjection of lactol 50 to these literature procedures26,27^ 
o^x HO 
[Pli3P(CH2)4COjI]Br ^ ^.^\=/\/^C02H 
VVVV^ base,rt VvA/V^ 
45-62% 
however, provided no new spot upon TLC analysis, giving the starting material back in 70 % 
yield. It was assumed that the sterically congested configuration around the cyclopentane 
ring in compound 50 might be causing difficulties in the Wittig reaction. Hence, another base 
was tried. Potassium hexamethyldisilazide was considered for use as a base, because it has 
been used^^ in the synthesis of compound 52 which has side chains with a cis configuration. 
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^ COoH 
We were quite pleased to see that potassium hexamethyldisilaâde was the right choice. The 
target molecule 8 was obtained as a single product in 54% yield (eq 41). Compound 8.was 
-OH 
- ) 4[Ph3P(CH2)4COjî3Br ^.^\=/N/^c02H 
HO 
.^\=/\/ q
(41) 
OH Î 
50 n-epi-PGFjOC 
54% 
characterized by % NMR, NMR and IR spectroscopy, plus high resolution mass 
spectrometry. Also, satisfactory result was obtained in elemental analysis. 
A concise, three-step synthesis of another PGF2a analogue from alcohol 1 was also 
accomplished as shown in Scheme V. Since compounds 35 and M are present as an 
inseparable mixture in a 6:1 ratio, the product 54 should consist of a similar mixture. Due to 
the predominance of one isomer, the and NMR spectra were clean enough to identify 
the major product Unfortunately, however, the two regioisomer olefins could not be 
separated by flash chromatography. 
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Scheme V. 
g 
.OCH2CH3 
5 
.OCH2CH3 
0.5N HCl 
y J y. THF 
TBDMSO^ 
35 
6 : 1 
54% 
36 
PH 
a 
4 [Ph3P(CH2)4CO^Br 
HO 
8 KN(TMS)2 
THF, rt, 1.5 h 
51 
89% 57% 
The asymmetric synthesis of a chiral compound which has interesting 
pharmacological properties is of great inçortance. Enantiomerically pure starting material 1 
was thus prepared following the sequence depicted in Scheme VI. czj-2-Cyclopenten-1,4-
diol C56) was prepared via dye-sensitized pbotooxygenation in which metastable singlet 
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Scheme VL 
55 
^©2/ hi) 
rose bengal 
thiourea 
CHgOH/O'C 
HO 
Ù 
HO 
56 
42% 
Acp 
pyridine 
It, 12 h 
AcO 
Ô 
AcO 
19 
80% 
pig liver esterase 
Ref. 9 
AcO AcO 
Ô TBDMSa imidazole 
CH2CI2, rt HO 
2Q 
80% 
[af D=-67°(cl.l, CHCI3) 
( > 96% ee) 
Ô cat. KCN 
TBDMSO 
21 
95% 
[a]^ D= +3.8° 
(c 0.52, CHCI3) 
ethanol 
rt, 60 h 
HO 
- 9 
TBDMSO 
i 
90% 
[af\,= -18.4° 
(c 1.28, CHCI3) 
oxygen is involved^ S. The acetylation of diol 56 provided of-1,4-diacetoxy-2-cyclopentene 
(19). Enzymatic hydrolysis^® of prochiral diester 12 afforded the optically active 
monohydrolyzed product 2Q ([a]^%) = - 37.4°, c 0.82, CHCI3) in 32% yield and the 
starting material 12 was recovered in 66% yield. Launen and Schneider^ Oa reported that 
compound 20 was obtained in 86% yield with [a]^^D = - 49.7®. My poor result can be 
attributed to the failure to accurately control the pH of the reaction solution. Successive 
recrystallization with 2:1 diethyl ether/skelly B provided crystalline compound 20, = 
- 58.6° (83% ee). Further effort to increase the ee was not successful. Later, optically pure 
20 ( [a]^^D = - 67®; c 1.1, CHCI3, >96% ee) was generously provided by Professor Sih at 
the University of Wisconsin. Protection of the alcohol in compound 20, followed by acetyl 
hydrolysis,was effected to give optically pure compound 1. 
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The asymmetric synthesis of PGFia and 12-epi-PGF2a are presented in Schemes 
Vn and Vni respectively. Since the separation of exocyclic acetal 1 from the endocyclic 
isomer is possible, all subsequent reactions were carried out using only the exo isomer. 
Thus, optical rotations were also measured on only exo isomers. 
Scheme Vn. 
TBDMSCf 15 Pd(0Ac)2 
1 2NaOAc,rt,3h 
[af\,= -18.4° 
(c 1.28, CHCI3) 
HO 
O 
TBDMSO n 
3 
72% 
-51.1° (c 0.83, ŒCI3) 
0.5N HCl 
^OCHs 
ii Ref.4 HO "COgH 
CH3OH 
rt, 3 d HO 
53% 
-44.4° (c 0.29, CHOs) 
PGFja 
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Scheme VM. 
3 LiAlH4 .OCH2CH3 
3CH3CH^H o.^Ha 
o: 
. WW 
TBDMSO J 
•IHF,-100'lCto-78<C ,.22_„„ 70% [a]%= -45.1° (c 1.00, "CHCI3) 
4 [Ph3P(CH2)4CO#I]Br 
..ÇWw >Ww HO" I THF, rt, 1.5 h HO 
50 OH & OH 
77% 54% 
The biological activity of optically pure 12-epi-PGF20t (S) was tested by the Bristol-
MyCTS Squibb Institute. To our disappointment, compound S has relatively littie biological 
activity against blood platelet aggregation; I50 > 1000 pM against ADP-induced aggregation, 
and I50 = 178.858 liM against arachidonic acid induced aggregation. The observed 
biological activity in compound & indicates that the natural configuration of the lower side 
chain at C-12 is of great importance in the biological activity of PGFlcc. 
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CONCLUSION 
The formal synthesis of PGF2a (© was accomplished from optically active ci5-4-r-
butyldimethylsilyloxy-2-cyclopenten-l-ol (1). Apalladium(II)-assisted three-component 
coupling approach to compound 3 was employed as the key step. 
The PGF2a analogue 12-epi-PGF2a (8) was also synthesized from compound 1 in 4 
steps with an overall yield of 21%. Compound 3 was used as a key intermediate. 
Examination of the biological activity revealed that compound 8 has relatively litde activity; 
l50 >1000 |iM against ADP-induced platelet aggregation, and I50 = 178.858 [iM against 
arachidonic acid-induced aggregation. 
A concise, three-step synthesis of the PGF20t analogue 54 from the readily available 
compound 1 was also accomplished. 
The one-pot coupling of three different alkenes provides an efficient synthetic route to 
the prostaglandin framework, which can lead to a variety of prostaglandins including PGF20t 
and PGC2. Further exploration in this area is warranted. 
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EXPERIMENTAL SECnON 
Equipment 
NMR spectra were recorded on a Nicolet NT-300 spectrometer ( NMR, 300 
MHz; 13c NMR, 75 MHz), and chemical shifts are reported in ppm relative to TMS (5 0.00) 
as an internal standard. IR spectra were obtained on an IBM IR 98. High-resolution mass 
spectra were recorded on a Kratos MS-50 spectrometCT. 
Reagents 
AU chemicals were used directly as obtained commercially unless otherwise noted. 
Tetrahydrofuran was distilled over sodium benzophenone ketal and used immediately. 
Methanol was distilled over sodium methoxide and stored over 4Â molecular sieves. 
Methylene chloride was distilled over phosphorous pentoxide and stored over 4Â molecular 
sieves. Ethanol was distilled azeotropically by adding a small amount of benzene and stored 
over 4Â molecular sieves. 
Preparation of racemic ic/y-4-f-butvldimethvlsilvloxv^2-cvclopenten-l-ol (1)30 
To a solution of 2.3 g of c/s-2-cyclopenten-l,4-diol (56) (23.0 mmol) and 3.9 g of 
imidazole (34.5 mmol) in 10 ml of DMF was added dropwise at room temperature over 2 h 
3.46 g of r-butyldimethylsilyl chloride (23.0 mmol) in 20 ml DMF. After overnight stirring 
at room temperature, the reaction was quenched with 10 ml of water. The solution was 
washed with brine (25 ml x 2), dried over anhydrous MgS04, and concentrated under 
reduced pressure. Flash chromatography gave 1.63 g of compound I (33% yield) as a 
colorless liquid: Rf =0.38 (2:1 hexane/EtOAc); ^H NMR (CDCI3) 5 5.95 (d, J= 5.7 Hz, 
IH, C=CH), 5.90 (d, J = 5.4 Hz, IH, C=CH), 4.66 (m, IH, CHO), 4.59 (m, IH, 
CHOSi), 2.69 (dt, J = 13.5 and 7.2 Hz, IH, H5), 1.66 (m, IH, OH), 1.51 (dt, J = 13.8 and 
4.2 Hz, IH, H5), 0.90 ( s, 9H, Si^Bu), 0.89 ( s, 6H, SiMei); IR (neat) 3393 (OH), 2957, 
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2930 cm-1; HRMS m/z 213.13098 [calculated for CnHilOiSi (M-H)+ m/z 213.13108]; 
Ammonia CI Mass, m/z 230.0 for M++ NH4. 
Preparation of optically pure 1^9 
A solution of compound 21 (1.5 g, 5.9 mmol, = +3.8®, c 0.52, CHCI3) and 
KCN (0.3 g) in 95% ethanol (30 ml) was stirred at room temperature for 4 d. After removal 
of the solvent, the residue was dissolved in ether. The solution was washed with brine, dried 
over anhydrous magnesium sulfate, and concentrated. Purification by flash chromatography 
gave compound 1(1.1 g, 90% yield, [aJ^^D = +18.4°, c 1.28, CHCI3). 
Preparation of l-octen-3-one 
To a solution of l-octen-3-ol (Aldrich, 20 g, 0.16 mmol) in 50 ml of acetone at 0 OC 
was added 70 ml of standard Jones' reagent dropwise. After the reaction was completed as 
indicated by TLC analysis, it was quenched with isopropyl alcohol and water (20 ml). The 
solution was extracted with ether (80 ml x 2), washed with saturated aqueous NaCl (80 ml x 
2) and dried over anhydrous MgS04. Concentration and vacuum distillation (68 0.5 mm 
Hg) gave the product (8.0 g, 40% yield) as a light yellow liquid: NMR (CDCI3) 5 6.33 
(dd, J = 17.7 and 10.5 Hz, IH, C=CHCO), 6.19 (d, J = 17.7 Hz, IH, HC=CHCO), 5.78 
(d, J = 9.0 Hz, IH, HC=CHCO), 2.55 (t, J = 7.2 Hz, 2H, CH2CO), 1.60 (m, 2H, CH2), 
1.29 (m, 4H, CH2CH2), 0.87 (t, J = 6.6 Hz, 3H, CH3) 
Preparation of opticallv pure 3 
In a vial were placed compound i (195 mg, 0.91 mmol, [a]^^D = +18.4°, c 1.28, 
CHCI3), ethyl vinyl ether (262 mg, 3.6 mmol), l-octen-3-one (2.3 g, 18.2 mmol), sodium 
acetate (149 mg, 1.8 mmol) and sodium iodide (27 mg, 0.18 mmol). The reaction mixture 
was stiixed for 3 min at room temperature. To this was added palladium acetate (306 mg, 1.4 
mmol). After stining for 3 h at room temperature, the reaction mixture was filtered through a 
small silica gel pad using 1:1 hexane/ EtOAc. The solution was concentrated under reduced 
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pressure, and the residue was purified by flash chromatography with 6:1 to 2:1 
hexane/EtOAc to give compound 3 (269 mg, 12% yield) as a diastereomeric mixture. Exo 
isomer: [ap-^D = -51.1® (c 0.83, CHCI3); Rf = 0.41 (4:1 hexane/EtOAc); % 
NMR(CDCL3) 8 6.93 (dd, J = 16.2 and 8.7 Hz, IH, HC=CHCO), 6.08 (dd, J = 16.2 and 
0.9 Hz, IH, HC=QiCO), 5.10 (d, J = 4.5 Hz. IH, ROCHOR ), 4.61 (dd, J = 7.2 and 6.9 
Hz, IH, CHOR), 4.19 (dd, J = 3.9 and 4.2 Hz, IH, CHOSi), 3.64 (ddq, J = 6.9 and 7.2 
and 9.6 Hz, IH, OCH2CH3), 3.37 (ddq, J = 6.9 and 7.2 and 9.6 Hz, IH OCH2CH3), 2.99 
(dt, J = 16.5 and 8.4 Hz, IH), 2.58 (dd, J = 4.2 and 8.7 Hz, IH), 2.51 (dt, J = 7.5 and 2.4 
Hz, 2H), 2.33 (ddd, J = 12.8 and 8.5 and 4.2 Hz, IH), 1.98 (d, J = 15.0 Hz, IH), 1.90 
(dd, J = 6.9 and 4.5 Hz, IH), 1.83 (dd, J = 12.3 and 9.3 Hz, IH), 1.58(m, 2H), 1.28 (m, 
4H), 1.14 (t, J = 6.9 Hz, 3H, OŒ2CH3), 0.86 (t, J = 6.1 Hz, 3H, CH3), 0.83 (s, 9H, t-
BuSi), 0.01 (s, 3H, SiMe), -0.02 (s, 3H, SiMe); NMR (CDCI3) 8 200.60, 145.33, 
132.04, 105.12, 83.26, 77.68, 62.14, 50.19, 45.80, 42.21, 39.51, 33.78, 31.53, 25.69, 
24.18, 22.47, 17.96, 15.28, 14.43, - 4.46, - 5.44; IR (neat) 2959, 2930, 1676 (C=0), 
1474,1371, 1254,1107 cm'l; HRMS calculated for C23H4l04Si 409.27742, found 
409.27796. Endo isomer: Rf = 0.32 (4:1 hexane/EtOAc); ^H NMR (CDCI3) 8 7.07 (dd, J 
=16.2 and 9.6 Hz, IH, HC=CHCO), 5.96 (d, J = 16.2 Hz, IH, HC=QiCO), 5.07 (t, J = 
8.1 Hz, IH, OCHRO), 4.53 (m, IH, CHOR), 4.19 (m, IH, CHOSi), 3.79 (m, IH, 
OCH2), 3.45 (m, IH, OCH2), 2.72-2.29 (m, 8H), 1.59 (m, 2H), 1.29 (m, 4H), 1.20 (t, J 
= 7.2 Hz, 3H), 0.87 (t, J = 6.6 Hz, 3H, CH3), 0.85 (s, 9H, f-BuSi), 0.02 (s, 3H, SiMe), 
-0.02 (s, 3H, SiMe). 
Preparation of compound 3 from compound 38 
Dimethoxy-2-oxoheptylphosphonate (Aldrich, 66 mg, 0.30 mmol) in dry DME (5 ml) 
at 0 OC, was treated in portions with NaH (50% dispersion in oil, 14 mg, 0.30 mmol) with 
stirring. The mixture was allowed to warm to room temperature, and stirring was continued 
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for 1 h. The gel fonned was transferred with swirling to a solution of aldehyde 38 (63 mg, 
0.20 mmol) in dry DME (2 ml), and the resultant mixture was passed through silica gel to 
obtain 97 mg of crude product The crade product was very clean by NMR spectral 
analysis and identified to be compound 1 (ca. 90% yield). 
Preparation of optically pure 4 
To a solution of compound 3 (47 mg, 0.11 mmol, [a]^^D = -51.1®, c 0.83, CHCI3) 
in 3.4 ml of methanol was added 0.11 ml of 0.5N aqueous HCl at room temperature. After 
being stirred for 3 d at room temperature, the mixture was neutralized by aqueous NaOH, 
then poured into 60 ml of CHCI3. The overall solution was washed with saturated aqueous 
Nad The organic phase was dried over anhydrous MgS04 and concentrated in vacuo. The 
crade product was chromatographed with 1:1 hexane/EtOAc to give 17 mg (53% yield) of 
compound 4: Rf =0.23 (1:1 hexane/EtOAc); = -44.4° (c = 0.29, CHCI3); 
NMR (CDCI3) 5 7.01 (dd, J = 16.2 and 8.1 Hz, IH, HC=CHCO), 6.21 (dd, J = 16.2 and 
0.9 Hz, IH, HC=CHCO), 5.04 (d, J = 4.8 Hz, IH, OCHRO), 4.07 (t, J = 6.3 Hz, IH, 
CHOR), 4.22 (m, IH, -QiOH), 3.29 (s, 3H, OCH3), 3.01 (ddt, J = 17.1 and 2.1 and 8.7 
Hz, IH), 2.61 (m, IH), 2.57 (t, J = 7.5 Hz, 2H, 0=CCH2), 2.18 (dd, J = 7.5 and 3.0 Hz, 
IH), 2.04 (d, J = 7.2 Hz, IH), 1.95 (dd, J = 13.2 and 9.6 Hz, IH), 1.60 (m, 4H), 1.30 (m, 
4H, CH2CH2), 0.87 (t, J = 6.9 Hz, 3H, Œ3); NMR (CDCI3) S 200.69, 143.74, 
132.68, 105.89, 83.89, 72.22, 54.38, 50.17, 44.45, 40.92, 40.07, 36.11, 31.53, 24.04, 
22.52,13.97; IR (neat) 3450 (OH), 2940,2920,1660 (C=0), 1090, 1040 cm-1; HRMS 
m/z 281.17466 [ calculated for C16H25O4 (M-H)+, m/z 281.17529], m/z 264.17160 [ 
calculated for C16H24O3 (M-H2O)'*', m/z 264.17253]; Ammonia CI Mass, m/z 300.2 for 
M++ NH4. The 1h NMR spectra for these compounds are identical to those found in 
supplementary material in the literature^. 
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Preparation of opticallv active 7^ 
To a solution of LiAIH4 (Aldrich, 0.539M in THF, 4.0 ml, 2.2 nimol) was added 
ethanol (2M in THF, 1.1 ml, 2.2 mmol) diopwise over 10 min at room temperature. 
Subsequently, a TflF solution of (S)-binaphthol ( Aldrich, [a] = -34°, 607 mg in 4.3 ml 
THF, 2.2 mmol) was added diopwise, and the resulting mixture was stirred for 30 min at 
room tewperatuie. To this was added the enone 3 [330 mg in 2.6 ml of THF, 0.80 mmol, 
[a]^^D = -51.1° (c 0.83, CHCI3)] dropwise over 3 min at -100 ®C (liq. N2 and methanol 
bath). The reaction mixture was stirred for 2 h at -100 °C, and then for another 2 h at -78 
OC. Methanol (1 ml) was added at -78 to destroy the excess reducing agent and the 
mixture was allowed to warm to room tempoerature. After the addition of water (25 ml) and 
diethyl ether (30 ml), stirring was continued for 10 min. The reaction solution was 
neutralized with 2N aqueous HCl, and extracted with ether (3 x 30 ml). The organic phase 
was dried over anhydrous MgS04 and concentrated in vacuo. The crude product was 
purified by flash chromatography with 3:1 hexane/EtOAc to give compound 7 (232 mg, 70% 
yield) as an oil: [a]^ = -45.1° (c 1.00, CHCI3); Rf = 0.40 (3:1 hexane/EtOAc); ^H 
NMR (CDQs) 5 5.80 (dd, J = 15.9 and 8.4 Hz, IH, HC=C), 5.53 (dd, J = 15.9 and 7.2 
Hz, IH, C=CH), 5.11 (d, J = 4.8 Hz, IH, OCHROEt), 4.65 (t, J = 7.2 Hz, IH, CHOR), 
4.12 (m, IH), 4.06 (m, IH), 3.68 (dq, J = 7.2 and 9.6 Hz, IH, Oai2CH3), 3.38 (dq, J 
=7.2 and 9.6 Hz, IH, OQÏ2CH3), 2.94 (m, IH), 2.45 (dt, J = 4.2 and 8.1 Hz, IH), 2.35 
(ddd, J = 12.6 and 8.1 and 4.8 Hz, IH), 1.95 (d, J = 15.0 Hz, IH), 1.84 (m, IH), 1.80 
(dd, J = 12.3 and 9.3 Hz, IH), 1.50 (m, 2H), 1.38 (d, J = 1.2, IH), 1.29 (m, 6H, CHi's), 
1.17 (t, J = 7.2 Hz, 3H, CH3), 0.89 (m, 3H), 0.87 (s, 9H, r-BuSi), 0.03 (s, 3H, SiMe), 
0.01 (s, 3H, SiMe); l^c NMR (0003) S 135.13, 129.74, 105.27, 83.23, 77.62, 73.44, 
62.14, 50.00, 45.77, 42.18, 37.29, 35.85, 31.84, 25.83, 25.22, 22.67, 18.10, 15.37, 
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14.01, -4.97; IR (neat) 3472 (OH), 2957, 2928,1472, 1464,1371, 1254 cm"!; HRMS 
m/z 411.29318 [calculated for C23H4304Si (M-H)+, m/z 411.29306] 
Preparation of opticallv active 12-epi-PGF2Ct (8) 
To a solution of (4-carboxybutyl)triphenylphosphonium bromide (Aldrich, dried for 
12 h at 100 oc under reduced pressure, 706 mg, 1.6 mmol) in 6.5 ml of freshly distilled 
TEIF was added KHMDS (Aldrich, 0.5 M in THF, 6.6 ml, 3.3 mmol) at room temperature 
under N2 gas. At this point the reaction mixture turned a deep red color. The reaction was 
stirred for 15 min at room temperature. To this was slowly added the lactol 50 (110 mg, 
0.41 mmol) in 1.5 ml of THF. The reaction mixture turned a deep brown color. After being 
stirred for 1.5 h at room temperature, the reaction mixture was quenched by the addition of 
water (25 ml). The reaction mixture was washed with ethyl acetate (25 ml) to remove any 
organic soluble material. The aqueous layer was acidified by adding 2N aqueous HQ. The 
solution was extracted with Œ2CI2 (20 ml x 2). The organic phase was dried over 
anhydrous MgS04 and concentrated under reduced pressure. The crude product was 
purified by flash chromatography with EtOAc/ MeOH/ HOAc (90 ml/15 ml/ 0.1 ml) to give 
12-epi-PGF2a (8,77 mg, 54% yield) as a white solid: Rf=0.29 (EtOAc/ MeOH/ HOAc 
(90 ml/ 15 ml/ 0.1 ml); % NMR (CDCI3) 5 5.90-5.70 (br s, 3H, OH's), 5.80 (dd, J = 15.0 
and 10.5 Hz, IH, HC=C), 5.49 (dd, J = 15.0 and 6.9 Hz, IH, C=CH), 5.38 (m, 2H, 
HC=CH), 4.19 (m, 2H), 4.10 (m, IH), 2.72 (m, IH), 2.32 (t, J = 6.6 Hz, 2H), 2.27 (m, 
IH), 2.13 (m, 4H), 1.86 (m, 2H), 1.66 (m, 3H), 1.50 (m, 2H), 1.28 (m, 6H, CHi's), 0.87 
( t, J = 6.6 Hz, 3H, CH3); NMR (CDCI3) 5 178.06, 187.07, 129.81, 129.29, 129.01, 
75.41, 73.51, 72.89, 50.00, 47.15, 42.56, 36.83, 33.18, 31.85, 26.52, 25.30, 24.58, 
24.29, 22.72,14.14; IR (neat) 3387 (OH), 2926,2856, 1707 (CO2H), 1439,1410 cm'l; 
HRMS m/z 336.22945 [calculated for C20H32O4 (M-H20)+, m/z 336.23006]; Ammonia 
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CI Mass m/z 372.4 (M"^+ NH4). Anal. Calcd for C20H34O5: C, 67.77; H, 9.67. Found C, 
67.57; H, 9.52. 
Preparation of m-3.5-diacetoxv-l-cvclopentene (19*) 
To a solution of the diol 56 (1.17 g, 11.7 mmol) in pyridine (2.81 ml, 35.1 mmol) 
was added 2.59 ml (23.4 mmol) of acetic anhydride drop wise over 30 min at room 
temperature. After being stirred at room temperature for 15 h, the reaction mixture was 
poured into 50 ml of water. The overall mixture was extracted with ether (2 x 50 ml). The 
organic layer was washed with brine, dried over anhydrous MgS04, and concentrated in 
vacuo. Purification by flash chromatography with 2:1 hexanë/EtOAc yielded compound 19 
(1.72 g, 80% yield): Ir NMR (CDCI3) 8 6.06 (s. 2H, HC=CH), 5.52 (dd, J = 7.5 and 3.9 
Hz, 2H, HCOAc), 2.87 (dt, J = 15.0 and 7.5 Hz, IH), 2.04 (s, 6H, 0=CCH3), 1.71 (dt, J 
= 15.0 and 3.9 Hz, IH). 
Preparation of opticallv active m-4-acetoxv-2-cvclopenten-l-ol9a (20'> 
Diacetate là (1.71 g, 9.3 mmol) suspended in a 0.1 M phosphate buffer (18 ml, pH = 
7.0, T = 32 OQ was treated with 1.3 mg (130 unit) of porcine liver esterase (Sigma) with 
stirring. By continuous addition of a 0.1 N aqueous NaOH solution, the pH was kept 
constant during the hydrolysis. After being stirred for 2 days, the mixture was extracted with 
ether. Concentration and flash chromatography afforded compound 20.(0.43 g, 32% yield) 
as a colorless liquid: [a]^ = -37.40 (c 0.87, CHCI3,53% ee); ^H NMR (CDCI3) 5 6.09 
(ddd, J = 5.4 and 1.8 and 1.2 Hz, IH, HC=C), 5.96 (ddd, J = 4.5 and 1.8 and 0.9 Hz, IH, 
C=CH), 5.47 (m, IH), 4.696 (m, IH), 2.78 (dt, J = 14.7 and 7.5 Hz, IH), 2.03 (s, 3H, 
0=CCH3), 1.81 (m, IH), 1.63 (dt, J = 14.4 and 3.9 Hz, IH); JR (neat) 3412 (OH), 1736 
(CO) cm-1. 
42 
Preparation of opticallv active «'.y-3-acetoxv-5-?-butvIdimethvlsilvloxv-l-cvclopentene (2!) 
To a solution of compound 20 (371 mg, 2.6 mmol, [aJ^^D = -67.0®, c 1.1, CHCI3, 
>96% ee) in CH2CI2 (15 ml) were added imidazole (620 mg, 9.1 mmol) and t-
butyldimethylsilyl chloride (590 mg, 3.9 mmol) at room temperature. Stirring was continued 
for 20 h, then the reaction was quenched with 20 ml of water. The overall mixture was 
extracted with hexane (2 x 50 ml). The resulting organic phase was washed with brine, dried 
over anhydrous MgS04, and concentrated under reduced pressure. Purification by flash 
chromatography gave confound 20 (637 mg, 95% yield) as a liquid: NMR (CDCI3) 5 
5.94 (dt, J = 5.1 and 1.8 Hz, IH, HC=C), 5.85 (dt, J = 5.1 and 1.5 Hz, IH, C=CH), 5.43 
(m, IH), 4.69 (m, IH), 2.77 (dt, J = 13.8 and 7.2 Hz, IH), 2.01 (s, 3H, 0=CCH3), 1.58 
(dt, J = 13.8 and 5.1 Hz, IH), 1.87 (s, 9H, r-BuSi), 0.09 (s, 6H, SiMei). 
Epimerization of the endocvclic acetal 23 to the exocvclic acetal 24 
To a solution of acetal 23 (130 mg, 0.32 mmol) in 3.0 ml of absolute ethanol was 
added pyridinium p-toluenesulfonate (21 mg, 0.08 mmol). The reaction mixture was stirred 
for 2 d at room temperature, then concentrated in vacuo and flash chromatographed to give 
acetal 24 (127 mg, 96% yield). 
Compound 33 
1H NMR (CDCI3) 6 5.15 (d, J = 5.1 Hz, IH, ROCHR'R"), 4.68 (q, J = 7.2 Hz, 
IH), 4.01 (m, IH), 3.78 (dq, J = 9.6 and 7.2 Hz, IH, OCH2), 3.40 (dq, J = 9.6 and 7.2 
Hz, IH, OCH2), 2.46 (m, IH), 2.30 (m, IH), 2.05 ( m, 2H), 1.85 (m, 2H), 1.72 (m, IH), 
1.20 (t, J = 6.9 Hz, 3H, CH3), 0.87 (s, 9H, f-BuSi), 0.04 (s, 6H, SiMei); NMR 
(CDCI3) 5 105.89, 82.83, 73.38, 62.54, 43.63, 41.28, 38.90, 38.64, 25.94, 18.18, 15.21, 
-4.57. 
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Preparation of compound 35 
In a vial were placed alcohol 1 (86 mg, 0.4 mmol), ethyl vinyl ether (116 mg, 1.6 
mmol), 1-octene (896 mg, 8.0 mmol), sodium acetate (66 mg, 0.8 mmol) and sodium iodide 
(14 mg, 0.093 mmol). The reaction mixture was stirred for 2 min at room temperature, then 
palladium acetate (135 mg, 0.6 mmol) was added. Stirling was continued for 6 h at room 
temperature. The reaction mixture was passed through a silica gel pad using 3:1 hexane/ 
EtOAc as eluenL Concentration and flash chromatography yielded compound 35 (85 mg) in 
54% yield. Later compound 35 was found to be present as a mixture with compound 36 in a 
6:1 ratio. Exo isomer Rf = 0.38 (10:1 hexane/EtOAc); NMR (CDCI3) 6 5.43 (m, 2H, 
HC=CH), 5.09 (d, J = 4.8 Hz, IH, ROCHR'OR"), 4.63 (t, J = 7.2 Hz, IH, HCOR), 4.06 
(t, J = 3.9 Hz, IH, HCOSi), 3.67 (dq, J = 9.6 and 7.2 Hz, IH, OCH2), 3.39 (dq, J = 9.6 
and 7.2 Hz, IH, OŒ2), 2.90 (m, IH), 2.31 (ddd, J = 12.6 and 9.3 and 4.8 Hz, IH), 2.16 
(m, IH), 1.93 (m, 4H), 1.77 (m, 3H), 1.27 (m, 6H), 1.17 (t, J = 7.2 Hz, 3H, CH3), 0.86 
(s, 9H, r-BuSi), 0.86 (m, 3H, CH3), 0.03 (s, 3H, SiMe), 0.00 (s, 3H, SiMe); NMR 
(CDCI3) 8 131.36, 128.81, 105.27, 83.31, 75.94, 62.01, 47.85, 43.90, 42.16, 33.10, 
32.66, 31.48, 29.78, 29.31, 25.81, 22.60, 18.02, 13.38, 14.12, -4.46, -5.12; IR (neat) 
2950,1455,1380,1250,1110 cm'l; HRMS m/z calculated for C23H4403Si 396.30598, 
found 396.30499. 
Ozonolvsis of compound 35 to compound 37 
Ozone was passed into a solution of compound 25 (50 mg, 0.13 mmol) in 3 ml of 
methanol at -78 ®C until a green color persisted. After the reaction was flushed with N2 at 
-78 OC, 0.5 ml of dimethyl sulfide was added to the reaction. Stirring was continued for 30 
min at -78 ®C, then for 1 h at 0 ^C, and finally for an additional 20 min at room temperature. 
The reaction mixture was poured into 60 ml of ether. The overall solution was washed with 
H2O (10 ml) and brine (10 ml). After the organic phase was dried and concentrated, the 
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crude product was purified by flash chromatography to give compound 37 (20 mg, 47 % 
yield): Rf = 0.44 (4:1 hexane/EtOAc); NMR (CDCI3) S 9.82 (t, J =1.2 Hz, IH, Œ0), 
5.10 (d, J = 4.8 Hz, IH, ROCHOEt), 4.65 (t, J = 7.2 Hz, IH, CHOR), 4.19 (t, J = 3.9 Hz, 
IH, CHOSi), 3.69 (dq, J = 9.6 and 6.9 Hz, IH, OCH2), 3.39 (dq, J = 9.6 and 6.9 Hz, IH, 
OCH2), 3.00 (m, IH), 2.75 (ddd, J = 18.0 and 6.3 and 1.2 Hz, IH, CH2C=0), 2.57 (ddd, 
J = 13.8 and 9.3 and 4.8 Hz, IH, CH2CHOEt), 2.35-2.16 (m, 2H), 1.94 (d, J = 15.0 Hz, 
IH), 1.80 (m, 2H), 1.17 (t, J = 6.9 Hz, 3H, CH3), 0.86 (s, 9H, f-BuSi), 0.04 (s, 3H, 
SiMe), 0.03 (s, 3H, SiMe). 
Preparation of compound 38 
Ozone was passed through a solution of the compound 45 (85 mg, 0.23 mmol) in 5 
ml of methanol at -78 until the blue color of ozone persisted. The solution was purged 
with N2, then 3 ml of dimethyl sulfide was added. After the solution had been warmed to ice 
bath temperature, it was stirred at that temperature for 1 h, then at room temperature for 1 h. 
The reaction mixture was diluted with 60 ml of ether, and then washed with water (2 x 25 
ml). The aqueous layer was extracted with ether (20 ml). The combined organic layer was 
dried with anhydrous MgS04, then concentrated under reduced pressure. Crude product (66 
mg, 90% yield) was obtained, which turned out to be pure by ^H NMR spectral analysis. 
Subsequent purification by flash chromatography with 1:1 hexan^ EtOAc gave 55 mg (75% 
yield) of the product 3&: Rf= 0.66 (1:1 hexane/ EtOAc); ^H NMR (CDCI3) 5 8.83 (d, J = 
1.5 Hz, IH, CHO), 5.11 (d, J = 4.8 Hz, IH, ROCHR'OEt), 4.67 (m, 2H), 3.65 (dq, J = 
9.6 and 6.9 Hz, IH, OŒ2), 3.39 (dq, J = 9.6 and 6.9 Hz, IH, OCH2), 3.11 (m, IH), 
2.59 (ddd, J = 8.1 and 4.2 and 1.5 Hz, IH), 2.32 (m, 2H), 2.14 (dd, J = 12.6 and 9.3 Hz, 
IH), 1.97 (d, J = 14.7 Hz, 3H, Œ3), 1.91 (ddd, J = 15.0 and 6.9 and 4.8 Hz, IH), 1.15 
(t, J = 7.2 Hz, 3H, CH3), 0.81 (s, 9H, f-BuSi), 0.05 (s, 3H, SiMe), 0.01 (s, 3H, SiMe); 
13c NMR (CDCI3) 5 202.57, 105.23, 82.92, 75.73, 62.20, 59.47, 42.20, 41.89, 36.64, 
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25.59,17.86, 15.25, -4.63, -5.33; IR (neat) 2920, 2850, 1720 (C=0), 1470, 1250,1100 
cm'l; HRMS tn/z 313.18403 [calculated for Ci6H2904Si (M-H)""", 313.18352]; Ammonia 
CI Mass m/z 332.4 (M++ NH4). 
Compound 43 
Rf = 0.70 (1:1 hexane/EtOAc); Ir NMR (CDCI3) 5 6.95 (dd, J = 15.9 and 8.4 Hz, 
IH, HC=CHCO), 6.09 (d, J = 15.9 Hz, HC=CHCO), 4.98 (d, J = 4.8 Hz, IH, CHOCH3), 
4.66 (t, J = 7.2 Hz, IH, CHOR), 4.19 (m, IH, CHOSi), 3.27 (s, 3H, OCH3), 2.96 (m, 
IH), 2.59-2.46 (m, 4H), 2.35 (ddd, J = 12.8 and 8.5 and 4.2 Hz, IH), 2.04-1.76 (m, 3H), 
1.56 (m, 2H), 1.27 (m, 4H), 0.85 (m, 12 H, CH3 and f-BuSi), 0.02 (s, 3H, SiMe), -0.02 
(s, 3H, SiMe). 
Preparation of compound 44 
To a solution of compound 3 (41 mg, 0.10 mmol) in 3.0 ml of methanol was added 
0.1 ml of 2N HCl at room temperature. After the reaction was stirred for 3d at room 
temperature, it was neutralized with aqueous NaOH, and then poured into 60 ml of ether. 
The overall solution was washed with H2O (10 ml) and brine (10 ml). The organic phase 
was dried over MgS04 and concentrated in vacuo. The crude product was purified by 
passing through a silica gel pad. The product 44 (22 mg) was obtained in 77% yield as a 
mixture of diastereomers with Rf = 0.59 and 0.53 (1:1 hexane/ EtOAc). Diastereomer of Rf= 
0.59: 1H NMR (CDCI3) 6 7.27 (d, J = 15.9 Hz, IH, HC=C), 6.04 (m, IH, HC=C), 6.01 
(d, J = 15.9 Hz, C=CH), 5.04 (d, J = 4.8 Hz, IH, CHOCH3), 4.82 (t, J = 6.3 Hz, IH, 
CHOR), 3.49 (m, IH), 3.34 (s, 3H, OCH3), 2.79 (m, IH), 2.61 (d, J = 20.1 Hz, IH), 
2.57 (t, J = 7.5 Hz, 2H), 2.29 (dd, J = 13.2 and 9.3 Hz, IH), 1.75 (dt, J = 13.2 and 6.0 
Hz, IH), 1.60 (m, 2H), 1.28 (m, 4H, CH2CH2), 0.88 (m, 3H, CH3); NMR (CDCI3) 
5 200.97, 143.41, 137.97, 137.20, 127.14, 105.81, 81.25, 54.40, 47.06, 40.65, 39.64, 
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38.09, 31.57, 24.19, 22.53, 13.99; IR (neat) 2920, 1660 (C=0), 1610, 1360, 1200, 1045 
cm"l; HRMS calculated for Ci^2403 264,17255, found 264.17249. 
Preparation of compound 45 
To a solution of compound i (107 mg, 0.5 mmol) in ethyl vinyl ether (108 mg, 1.5 
mmol) and ethyl vinyl ketone (840 mg, 10.0 mmol) was added Pd(OAc)2 (134 mg, 0.6 
mmol). The resulting mixture was stirred at room temperature for 2 h, and diluted with 
hexane (10 ml). The mixture was filtered through silica gel and concentrated under reduced 
pressure. The residue was purified by flash chromatography using 4:1 hexane /EtOAc. 
Compound 45 (119 mg, 65% yield) was obtained as a mixture of diastereomers with Rf = 
0.38 and 0.30 (4:1 hexane/EtOAc). Exodiastereomer (Rf = 0.38): NMR (CDCI3) Ô 
6.95 (dd, J = 16.2 and 8.4 Hz, IH, HC=C), 6.11 (d, J = 16.2 Hz, IH, C=CHC=0), 5.12 
(d, J = 4.8 Hz, IH, ROCHR'OEt), 4.68 (t, J = 6.9 Hz, IH, CHOR), 4.20 (m, IH, 
CHOSi), 3.66 (dq, J = 9.9 and 7.2 Hz, IH, OCH2), 3.40 (dq, J = 9.9 and 7.2 Hz, IH, 
OCH2), 3.00 (m, IH), 2.56 (m, 3H), 2.34 (ddd, J = 12.3 and 9.0 and 5.1 Hz, IH), 1.99 
(d, J = 14.7 Hz, IH), 1.91 (dd, J = 6.9 and 4.5 Hz, IH), 1.85 (dd, J = 12.6 and 9.6 Hz, 
IH), 1.15 (t, J = 6.9 Hz, 3H, CH3), 1.09 (t, J = 7.5 Hz, 3H, CH3), 0.86 (s, 9H, r-BuSi), 
0.03 (s, 3H, SiCH3), -0.01 (s, 3H, SiŒ3); NMR (CDCI3) 5 200.80, 145.16, 
131.74, 105.15, 83.23, 77.72, 62.13, 50.24, 45.72, 42.23, 35.80, 32.71, 25.71, 17.20, 
15.30, 8.39, -4.81, -5.18; IR (neat) 2955,1674 (C=0), 1256 cm'l. 
Compound 47 
1h NMR (CDCI3) 6 9.70 (d, J = 1.8 Hz, IH, CHO), 5.22 (d, J = 4.5 Hz, IH), 
4.51 (dt, J = 3.6 and 7.2 Hz, IH), 4.41 (q, J = 6.6 Hz, IH), 3.69 (dq, J = 9.6 and 7.2 Hz, 
IH), 3.42 (dq, J = 9.6 and 7.2 Hz, IH), 2.94 (m, IH), 2.69 (dt, J = 1.8 and 6.9 Hz, IH), 
2.20 (dd, J = 13.5 and 6.6 Hz, IH), 2.13 (d, J = 13.2 Hz, IH), 2.00 (dt, J = 12.9 and 5.3 
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Hz, IH), 1.84 (ddd, J = 13.8 and 6.3 and 7.2 Hz, IH), 1.18 (t, J = 7.2 Hz, 3H), 0.87 (s, 
9H, r-BuSi), 0.05 (s, 3H, SiMe), 0.04 (s, 3H, SiMe). 
Compound 48 
1H NMR (CDCI3) 6 9.76 (s, IH, CHO), 6.73 (m, IH), 5.11 (d, J = 4.8 Hz, IH), 
4.80 (t, J = 6.3 Hz, IH), 3.72 (dq, J = 9.6 and 7.2 Hz, IH), 3.52 (m, IH), 3.44 (dq, J = 
9.6 and 7.2 Hz, IH), 2.50 (dd, J = 21.0 and 6.0 Hz, IH), 2.72 (d, J = 20.4 Hz, IH), 2.31 
(dd, J = 13.5 and 9.6 Hz, IH), 1.89 (dt, J = 13.5 and 5.1 Hz, IH), 1.20 (t, J = 7.2 Hz, 
3H). 
Preparation of compound 49 ftom aldehyde 38 
To a solution of TMSOTf (Aldrich, 22.8 mg, 0.10 mmol) and triethylamine (13 mg, 
0.13 mmol) in ether (5 ml) was added aldehyde 3& (27 mg, 0.085 mmol, dissolved in 4 ml of 
ether) dropwise at 0 °C under a N2 atmosphere. After stirring for 2 h at 0 °C, the reaction 
mixture was taken up with 50 ml of ether. The mixture was washed with 25 ml of cold 
saturated NaCl. After drying and concentration, the mixture was purified by flash column 
chromatography using 6:1 hexane/EtOAc to give compound 49:11 mg, 25% yield; Rf = 0.67 
(6:1 hexane/EtOAc); ^H NMR (CDCI3) 8 6.23 (s, IH), 5.20 (d, J = 4.8 Hz, IH), 4.62 (m, 
IH), 4.49 (m, IH), 3.72 (dq, J = 9.9 and 7.2 Hz, IH, OCH2), 3.45 (m, 2H), 2.27 (m, 
IH), 1.93 (m, 3H), 1.20 (t, J = 6.9 Hz, 3H). 0.87 (s, 9H, f-BuSi), 0.17 (s, 9H, SiMeg), 
0.05 (s, 3H, SiMe), 0.04 (s, 3H, SiMe). 
Preparation of optically active 50 
To a solution of compound 7 (220 mg, 0.53 mmol, [a]22g = -45.1°, c 1.00, 
CHCI3) in 5.3 ml of THF was added 5.3 ml of 0.5N aqueous HCl at room temperature. 
After the reaction was stirred for 4 hr at room temperature, it was neutralized with 0.9 ml of 
3N NaOH. The organic phase was extracted with CH2CI2 (2 x 25 ml and then 10 ml), dried 
over anhydrous MgS04, and concentrated in vacuo. Purification by flash chromatography 
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with 10:1 EtOAc/ MeOH gave compound ^ (111 mg, 77% yield) as an inseparable 10:8 
mixture of exo and endo diastereomers: Rf =0.17 (EtOAc); NMR (CDCI3) 6 5.91 (dd, 
J = 15.0 and 8.1 Hz, IH, HC=C), 5.82 (dd, J = 15.0 and 8.1 Hz, 0.8H, HC=C), 5.65-5.55 
(m, 2.8 H), 4.50 (m, IH), 4.84 (t, J = 6.3 Hz, 0.8H), 4.74 (t, J = 6.9 Hz, IH), 4.21-4.07 
(m, 4H), 2.88 (m, 3H), 1.69 (m, 1.2 H), 2.56 (m, IH), 2.29-1.89 (m, 9H), 1.54 (m, 4H), 
1.30 (m, lOH), 0.89 (t, J = 6.6,6H, CH3) (since this compound was obtained as an 
inseparable mixture of diastereomers in about a 10:8 ratio, the assignment and integration of 
proton peaks was difficult); IR (neat) 3356 (OH), 2930,2858,1456,1340 cm"l; HRMS 
m/z 252.17222 [calculated for C15H24O3 (M-H)+, m/z 252.17254] 
Preparation of compound 53 
To a solution containing a 6:1 mixture of compounds 35 and 36 (69 mg, 0.17 mmol) 
in 5.1 ml of THF was added 5.1 ml of 0.5N aqueous HCL After the reaction was stirred for 
2 d at room temperature, it was neutralized with 3N aqueous NaOH. The mixture was then 
extracted with ethyl acetate (25 ml x 2). The organic phase was washed with brine (15 ml), 
dried, and concentrated. The crude product was flash chromatographed using 1:2 hexane/ 
EtOAc to give compound 53.(46 mg, 84% yield) as a diastereomeric mixture: Rf=0.27 (1:1 
hexane/EtOAc); ^H NMR (CDCI3) S 5.59-5.31 (m, 3H, HC=CH and ROCHOH), 4.82 (t, 
J = 6.6 Hz, 0.5 H), 4.72 (t, J = 6.6 Hz, 0.5 H), 4.09 (m, IH), 3.51 (br s, IH), 2.95-2.78 
(m, IH), 2.25-1.82 (m, 8H), 1.22 (m, 5H), 0.87 (t, J = 6.9 Hz, 3H, CH3) [since this 
compound was obtained as an inseparable mixture of diastereomers, the assignment and 
integration of proton peaks was difficult However, disappearance of protons corresponding 
to the f-butyldimethylsilyl (1.00-0.00 ppm) group and acetal methylene (OCH2,4.00-3.00 
ppm) in compounds 25 and 26 was cleanly observed]; IR (neat) 3605 (OH), 3346 (OH), 
2955,1717,1464,1377 cm"l; HRMS calculated for C15H26O3,254.18820, found 
254.18804. 
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Preparation of racemic 54 
To a solution of (4-carboxybutyl)triphenylphosphoniiim bromide (dried for 15 h 
under vacuum pressure at 100 ^C, 559 mg, 1.29 nmol) in 5.5 ml of THF was added 
KHMDS (0.5 M in toluene, 5.2 ml, 2.6 mmol) at 0 °C. After the reaction mixture was 
allowed to warm to room temperature, it was stirred for 10 min at room ten^erature. To this 
was added compound 51 (82 mg, 0.32 mmol) in 1.5 ml of THF. The reaction mixture was 
stirred for 20 h at room temperature, then quenched by adding 25 ml of H2O. After the 
resulting mixture was washed with 25 ml of ethyl acetate to remove organic soluble material, 
the aqueous layer was acidified by 2N aqueous HCl, and then extracted with CH2CI2 (25 ml 
X 2, then 10 ml). The organic phase was dried over anhydrous MgS04 and concentrated in 
vacuo. The residue was purified by flash chromatography using EtOAc/ MeOH/ AcOH (90 
m]/5 ml/0.5 ml) to give compound 54 as a mixture of olefin isomers (62 mg, 57% yield): Rf 
= 0.33 (18:1 EtOAc/MeOH); % NMR (CDCI3) S 5.50 (m, 4H, HC=CH, HC=CH), 4.28 
(m, IH, QiOH), 4.22 (m, IH, CHOH), 2.36 (m, 3H), 2.15 (m, 7H), 1.97 (m, 4H), 1.80 
(dt, J = 14.4 and 4.5 Hz, IH), 1.71 (t, J = 7.5 Hz, 2H), 1.28 (m, 8H), 0.88 (t, J = 6.6 Hz, 
3H, CH3); NMR (CDCI3) 6 178.92,131.68,130.58, 129.77, 129.18,75.55, 75.47, 
45.80, 45.28, 41.56, 33.45, 32.63, 31.43, 29.38, 29.26, 26.68, 24.58, 23.99, 22.57, 
14.12 (small peaks corresponding to minor isomer was not showed up deary); IR (neat) 
3400 (OH), 2928,2856,1711,1439, 1379 cm'l; HRMS calculated for C20H34O4, 
338.24572, found 338.24578. 
Preparation of compound 56^8 
To a solution of rose bengal (0.3 g) and thiourea (7.8 g) in 850 ml of methanol 
precooled to 0 ®C was added freshly distilled cyclopentadiene (12 ml, 10 g). The reaction 
flask was irradiated with light from a Hanovia lamp, while continuously bubbling oxygen 
through the solution at 0 ®C. The irradiation and oxygen bubbling were stopped after 2.5 h 
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and the reaction mixture was allowed to warm to room temperature and to stand overnight 
After the methanol was removed by rotary evaporator, water (200 ml) was added. The 
insoluble residue was filtered and the aqueous solution was washed with benzene (150 ml x 
2) to remove soluble organic side products. The water layer was removed by use of a rotary 
evaporator. The residue was distilled under reduced pressure (bp 105 / 0.7 mm Hg) to 
give 6.35 g of the product 56 (42% yield); NMR (CDQs) 5 6.00 (s, 2H, HC=CH), 4.9-
4.1 (m, 4H, CHOH), 2.66 (dt, J = 14.0 and 6.0 Hz, IH, CH), 1.64 (dt, J = 14.0 and 2.1 . 
Hz, IH, CH). 
Typical procedure for the reactions summarized in Table 1 
See preparation of conqjound 3. 
Typical procedure for the reaction summarized in Table 2 
See preparation of compound 45. 
0CH2CH3 /y ^ ' 
OH ° 
14 52 = ^ a = y^ph 
i'll O 
TBD^ISOI^IS =^SO,Ph ^ 
^OH 
63 ^ ^ ^ /%/Ny\ 
OAc 
Compound 57 
1h NMR (CDCI3) 5 6.95 (dd, J = 16.2 and 8.4 Hz, IH, H13), 6.10 (d, J = 16.2 
Hz, IH, Hi4), 5.14 (d, J = 4.8 Hz, IH, H6), 4.69 (t, J = 4.5 Hz, H9), 4.23 (m, IH, Hi 1), 
3.68 (dq, J = 9.6 and 7.2 Hz, IH, H5), 3.41 (dq, J = 9.6 and 7.2, IH, H5), 3.03 (dt, J = 
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16.3 and 8.4 Hz, IH, Hio), 2.61 (dt, J = 4.2 and 8.4, IH, Hi2), 2.36 (ddd, J = 12.3 and 
8.4 and 4.8 Hz, IH, H?), 2.26 (s, 3H, COCH3), 1.51 (d, J = 15.0 Hz, Hio), 1.94 (dd, J = 
6.6 and 4.5 Hz, IH, Hg), 1.88 (dd, J = 12.0 and 9.0 Hz, IH, H7), 1.72 (t, J = 7.2 Hz, 
H4), 0.88 (s, 9H, f-BuSi), 0.05 (s, 3H, SiMe), 0.01 (s, 3H, SiMe). 
Compound 58 
1h NMR (CDCI3) 8 7.10 (dd, J = 15.9 and 8.7 Hz, IH, H13), 5.86 (d, J = 15.9 
Hz, IH, Hi4), 5.12 (d, J = 4.8 Hz, IH, H6), 4.67 (t, J = 6.9 Hz, IH, Hg), 4.19 (m, IH, 
Hii), 3.72 (s, 3H, OCH3), 3.65 (dq, J = 9.6 and 7.2 Hz, IH, H5), 3.39 (dq, J = 9.6 and 
7.2 Hz, IH, H5), 2.99 (m, IH), 2.58 (dt, J = 3.9 and 8.4 Hz, IH), 2.35 (ddd, J = 12.3 and 
8.7 and 4.8 Hz, IH, H7), 2.00 (d, J = 15.0 Hz, IH, Hio), 1.91-1.74 (m, 2H), 1.15 (t, J = 
7.2 Hz, 3H, CHs), 0.86 (s, 9H, f-BuSi), 0.02 (s, 3H, SiMe), 0.00 (s, 3H, SiMe). 
Compound 59 
1h NMR (CDCI3) 5 9.52 (d, J = 8.1 Hz, CHO), 6.98 (dd, J = 15.9 and 8.7 Hz, 
IH, His), 6.17 (dd, J = 15.9 and 8.1 Hz, IH, H14), 5.14 (d, J = 4.8 Hz, IH, H6), 4.70 
(t, J = 6.9 Hz, IH, Hg), 4.27 (m, IH, Hu), 3.67 (dq, J = 9.6 and 7.2 Hz, IH, H5), 3.41 
(dq, J = 9.6 and 7.2 Hz, IH, H5), 3.06 (m, IH), 2.74 (dt, J = 3.9 and 8.1 Hz, IH), 2.34 
(ddd, J = 12.3 and 8.7 and 5.1 Hz, IH), 2.30 (d, J = 15.0 Hz, IH, Hio), 1.98-1.84 (m, 
2H), 1.17 (t, J = 7.2 Hz, 3H, H4), 0.87 (s, 9H, r-BuSi), 0.05 (s, 3H, SiMe), 0.00 (s, 3H, 
SiMe). 
Compound 60 
1h NMR (GDQs) 5 7.32 (m, 5H, Ar), 6.43 (m, 2H, H13 and H14), 5.16 (d, J = 
4.8 Hz, IH, H6), 4.72 (t, J = 6.9 Hz, IH, Hg), 4.23 (m, IH, Hn), 3.64 (dq, J = 9.6 and 
7.2 Hz, IH, H5), 3.41 (dq, J = 9.6 and 7.2 Hz, IH, H5), 3.02 (m, IH), 2.62 (dt, J = 4.2 
and 7.2 Hz, IH), 2.47 (ddd, J = 12.6 and 8.7 and 4.8 Hz, IH, H7), 2.00 (d, J = 15.0 Hz, 
52 
IH, Hio), 1.95-1.83 (m, 2H), 1.17 (t, J = 7.2 Hz, 3H, H4), 0.87 (s, 9H, f-BuSi), 0.03 (s, 
3H, SiMe), 0.00 (s, 3H, SiMe). 
Compound 61 
Clean separation of this compound was difficult, because the Rf value of compound 
61 is very close to that of phenyl vinyl sulfone. 
Compound 62 
Since this compound was obtained as a mixture of diastereomers which are difficult to 
separate, a clean ^H NMR spectrum was not obtained. 
Compound 63 
A clean ^H NMR spectrum could not be obtained due to the presence of 4 
diastereomers. 
Compound 64 
1h >ÎMR (CDCI3) S 5.43 (m, 2H, HC=CH), 5.09 (d, J = 4.5 Hz, IH, Hô), 4.23 (t, 
J = 7.2 Hz, IH, H9), 4.07 (m, IH, Hn), 4.67 (dq, J = 9.6 and 7.2 Hz, IH, H5), 3.39 
(dq, J = 9.6 and 7.2 Hz, IH, H5), 2.90 (m, IH, Hio), 2.30 (ddd, J = 10.8 and 7.8 and 
4.8, IH, H7), 2.16 (m, IH, H12), 2.01-1.89 (m, 4H), 1.81-1.70 (m, 3H), 1.31 (m, 4H), 
1.17 (t, J = 7.2 Hz, 3H, H4), 0.87 (m, 12 H, f-BuSi and CH3), 0.03 (s, 3H, SiMe), 0.00 
(s, 3H, SiMe). 
Typical procedure for the epimerization reaction shown in Table 3 
To a solution of aldehyde 38 (10 mg, 0.03 mmol) in 1.5 ml of dry methanol was 
added with stirring 1.0 g of silica gel. After standing one or two days at room temperature, 
the reaction mixture was diluted by adding methanol, then filtered and concentrated. The 
crude product was analyzed by ^H NMR spectroscopy for the characteristic aldehyde peaks 
(Compound 28:9.86 ppm, d, J = 1.8 Hz. Compound 47: 9.70 ppm, d, J = 1.8 Hz. 
Compound 48: 9.76 ppm, s). 
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Typical procedure for the epimerization reaction shown in Table 4 
To a solution of moipholine (96 mg, 1.1 mmol), and HOAc (199 mg, 3.3 mmol) in a 
mixed solvent (4.5 ml DME plus 2.2 ml H2O) was added aldehyde 38 (14 mg, 0.44 mmol) 
at room tenqjerature. After the reaction mixture was stirred for 1 d at room temperature, the 
organic phase was decanted with 5:1 hexane/EtOAc. The reaction solution was washed with 
saturated NaHCOg (10 ml) and saturated NaCl (25 ml), then dried and concentrated. The 
crude product (19 mg) was analyzed by NMR spectroscopy as indicated above for Table 
3. 
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CHAPTER n. ORGANOPALLADIUM APPROACHES TO 
BENZOPROSTACYCLINS 
57 
INTRODUCTION 
Prostacyclin (1), abbreviated PGI2, was first discovered in 1976 by a research group 
at the Wellcome Laboratories This new compound was found to be one of the most potent 
natural inhibitors of platelet aggregation yet discovered. Since platelet aggregation is a major 
risk factor for heart attack, PGI2 is intimately involved in many of the cardiovascular 
disorders. 
rCOgH HO _r^ pH = 7.6 Y ^ ±i Lb O 
ti/2=10min " VvN/\/\/ 
HO gH 
1 OH 
PGI2 Q), however, is very unstable due to the labile cyclic enol ether moiety. 
Pharmacological evaluations revealed that PGI2 is metabolized to biologically much less 
active 6-oxo-PGFia (2) under physiological conditions, having a half-life of 10 min^b. 
Since its discovery, many attempts have been made to synthesize chemically stable 
and biologically active PGI2 analogues^. Some of the more important analogues involve the 
introduction of a phenyl ether in place of the enol ether (compounds 4^, ^3 and 
Compounds 2,-6 have been reported to exhibit substantial inhibition of platelet aggregation; 
conz^ounds 3 and 4 inhibited ADP-induced aggregation with EDgo's of 16 and 0.9 ng/mL 
respectively. The IC50 value for compound 6 against ADP-induced aggregation is 5.8 
ng/mL. In addition, biological examination revealed that TRK-100 (5) has potent antiplatelet 
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activity and is orally and intravenously effective for a variety of thrombosis models, 
suggesting that it may have therapeutic value as an antithrombic drug^b. 
COgH 
HO ÔH 
3, R — /ï-CjHjj 
4 R = 
5 sodium salt of 4 (TRK-100) 
<^C02H 
OH 
In our continuing effort to synthesize prostaglandins utilizing palladium chemistry, 
we decided to examine the preparation of compound 3 and its 12-epi analogue 7. The 
COgH 
synthetic strategy is shown in Scheme L It appeared that compound 10 could be 
prepared from cyclopentadiene monoepoxide (8) and functionalized phenol 9 employing 
palladium chemistry previously developed^. The key steps in these syntheses are the 
preparation of compounds 11 and 12 fiom intermediate 10. A radical promoted cyclization. 
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followed by P-stannyl enone trapping, previously employed in the synthesis of PGFia^ was 
envisioned for the efficient synthesis of compound li from compound 10. 
Scheme L 
COgEt 
u 
a 
PC 
cat. Pd(0) 
AIBN 
10 
O 
10 
cat Pd(0) 
Ar 
o 
CcH 5^11 
o 
COgEt 
COoEt 
12 O 
Previously, Larock and Baker^ reported a cross-coupling reaction of aryl halides and 
cyclic alkenes using a catalytic amount of palladium (eq 1). Larock and Stinn^ also utilized 
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aOCH; ^ 5%Pd(OAc)2 o " 
a palladium-promoted cyclization reaction for the synthesis of benzofurans (eq 2). Based on 
5% Pd(0Ac)2 QO 
83% ^ 
( 2 )  
the results in equations 1 and 2, an intramolecular organopalladium addition reaction was 
considered to be applicable to the synthesis of compound 12. Moreover, the resulting 
organopalladium intermediate 13 should be readily converted to compound 12 by trapping 
with l-octen-3-one in a one-pot procedure (eq 3). 
cat. Pd(0) 
10 
COgEt 
o 12 (3) 
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RESULTS AND DISCUSSION 
Compound 9 was synthesized by the sequence shown in Scheme n from o-
iodophenol which is commercially available. While this approach is rather lengthy, our 
primary concern was to obtain sufficient amounts of compound 9 to explore subsequent 
chemistry. 6-Allyl-2-iodophenol (15) was obtained via Lewis acid-catalyzed Claisen 
Scheme n. 
1.2 allyl bromide 
I.2K2CO3 
94% 
0.8 MeAlClz 
-20 °C 
70% 
TBDMSCl 
 ^ OTBDMS 
.1 P3/-78 9C 
imidazole 
90% 
lir' 
Ph3P=CHC0  ^ EtO, 
83% 
EtO 
OTBDMS 
19 
16 
CH3SCH3 
83% 
OTBDMS 
I 
HÇO OTBDMS 
.1 
/z-Bu^NF 
THF 
94% 
H2/cat Pt02 
90% 
EtO 
OH 
9 
rearrangement of ether 14. "When compound 14 was subjected to thermal rearrangement 
either neat or in high boiling solvents, such as decalin or diphenyl ether, a 1:1 mixture of 
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ortho- and para- rearranged products was obtained in about 20% yield. A literature survey 
showed^ that allyl o-chlorophenyl ether undergoes clean rearrangement to only the ortho-
isomer when promoted by diethylaluminum chloride (eq 4). This led us to examine Lewis 
ij^O OH 
rV" , Yr" hexane, rt 
94% 
acids as possible catalysts. Employment of Et2AlQ or BF3*OEQ provided no reaction. 
Only starting material was recovered. With MeAlQ2 at -20 ®C, however, the desired 
product 15 was obtained in a >20:1 isomeric ratio as indicated by NMR spectral analysis. 
It was envisioned that ozonolysis of the terminal olefin in compound 15, followed by 
a Wittig reaction and hydrogénation of the resulting unsaturated ester would lead to 
compound 2- The major problem encountered was that treatment of confound 13 with 
ozone afforded only 15% of the desired product Most of the starting material provided 
unidentified products (eq 5). To avoid the phenolic hydroxy group that may complicate the 
HÇO OH 
15% 
ozonolysis reaction, the silyl protected compound 1^ was subjected to ozonolysis. 
Fortunately, good results were obtained with compound lâ providing the desired product 17 
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in 88% yield. The subsequent Wittig reaction was quite routine and gave compound 18 
efficiently. 
Attempts to reduce ((.^-unsaturated esta-18 to saturated conq)ound 19 failed using 
hydrogen and Pd/C as a catalyst; only compound 2Q was obtained (eq 6). The use of Pt02 as 
a catalyst, however, led to compound 19 along with reduced product 2Q (eq 7). When a 
65 °c 
 ^ EK>H • 5 
"OH 
20 
( 6 )  
18 + ptOz + H2 n + m (7) 
EtOH 32% 24% 
small amount of aqueous HQ was added, the reaction gave the desired product 19 in 90% 
yield. The subsequent deprotection was effected with n-Bu4NF in THF at -78 ®C to give 
compound â in 94% yield. 
In an effort to avoid the many steps utilized in going from compound 15 to compound 
9 in Scheme H, hydrocarboxylation was attempted using either zirconiumlO, borane^ ^  or 
palladiuml2 reagents to obtain compound 9 in a single step (eqs 8-10). The desired product 
Z L^PyCTfiUl BT2 
~~ CO/7atm CHoOH OH 
Br 
2Cp2ZrHC r || J (8) 
3  
' 20% 
64 
15 
2 9-BBN CO pH 7.0 
m > 
LiHAl(0^u)3 H2O2 
OH ( 9 )  
83% 
6% PdClz, 0.4 CUCI2 
— HCl, CO, O2, HCO2CH3 
CO2CH3 
(10) 
10% 
9, however, was not obtained, probably due to the poor hydrozirconation reaction in equation 
8, and the ineffective carboxylation reaction in equation 9. In the reaction of equation 10, the 
carbonyl group was added to the internal carbon of the olefin. The phenolic oxygen was 
probably chelated to the Pd metal to form an organopalladium intermediate such as 21. No 
further attempts were made to shorten the synthesis of compound 9. 
With compound 2 at hand, the preparation of compound 1Û was examined. Deardorff 
in the presence of a catalytic amount of Pd(0) species provided cij-4-phenoxy-2-cyclopenten-
l-ol (eq 11). The procedure illustrated in equation 11 proved to be quite efficient for the 
21 
and co-workers^ in 1984 reported that treatment of cyclopentadiene monoepoxide and phenol 
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O ^ 
THF, 0 °C 
,jO 
2% Pd(PPhg)^ ^ ( 11 ) 
82% 
synthesis of compound IQ (eq 12). Compound 22 was also prepared employing the same 
procedure (eq 13). It is worth commenting that the iodide functionalities in compounds 10 
COgEt 
-a 
2% Pd(PPh3)4 
TEÎF, rt, 24 h o 
HO 1Û 
72% 
( 1 2 )  
1 5 + 2  
•a 
2% Pd(PPh3)4 
THF, rt, 24 h o 
(13) 
HO 22 
64% 
and 22 are unreactive toward Pd(0) attack under the reaction conditions. 
Stork and co-woikers^^ reported a radical cyclization-trapping method for the 
construction of the PGF2a framework. Keck and Bumett^^ lata: improved this procedure 
employing a j3-stannyl enone as a radical trapping reagent (eq 14). 
66 
OEt 
AIBN ( 14 ) 
TBDMS(? O TBDMSO 
toluene, 1101 
We decided to apply the basic procedure employed in equation 14 to the synthesis of 
compound 11. P-Stannyl enone 24 was prepared following the literature precedure^^ (eq 
15). 
"-BusSn x^CsH,, "-BuaSn^^^ CjH,, 
1.5 «-BnsSaH ^ Y 1.5PDC Y 
2% AIBN CHA ° 
801C. neat it 
Confound 22 was subjected to Keek's reaction conditions as a model study. Quite 
pleasantly, the desired product 25 was obtained as a single diastereomer in 81% yield (eq 
16). Considering that there are relatively few examples of the use of aryl radicals in organic 
0.1 AIBN 
toluene 
+ 4 /T-BUgSn^^ C5H11 
HO HO 
22 81% 
synthesis it is of interest to find that compound 25 was prepared efficiendy. 
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Upon conducting the reaction with compound 10, product ii was obtained in 66% 
yield (eq 17). Conducting the reaction at 90 OQ instead of at 110 °C, increased the yield of 
COgEt COaEt 
O.IAIBN O* ^ 
O toluene (17) 
, + 4 C.H„ 
n H(? " o 
HO 
10 ii 66% 
the product to 80% (eq 18). The only side-product was the eliminated product 26. 
10 + 4 n-BusSn^^^CgHn 
O 
0.1 AIBN 
toluene 
9 0 1 5  h  
il + 
80% 
COgEt 
o 
( 1 8 )  
M 
10% 
The diastereoselecdve reduction of the enone in compound il was attempted. Noyori 
and co-workers previously reported that (S)-BINAL-H shows an excellent 
enantioselectivity in reducing oc,P-unsaturated ketones in a predictable manner. They also 
showed^^ that (S)-BINAL-H can be applicable to the reduction of enone side chains in 
prostaglandins to provide the desired 15-(S) configuration (eq 19). Thus, we used 
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( 1 9 )  
3 (S)-BINAL-H (R), 
11 
HO HO OH OH 
(100:0)  
97% 
(based on 47% conversion) 
(S)-BINAL-H to obtain compound 22 by a diastereoselective reduction of ketone li (eq 20). 
To our surprise, the 15-(R) isomer 28 was apparently obtained as the major product from 
3 (S)-BINAL-H + 
11 
THF ^ 
-100 °C to -78 °C H(5 HO OH OH 
1 : 5 )  
50% 
(56% based on recovered starting material) 
compound ii. The stereochemistry at C15 was assigned based on the polarity of the 
products 1 and its 15-(R) diastereomer 22 already known in the literature^c. According to the 
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COgH 
OH HO OH 
Literature^c the more polar isomer which has been assigned as the 15-(S) isomer 3 has more 
biological activity. They also cited an X-ray analysis underway. Eventually, the 
stereochemistry at C15 was assigned after compounds 22 and 2S were converted to acids 3 
and 22. The 15-(S) isomer 2% and 15-(R) isomer 2& show a big difference in polarities (Rf = 
0.17 for compound 2Z and Rf=0.38 for compound 2S in 1:2 hexane/EtOAc). 
The unusual reversed stereoselectivity of (S)-BINAL-H in this reaction is interesting. 
It is known that the reactivity of BINAL-H toward carbonyl substrates is influenced by 
steric effects and various electronic factors including the LUMO energy levels. One might 
suppose that the %-electrons present in the phenyl ring in conqjound 11 are responsible for 
the imejqjected result shown in equation 20. 
A more direct pathway to compound 2% would appear to involve the use of y-stannyl 
allylic alcohol 2Q as a radical trapping reagent It was of great interest to ascertain whether 
optically active alcohol 30 would provide the optically active product 27 60m the racemic 
compound 10 (Scheme HI). 
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Scheme HI. 
COpEt 
H(5 lacemic 
+ i I > 
OH 22 
optically active 
COgEt ys^COgEt 
HO^  
optically active optically active 
separable by flash chromatography 
Several different procedures have been reported for the synthesis of allylic alcohol 30 
in up to 99% ee. These include the preparation of optically pure l-octyn-3-ol, followed by 
hydrostannylation (eq 21). In addition, the stereoselective reduction of the corresponding |3-
Ref. 17 
OH \ 
Ref.l8 
O OH 
Ç^OH Ref-19 / 
y^ o 
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stannyl enone or kinetic resolution of the j3-stannyl allylic alcohol have been reported to 
afford enantiomeiically pure alcohol 3Q (eq 22). 
n-BuaSn^^CsH,, 21 '^ ^UaSn^^CsH,, ,22) 
X " 2!! Ih 
Indeed, optically pure alcohol 30 was prepared by deprotection of the corresponding 
ether which was generously provided by Professor Josef Fried at the University of Chicago 
(eq 23). Compound 3Q was also prepared by the enantioselective reduction of the 
CFsCO^ , 30 (23) 
f-BuÔ OH AIBN 58% 
[a] =-65°inCHCl3 59% 
corresponding enone using the literature procedure^O (eq 24). The optical purity of 
compound 2Û has usually been determined using HPLC on a chiral phase after it was 
n-Bu3Sn,^^^%. CgHi ^ 3 (S)-BINAL-H ^ ^ (24) 
O -100 "t: to-78 T 58% 
converted to the corresponding diastereomeric ester20>21^ Because of the lack of appropriate 
equipment, the optical purity of alcohol 30 was not determined. The literature^O reports that 
stannane 30 was obtained in 98% ee by an enantioselective reduction with (S)-BINAL-H. 
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With the y-tri-n-butylstannyl allylic alcohol 30 at hand, the radical-promoted 
cyclization-trapping method was examined (eqs 25 and 26). When the racemic compound 22 
racemic^ + 4 2Û 
0.1 AIBN 
130 "C 
toluene 
10 h 
racemic 10 4 30 
0.1 AIBN 
130 T 
toluene 
16 h 
^COgEt COgEt 
was reacted with optically active 2D in the presence of AIBN at 110 ^C, TLC analysis 
showed that the starting material 22. was almost unchanged after 4 h stirring. Therefore, the 
reaction temperature was raised to 130 ®C. Pleasantly, products 22 and 22 were obtained as 
separable diastereomers (eq 25). Subjection of racemic IQ to the reaction conditions shown 
in equation 26 led to the desired product 22 along with its diasteieomerSl in 41% yield. The 
compounds 2% and 21 are cleanly separable by flash chromatography. 
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Many examples have been reported of the radical addition to 7C-systems, followed by 
P-scission of trialkylstannyl radicals. Most of the reactions have focused on activated 
staimanes, such as allylic compounds^ ,^ propargylic compounds^  ^and a,P-unsaturated 
compounds6b,24 jg interesting to note that few examples have been reported on simple 
vinylic stannanes, such as compound 30. 
The hydrolysis of compounds 27 and 31 with aqueous NaOH led to optically active 
carboxylic acids 2. and 34 (eqs 27 and 28). 
22 
31 
3NNaOH/TfiF/rt 
4d 
3NNaOH/THF/rt 
4d 
COgH 
HO 1 ^ OH 
72% 
COgH 
HO  ^ 34 5h 
74% 
2 7 )  
(28 )  
Considering that the previous synthesis of the PGI2 analogue 2. outlined in equation 
29 required 23 steps '^^ , the synthetic sequence developed here is quite efficient. 
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Br 
ô 
Br 
HO2Q 
lacemate 
HO2Q 
resolution 
(29) 
In our continuing effort to synthesize prostaglandins, it was desirable to synthesize 
12-epi-benzoprostacyclin 2 using a palladium-promoted cyclization, followed by enone 
trapping, a proctocol developed in Chapter I of this dissertation (eq 30). It has previously 
CO2H 
10 
cat Pd(0) 
l-octen-3-one 
COgEt 
(30) 
11 
been reported^»  ^that aryl haUdes have been added to alkenes in an inter- or intramolecular 
process under the influence of a catalytic amount of a Pd(0) species. 
As a model study, compounds and 2S were subjected to similar reaction 
conditions '^^  in the presence of an organopalladium trapping reagent such as l-octen-3-one, 
1-heptene or ethyl vinyl ketone (eqs 31-33). To our disappointment, none of the desired 
product was obtained from any of the reactions after examination of various reaction 
conditions. The intennolecular Heck-type product or 22 was obtained along with the 
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<^9 
O' 
5 l-octen-3-one 
5%Pd(OA0), ^ (31) 
2.5 KOAc 
TBDMSO^j (R = TBDMSorH) 
42% 
5 1-heptene 
5%Pd(OAc)2 Q-"^  ^
01 KOAc / I + 3 spots ( 32 ) •' 1.1 M-Bu^NCl 
TBDMSd DMF, 80 'C, 3 d 22 
M 30% 
10 ethyl vinyl ketone  ^
5% Pd(0Ac)2 Ô ,-9  ^
2.5 KOAc >Kj + 3 spots (33) 
r 1.1 n-Bu^Cl \J 
O38 DMF,rt,3d ^ 29 
 ^ 14% 
starting enone, while the eliminated product 37 was obtained as a major product with the less 
reactive olefin 1-heptene (eq 32). 
It was envisioned that a change of steric or electronic environment around the phenyl 
ring might provide a better result. Indeed, it is reasonable to assume that introduction of a 
bulky group at C-6 in place of a hydrogen in compound 40 will favor rotamer 40a over 40b. 
To induce the desired cyclization, it is required that rotamer 40a be formed. Furthermore, the 
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HC? 
40a 
final product 2 we are attempting to prepare has an alkyl group at C6. Thus, we decided to 
examine the reaction with substrates which have alkyl functionality at the C-6 position. 
Upon subjection of compound 22 to the reaction conditions shown in equation 31, it 
was found that compound 22l is much more reactive than compound 35. The starting material 
spot upon TLC analysis disappeared within 5 h, while 2 days were needed to complete the 
reaction of compound 35. Upon reaction, five spots showed up on TLC analysis. One of 
them was identified to be cis-4-acetoxy-2-cyclopenten-l-ol which is probably formed by the 
nucleophilic attack of acetate on a Tt-allylpalladium complex (eq 34). Therefore, the organic 
5 ethyl vinyl ketone 
5%Pd(OAc)2 
22 *-
— 2.5 KOAc 
1.1 m-Bu^Cl 
DMF, 80't, 5 h 
AcO 
+ 4 spots (34) 
Hcf 
10% 
base Et3N was tried in order to eliminate this side-product Surprisingly, the desired product 
41 was obtained as a major product, along with the cleavage product An examination of 
the reaction temperature revealed the optimum temperature is around 50 (eq 35). For 
construction of the prostaglandin framework, compound 10 was subjected to this 
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22 
O 
Et 5%Pd(OAc)2 
2.5 EtsN 
1.1 n-Bu4NQ 
DMF 
80 1 h 
50 6 h 
(35) 
intramolecular addition, followed by cross-coupling with l-octen-3-one. The reaction 
conditions examined are presented in Table 1. 
Table 1. The synthesis of compound 12 
5% Pd(OAc)2 
02 4. X •<-2^base 1-2 
O DMF.T-C .C,H 
HO 
COgEt 
" s 12 
% IsolatedYield 
Entry x Base T^C Time (h) 12 10 
1 5 Et3N 50 9 21 
2 40 18 21 
3 KOAc 50 24 0 
4 Na2C03 12 24 
5 K2CO3 12 <5 
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Table 1. Continued 
Entry X Base Toc Time (h) 
% Isolated Yield 
12 10 
6 i-Pr2NEt 9 34 -
7 10 12 42 -
8 2,6-di-r-butylpyridine 36 0 70 
9 PhsN 65 30 0 68 
10 proton sponge 50 24 0 61 
11 10 dicyclohexylethylamine 53 12 42 15 
12 15 z-Pr2NEt 42 22 39 -
13 20 50 30 41 -
14a 10 70 19 25 -
15b 100 24 0 59 
16C 65 48 17 -
17d 60 16 29 -
18 1.5 z-Pr2NEt 48 12 38 -
19 3.5 /-Pr2NEt 55 36 30 _ 
^The reaction was conducted using DMSO as the solvent, instead of DMF. 
^The reaction was conducted using CH3CN as the solvent, in place of DMF. 
^The reaction was conducted with 5% ofPPhg as an additive. 
^The reaction was conducted with 5% of Pd(dba)2, instead of Pd(OAc)2. 
79 
The best result was obtained by using a hindered organic base, such as 
diisopropylethylamine (entry 7) or dicyclohexylethylamine (entry 11). In entry 11, the 
product 12 was obtained in 42% yield, along with the recovery of starting material 10 in 15% 
yield. A longer reaction time resulted in a decrease in the yield of product for some reason. 
The temperature dependence was examined in entries 1 and 2. With tdethylamine as 
the base, no difference was observed in the yield of the product. 
The variations of base are presented in entries 2 to 11. Hindered aliphatic amines 
seem to be a better choice in this reaction. It is noteworthy that the aromatic amines in entries 
8,9 and 10 gave no reaction. The starting material upon examination by TLC analysis was 
left unchanged. 
In entries 12 and 13, along with entry 7, the optimum number of equivalents of 1-
octen-3-one was examined. The use of 15 or 20 equivalents of l-octen-3-one, in place of 10 
equivalents, didn't increase the product yield significantly. 
The solvent effect was checked in entries 14 and 15. With DMSO as the solvent, the 
reaction was very slow. Actually, the reaction temperature had to be raised up to 70 to get 
a reasonable rate of reaction. With Œ3CN as the solvent, no reaction occurred even though 
the reaction temperature was raised to 100 ®C. 
A reaction with 5% PPhg was conducted (entry 16). Both the reaction rate and 
product yield decreased. In entry 17, a reaction was examined in which 5% Pd(dba)2 
replaced 5% Pd(OAc)2. This resulted in a decrease in product yield, as well as the reaction 
rate. The optimum amount of z-Pr2NEt was examined in entries 18 and 19. With 1.5 
equivalents of base, instead of 2.5 equivalents, a comparable result was obtained. Increasing 
the amount of /-Pr2NEt to 3.5 equivalents, however, provided a slight decrease in reaction 
rate and yield of product 
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As previously described, the major side-product was compound 45. Compound 45 is 
presumably formed via Pd(0)-promoted generation of phenoxide followed by enone 
cross-coupling (eq 36). Compound IQ seems to be very susceptible to Pd(0) attack to 
generate intermediates 4  ^and 44, which is undoubtedly the major reason we obtain a low 
yield of the product 12 in this reaction. 
•COpEt COoEt 
"0 HO 
l-octen-3-one Pd(0) 10 (36) 
.+ 
Pd 
45 
Oxidation of the hydroxy group in compound 10 by Pd(II) in this reaction might be 
responsible for the lower yield of product 12. Therefore, the silyl-protected compound 46 
was subjected to the optimum reaction conditions (eq 37). The result was no different from 
^^^COgEt yx^COgEt 
TBDMSa 
10 . , 
mndazole 
OTBDMS 
46 
70% 
10 l-octen-3-one 
5%Pd(OAc)2 
2.5 f-Pr^NEt 
2.0 n-Bu^Cl 
DMF,50't 
(37) 
CcH. 
OTBDMS  ^
47 
20% 
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the reaction with the free hydroxy substrate 10. The desired product 47 was obtained in only 
a 20% yield. 
A reaction mechanism for the formation of the desired product 12 is proposed in 
Scheme IV. Aryl iodide 10 is oxidatively added to palladium(0) to generate organopalladium 
Scheme IV. 
m 
Pd(0) 
COgEt 
O 
HO  ^
Pdl 
COgEt 
COgEt 
HO 49 
l-octen-3-one J.  ^
^ \ ^ 
O 
-HI 
- Pd(0) 
12 
HO 
intermediate 4&, which undergoes cyclization, followed by coupling with l-octen-3-one, to 
produce the product 12 in a sin^e synthetic step. 
The next step in the synthesis of compound 7 required the stereoselective reduction of 
the enone (co-side chain) in compound 12. The diastereoselective reduction was conducted 
using Noyori's (S)-BINAL-h15 (eq 38). The reaction was quite clean; only two spots were 
observed upon TLC analysis with a big difference in polarity (Rf = 0.25 for compound 5Û, 
0.48 for compound 51 in 1:2 hexane/EtOAc). The more polar component was tentatively 
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12 
3 (S)-BINAL-H 
-100to-78'C 
COgEt COgEt 
50 OH 51 
50% 
1 : 1  
assigned as the desired 15-(S) isomer. It is generally recognized^S that the more polar 
isomer has the 15-(S) configuration in prostaglandins. Comparison of the NMR spectra of 
the final products 1 and 7, which will be described later, also supports this assignment. 
While BINAL-H has been reported to reduce a,P-unsaturated ketones with very high 
diastereoselectivity (usually >80% ee)^5,16  ^no selectivity was observed in this reaction. As 
previously described in the reduction of compound H, 7C-electrons present in the phenyl ring 
might be responsible for the poor selectivity. 
The reaction mechanism in Scheme IV suggests that the use of optically pure tri-n-
butylstannyl allylic alcohol 30 might lead to optically active diol 50 directly fiwm compound 
10 (eq 39). Cross-coupling reactions between organopalladium and organotin reagents have 
10 Pd(0) 
COgEt 
^Bu? 
22 OH 
COgEt 
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been well studied^ô. Thus, the racemic compound 10 was subjected to palladium-assisted 
cyclization in the presence of the vinylic tin compound 2Q (eq 40). The desired product 50 
COgEt 
5%Pd(OAc)2 
2.5 z-Pr2NEt 
racemic 10 + 1.5 ^—-—  ^
1.2 M-Bu^Na 
DMF, rt, 12 h 
COgEt 
H O  ^ Ô H  
(40) 
30% 
1 : 1  
along with its diastereomer 52 were obtained in 30% yield. Compound 52 is separable from 
compound 5Q by flash chromatography. like in the reaction in equation 36, compound 53 
was obtained as a major side-product When the reaction was conducted with LiCl as an 
EtOgC 
additive or with Na2C03 as a base, it gave the same results as in equation 40. Upon adding 
5% PPhg, the yield of the desired product was reduced and the amount of compound 53 
increased. It is noteworthy that the reaction is much faster with compound 3Q, than with 1-
octen-3-one, as a trapping reagent While more than 12 h was needed at 50 to complete 
the reaction with l-octen-3-one (Table 1), it took only 1 h at 50 for completion of ±e 
reaction with organotin reagent 30. 
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The final products 7 and 54 were obtained upon hydrolysis of racemic compounds 50 
and 51 (eqs 41 and 42). 
50 
51 
SNNaOH 
THF,6d 
SNNaOH 
THF,6d 
COgH 
HO 2 Sh 
83% 
COgH 
54 OH 
92% 
(41) 
(42) 
As described earlier, the stereochemistiy of C-15 was assigned based on the polarity 
of the compounds 7 and 54. The NMR spectral data for compounds 3,7,29 and 54 are 
shown in Scheme V. The chemical shifts of H13, H14 and H15 in 15-(S) isomers 3 and 7 
consistently appear at higher field than those in 15-(R) isomers 29 and 54. 
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Scheme V. 
COgH 
(^-29) H 0'-<^_/-H(6.71) 
(4. 17) 
2. 
(more polar) 
7^H(3.85) 
(4.18) HV^VN^N/N/ 
HO JiTOH 
(5.61) (4 03) 
(more polar) 
H (6.73) 
(less polar) 
o!Q-H(6.72) 
<""'"^«(3.87) 
(4.17) 
HO  ^,f*OH 
(4 10) 
M 
(less polar) 
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CONCLUSION 
An efficient synthesis of PGI2 analogue 3 which is known to have potent inhibitory 
activity for platelet aggregation has been accomplished. Compound 10 was prepared from 
cyclopentadiene monoepoxide (8) and the functionalized phenol 9 employing Pd(0) 
chemistry. The desired cyclization and subsequent enone trapping of compound 10 was 
effected in one step by radical chemistry to give compound H which can be readily converted 
to prostaglandin 3. 
Even more efficiently, the use of optically active y-stannyl allylic alcohol 30 as a 
trapping reagent directly led to optically active 27 which was converted to compound 3 upon 
hydrolysis. 
The q)imer 7 and its diastereomer 54 were also synthesized via one-step Pd(0)-
mediated cyclization and subsequent enone coupling to give intermediate 12 which has been 
carried on to prostanoids 7 and 54. Employment of optically active organotin reagent 30 
provided an even more direct synthetic pathway to optically active prostaglandin 7. 
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EXPERIMENTAL SECTION 
Eqmpment 
NMR spectra were recorded on a Nicolet NT-300 spectrometer ( NMR, 300 
MHz; 13(2 nmR, 75 MHz), and chemical shifts are reported in ppm relative to TMS (Ô 0.00) 
as an internal standard. IR spectra were obtained on an IBM IR 98. High-resolution mass 
spectra were recorded on a Kratos MS-50 spectrometer. 
Reagents 
All chemicals were used directly as obtained commercially unless otherwise noted. 
Tetrahydrofuran was distilled over sodium benzophenone ketal and used immediately. 
Methanol was distilled over sodium methoxide and stored over 4Â molecular sieves. 
Methylene chloride was distilled over phosphorous pentoxide and stored over 4Â molecular 
sieves. Ethanol was distilled azeotropically by adding a small amount of benzene and stored 
over 4Â molecular sieves. Toluene was distilled over sodium hydride. Hexane was distilled 
over sodium hydride. DMF was distilled over sodium hydride and stored over 4Â molecular 
sieves. 
Preparation of ('+V5.6.7-trinor-4.8-inter-m-phenylene PGI? (3  ^
To a solution of compound 27 (40 mg, 0.10 mmol) in 1.2 ml of THF was added 0.6 
ml of 3N aqueous NaOH. After the reaction mixture was stirred for 4 d at room temperature, 
it was neutralized with 2N aqueous HCl. The organic phase was decanted with ethyl acetate 
(3x5 ml), then dried over MgS04 and concentrated in vacuo. Flash chromatography with 
20:1 EtOAc/MeOH gave the tide product: 27 mg, 72% yield; Rf =0.21 (20:1 EtOAc/MeOH); 
1h NMR (CDa3) 8 6.91-6.87 (m, 2H, Ar), 6.70 (t, J = 7.5 Hz, IH, Ar), 5.59 (m, 2H, 
HC=CH), 5.29 (t, J = 6.9 Hz, IH, CHOAr), 4.95 (br s, 2H, OH's), 4.17 (m, IH, ŒOH), 
4.03-3.99 (m, IH, C=CH-CHOH), 3.84 (t, J = 8.7 Hz, IH, CHAr), 2.75-2.64 (m, 2H), 
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2.57-2.48 (m, IH), 2.34 (d, J = 15.3 Hz, IH, CH2 in cyclopentane), 2.25 (t, J = 6.6 Hz, 
2H), 2.16-1.99 (m, 2H), 1.88-1.76 (m, IH), 1.48 (m, 3H), 1.31 (m, 6H, Œ2's), 0.91 (t, 
J = 6.9 Hz, 3H, CH3). This compound has ^H NMR spectral data very close to those 
reported in the literature^C; 13c NMR (CDCI3) 5 178.14,158.02,136.25,128.87,128.38, 
127.64, 123.94, 122.75, 119.86, 88.30, 77.00, 73.03, 52.10, 49.87, 41.92, 36.89, 32.89, 
31.80, 28.79, 25.24, 24.79, 22.72, 14.14; IR (neat) 3510 (OH), 2935,1703 (C=0) cm'l; 
HRMS m/z calculated for C23H32O5 388.22497, found 388.22530. Anal. Calcd for 
C23H32O5: C, 71.11; H, 8.30. Found: C, 69.21; H, 8.43. The poor elemental analysis is 
possibly due to insufficient drying of compound 1. 
Preparation of 12-epi-5.6.7-trinor-4.8-inter-m-phenvlene PGI? (7)  
To a solution of compound JO (22 mg, 0.06 mmol) in 0.74 ml of THF was added 3N 
aqueous NaOH (0.37 ml) at room temperature. After the mixture was stirred for 6 d at room 
temperature, it was neutralized by 2N aqueous HQ. The organic phase was decanted with 
EtOAc, and then dried over MgS04 Concentration, followed by flash chromatography with 
20:1 EtOAc/MeOH, gave product 7:17 mg, 83% yield; Rf=0.29 (20:1 EtOAc/MeOH); ^H 
NMR (CDCI3) 5 6.90 (d, J = 7.5 Hz, IH, Ar), 6.89 (d, J = 7.5 Hz, IH, Ar), 6.72 (t, J = 
7.5 Hz, IH, Ar), 5.61 (m, 2H, HC=CH), 5.31 (dd, J = 0.9 and 7.8 Hz, IH, CHOAr), 4.30 
(br, 2H, OH's), 4.18 (m, IH, ŒOH), 4.03 (m, IH, C=CCHOH), 3.85 (t, J = 9.0 Hz, 
IH, CHAr), 2.75-2.65 (m, 2H), 2.53 (m, IH), 2.36 (d, J = 15.0 Hz, IH, CH2 in 
cyclopentane), 2.26 (m, 2H), 2.17-2.01 (m, 2H), 1.81 (m, IH), 1.53 (m, 3H), 1.32 (m, 
6H), 0.91 (t, J = 6.9 Hz, 3H, CH3); NMR (CDCI3) S 177.93, 157.99, 136.35, 
128.91, 128.29, 127.65, 123.97, 122.80, 119.98, 88.37, 77.00, 73.04, 52.18, 49.95, 
42.02, 36.96, 32.89, 31.83, 28.83, 25.28, 24.85, 22.73, 14.12; IR (neat) 3383 (OH), 
2928,1709 (C=0), 1595,1454 cm'l; HRMS m/z calculated for C23H32O5 388.22497, 
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found 388.22406. Anal. Calcd for C23H32O5: C, 71.11; H, 8.30. Found: C, 70.75; H, 
8.92. 
Preparation of cvclopentadiene monoepoxide (8")^  ^
To an ice-cold, mechanically stirred mixture of 35 ml (0.47 mol) of 6eshly cracked 
cyclopentadiene and 203 g of powdered, anhydrous sodium carbonate in 520 ml of Œ2CI2 
was added drop wise over 1.5 h 100 ml (0.47 mol) of 32% peracetic acid which has been 
pretreated with 2 g of sodium acetate. The mixture was stirred at room temperature until a 
negative test was obtained with moist starch-iodine paper. The solid salts were removed by 
suction filtration and washed with CH2C12' The solvent was removed from the filtrate by 
distillation through a Vigreux column. Then distillation continued under partial vacuum 
pressure (bath temperature, 50 °C, 15 mm Hg) to give a mixture of the product and CH2CI2, 
and the vacuum was increased to 4.5 mm Hg to give the product £. The mixture (product 8 
plus CH2CI2) was redistilled under atmo^heric pressure and then with partial vacuum 
pressure (15 mm Hg). The combined yield was 15 g (38% yield): ^ H NMR (CDCI3) 5 6.12 
(m, IH, HC=C), 5.96 (dt, J = 5.7 and 2.1 Hz, IH, C=CH), 3.89 (dd, J = 5.4 and 3.0 Hz, 
IH, CHOR), 3.78 (m, IH, ŒOR), 2.61 (ddd, J = 19.2 and 3.9 and 1.8 Hz, IH, CH2), 
2.37 (ddt, J = 19.2 and 3.6 and 1.8 Hz, IH, CH2). 
Preparation of compound 9 
To a solution of compound 19 (2.85 g, 6.2 mmol) in 60 ml of THF at -78 OC was 
added /z-Bu4NF (Aldrich, 1.0 M in TEIF, 6.2 ml, 6.2 mmol). The reaction mixture was 
stilted for 1 h at -78 ^ C, then allowed to warm to 0 ®C, and quenched by adding H2O (10 
ml). The mixture was poured into 50 ml of EtOAc, washed with H2O (25 ml) and brine (20 
ml). The organic phase was dried and concentrated. The residue was purified by flash 
chromatography with 4:1 hexane/EtOAc to give the title compound; 2.02 g, 94% yield; Rf= 
0.37 (5:1 hexane/EtOAc); ^H NMR (CDCI3) 5 7.53 (dd, J = 7.8 and 1.2 Hz, IH, Ar), 7.05 
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(dd, J = 7.8 and 1.2 Hz, IH, Ar), 6.58 (t, J = 7.8 Hz, IH, Ar), 6.18 (s, IH, OH), 4.15 (q, 
J = 7.2 Hz, 2H, CH2), 2.69 (t, J = 7.2 Hz, 2H, CH2), 2.36 (t, J = 7.2 Hz, 2H, CH2), 1.91 
(m, 2H, CH2), 1.27 (t, J = 7.2 Hz, 3H, CHg); NMR (CDC13) Ô 174.15,152.96, 
136.44, 130.64, 128.05, 122.06, 86.28, 60.59, 33.28, 30.54, 24.68, 14.24; IR (neat) 
3373 (OH), 2980,2957,1707 (C=0), 1445 cm"!. HRMS m/z calculated for C12H15O3I 
334.00660, found 334.00617. 
Preparation of compound 10 
To a dried flask was added Pd(PPh3)4 (18 mg, 0.016 mmol). To this was added 
compound 2 (264 mg, 0.79 mmol) in 2 ml of TEIF, and the reaction mixture was stirred in an 
ice-water bath. Cyclopentadiene monoepoxide (97 mg, 1.18 mmol) in 2 ml of THF was 
added dropwise at 0 ^ C, and stirring was continued for 20 min at this temperature and 
another 24 h at room teniperature. The reaction mixture was concentrated. The residue was 
purified by flash chromatography with 2:1 hexane/EtOAc to give product 10:235 mg, 71% 
yield; Rf = 0.27 (2:1 hexane/EtOAc); ^H NMR (CDQs) 8 7.58 (dd, J = 7.8 and 1.5 Hz, 
IH, Ar), 7.15 (dd, J = 7.8 and 1.5 Hz, IH, Ar), 6.77 (t, J = 7.8 Hz, IH, Ar), 6.09 (m, IH, 
HC=C), 6.01 (m, IH, HC=C), 5.11 (m, IH, CHOAr), 4.68 (m, IH, ŒOH), 4.12 (q, J = 
7.2 Hz, 2H, OCH2), 2.85 (m, 2H), 2.60 (ddd, J = 15.3 and 9.6 and 6.0 Hz, IH, CH2 in 
cyclopentane), 2.30 (dt, J = 1.8 and 6.9 Hz, 2H), 2.06 (dt, J = 14.7 and 3.9 Hz, IH, CH2 
in cyclopentane), 1.88 (m, 2H), 1.25 (t, J = 6.3 Hz, 3H, CH3), 0.88 (m, IH, OH); 
NMR (CDCI3) S 173.69, 156.22, 138.09, 137.98, 136.65, 133.55, 130.56, 125.87, 
92.45, 85.71, 74.97, 60.52, 41.28, 33.50, 30.86, 25.47, 14.28; IR (neat) 3350 (OH), 
2959,1720 (C=0), 1599,1462,1352 cm'^ ; HRMS m/z calculated for C17H21O4I 
416.04847, found 416.04747. 
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Preparation of compound 11 
To a solution of compound 10 (70 mg, 0.17 mmol) in 1.7 ml of toluene were added 
compound 24 (279 mg, 0.67 mmol) and AIBN (Aldrich, 2.8 mg, 0.017 mmol). The 
resulting mixture was placed into an oil bath preheated to 90 and stirred for 12 h. After 
cooling to room temperature, the mixture was purified by flash chromatography with 1:1 
hexane/EtOAc to give product H as a yellow oil: 65 mg, 80% yield; Rf = 0.32 (1:1 
hexane/EtOAc); NMR (CDCI3) 5 6.93 (d, J = 7.5 m, IH, Ar), 6.86 (d, J = 7.5 Hz, IH, 
Ar), 6.84 (dd, J = 16.2 and 9.6 Hz, IH, HC=C), 6.73 (t, J = 7.5 Hz, IH, Ar), 6.19 (d, J = 
16.2 Hz, IH, C=CH), 5.38 (dd, J = 7.5 and 6.3 Hz, IH, CHOAr), 4.28 (m, IH, CHOH), 
4.09 (m, 2H, OCH2), 3.98 (t, J = 8.7 Hz, IH), 2.86 (dt, J = 3.9 and 9.6 Hz, IH), 2.66-
2.43 (m, 4H), 2.25 (m, 2H), 2.17 (ddd, J = 15.3 and 6.4 and 4.1 Hz, IH), 2.09 (d, J = 5.7 
Hz, IH), 2.02 (m, IH), 1.86 (m, IH), 1.59 (m, 3H), 1.41-1.22 (m, 7H), 0.88 (t, J = 6.9 
Hz, 3H, CH3); 13c NMR (CDCI3) 8 200.99,173.84, 157.67, 144.28, 132.82, 129.09, 
127.05, 123.65, 123.23, 120.11, 88.58, 76.77, 60.30, 52.65, 50.70, 43.03, 38.93, 33.38, 
31.48, 28.93, 24.84,24.02, 22.48, 14.30, 14.00; IR (neat) 3466 (OH), 2930,1666 (C=0), 
1372,1456 cm"l; HRMS m/z calculated for C25H34O5 414.24062, found 414.24080. 
Preparation of compound 12 
In a vial were placed compound IQ (94 mg, 0.23 mmol), l-octen-3-one (285 mg, 2.3 
mmol), /1-BU4NCI (Lancaster, 70 mg, 0.25 mmol), i-Pr2NEt (98 |il, 0.58 mmol), Pd(OAc)2 
(2.5 mg, 0.011 mmol) and DMF (0.46 ml). After the reaction was stirred for 12 h at 50 ^ C, 
it was poured into 40 ml of EtOAc. The mixture was washed with saturated NH4CI (15 ml) 
and then the aqueous phase was back-extracted with EtOAc (15 ml). The overall organic 
phase was washed with brine (15 ml), and then dried over MgS04 and concentrated under 
reduced pressure. The residue was purified by flash chromatography to give product 12:37 
mg, 42% yield; Rf = 0.44 (1:1 hexane/EtOAc); ^H NMR (CDCI3) 8 6.94 (d, J = 7.5 Hz, 
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IH, AT), 6.88 (d, J = 7.5 Hz, IH, Ar), 6.85 (dd, J = 15.9 and 9.9 Hz, IH, C=CH), 6.75 (t, 
J = 7.5 Hz, IH, Ar), 6.21 (d, J = 15.9 Hz, IH, HC=C), 5.39 (dd, J = 8.1 and 6.0 Hz, IH, 
CHOAT), 4.30 (m, IH, CHOH), 4.12 (m, 2H), 3.99 (t, J = 8.4 Hz, IH), 2.85 (dt, J = 3.9 
and 9.6 Hz, IH), 2.55 (m, 4H), 2.26 (m, 2H), 2.18 (ddd, J = 15.3 and 6.0 and 4.5 Hz, 
IH, CH2 in cyclopentane), 2.02 (m, 2H), 1.88 (m, IH), 1.63 (m, 2H), 1.28 (m, 7H, 
CH2's and OCH2Œ3), 0.89 (t, J = 6.9 Hz, 3H, CH3); NMR (CDCI3) 5 200.94, 
173.79, 157.68, 144.27, 132.17, 129.05, 127.05, 123.61, 123.20, 120.06, 88.92, 76.69, 
60.26, 52.63, 50.69, 43.01, 38.94, 33.36, 31.46, 28.94, 24.81, 24.00, 22.42, 14.22, 
13.90; IR (neat) 3464 (OH), 2932,1732 (C=0), 1688 (C=0), 1465 cm-1; HRMS m/z 
calculated for C25H34O5 414.24063, found 414.24118. 
Preparation of compound 14 
A solution of o-iodophenol (6.6 g, 30 mmol), aïïyl bromide (4.0 g, 33 mmol) and 
potassium carbonate (4.6 g, 33 mmol) in 7.5 ml of acetone was refluxed for 8 h. The 
reaction mixture was diluted with 40 ml of H2O, and extracted with e±er (2x25 ml). The 
organic phase was washed with brine (25 ml), and then dried over MgS04. Concentration, 
followed by flash chromatography, gave confound 14 as a colorless oil: 6.8 g, 94% yield; 
1h NMR (CDCI3) 6 7.77 (dd, J = 7.8 and 1.5 Hz, IH, Ar), 7.27 (dt, J = 1.8 and 7.8 Hz, 
IH, AT), 6.80 (dd, J = 7.8 and 1.2 Hz, IH, Ar), 6.70 (dt, J = 7.8 and 1.2 Hz, IH, Ar), 
6.06 (ddt, J = 17.4 and 10.5 and 7.8 Hz, IH, HC=C), 5.52 (dd, J = 17.4 and 1.8 Hz, IH, 
HC=C), 5.31 (dd, J = 10.5 and 1.2 Hz, IH, HC=C), 4.59 (dt, J = 4.8 and 1.5 Hz, 2H, 
CH2); 13C NMR (CDCI3) 5 157.09, 139.51, 132.57,129.35, 122.66, 117.59, 112.58, 
86.72,69.68; IR (neat) 1582,1477 cm'l. 
Preparation of 6-allvl-2-iodophenol (15) 
To a solution of compound 14 (7.0 g, 27 mmol) in 130 ml of hexane was added 
MeAlCl2 (Aldrich, 1.0 M in hexane, 22 ml, 22 mmol) dropwise at -20 ®C. After the reaction 
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was stirred for 2 h at -20 ®C under N2, it was quenched by adding H2O (40 ml) and slowly 
warmed to room temperature with swirling. EtOAc (30 ml) was added to the reaction 
mixture; then stirring was continued for 5 min. After separating phases, the organic phase 
was washed with H2O (30 ml) and brine (30 ml), then dried and concentrated. The residue 
was purified by flash chromatography with 15:1 hexane/EtOAc to give product 15:4.9 g, 
70% yield; Rf = 0.38 (20:1 hexane/EtOAc); % NMR (CDCI3) 6 7.51 (dd, J = 1.2 and 7.8 
Hz, IH. Ar), 7.07 (d, J = 7.8 Hz, IH, Ar), 6.62 (t, J = 7.8 Hz, IH, Ar), 5.98 (ddt, J = 
17.4 and 9.6 and 6.6 Hz, IH, HC=C), 5.37 (s, IH, OH), 5.12 (m, IH, HC=C), 5.07 (m, 
IH, HC=C), 3.43 (d, J = 6.6 Hz, 2H, Œ2); NMR (CDCI3) 5 152.60,136.33, 
136.01, 130.73,126.81, 122.42, 116.22, 86.41, 35.56; IR (neat) 3487 (OH), 1593, 1234 
cm-1; LRMS m/z (relative intensity) 51.1 (34), 77.1 (47), 105.1 (58), 118.1 (41), 133.1 
(42), 260.0 (M+, 100). 
Preparation of compound 16 
To a solution of compound 15 (4.9 g, 18.7 mmol) and imidazole (3.2 g, 47.1 mmol) 
in 20 ml of DMF was added r-butyldimethylsilyl chloride (3.1 g, 20.5 mmol) dissolved in 15 
ml of DMF at room temperature under N2. After the mixture was stirred for 12 h at room 
temperature, it was extracted with hexane (50 ml x 8). The hexane phase was concentrated 
and then flash chromatographed to give compound 16:6.3 g, 90% yield; Rf = 0.52 (hexane); 
1h NMR (CDCI3) S 7.63 (dd, J = 7.8 and 1.8 Hz, IH, Ar), 7.11 (dd, J = 7.8 and 1.8 Hz, 
IH, Ar), 6.66 (t, J = 7.8 Hz, IH, Ar), 5.86 (ddt, J = 17.4 and 9.6 and 6.6 Hz, IH, 
C=CHCH2), 5.08 (m, 2H, H2C=C), 3.39 (d, J = 6.9 Hz, 2H, Œ2), 1.06 (s, 9H, f-BuSi), 
0.331 (s, 6H, SiMe2). 
Preparation of compound 17 
Ozone was passed through a solution of compound 16 (722 mg, 1.9 mmol) in 19 ml 
of methanol at -78 until the deep blue color persisted (about 15 min). The reaction was 
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flushed with N2 gas and 8 ml of ŒI3SCH3 was added at -78 "C. The reaction mixture was 
then allowed to stir for 30 min at -78 ®C, for 1 h at 0 and for another 30 min at room 
temperature. The methanol solvent was evaporated under reduced pressure, and 60 ml of 
ether was then added to the residue. After the mixture was washed with water (10 ml) and 
brine (20 ml x 2), it was dried and concentrated. Flash chromatography gave product 17 : 
638 mg, 83% yield; Rf = 0.63 (3:1 hexane/EtOAc); NMR (CDCI3) 5 9.63 (t, J = 2.1 Hz, 
IH, CHO), 7.74 (dd, J = 8.1 and 1.5 Hz, IH, Ar), 7.09 (dd, J = 7.5 and 1.5 Hz, IH, Ar), 
6.72 (t, J = 7.5 Hz, IH, Ar), 3.68 (d, J = 2.1 Hz, 2H, Œ2), 1.05 (s, 9H, r-BuSi), 0.32 (s, 
6H, SiMe2); NMR (CDCI3) 8 199.34,153.92,139.70, 131.54, 124.26,123.81, 
91.23, 46.16, 26.37, 18.85, -1.52. 
Preparation of compound 18 
To a solution of (carbe±oxymethylene)triphenylphosphorane (Aldrich, 3.88 g, 11.5 
mmol) dissolved in 30 ml of CH2CI2 was added dropwise at room temperature aldehyde 17 
(3.57 g, 9.3 mmol) dissolved in 14 ml of CH2CI2. After the reaction was stirred for 12 h at 
room temperature, it was concentrated in vacuo and purified by flash chromatography with 
5:1 hexane/EtOAc to give ester 18: 3.52 g, 83% yield; Rf=0.46 (5:1 hexane/EtOAc); ^H 
NMR (CDCI3) S 7.67 (dd, J = 7.8 and 1.5 Hz, IH, Ar), 7.05 (dd, J = 7.5 and 1.5 Hz, IH, 
Ar), 6.99 (dt, J = 15.6 and 6.6 Hz, IH, HC=C), 6.66 (t, J = 7.5 Hz, IH, Ar), 5.80 (d, J = 
15.6 Hz, IH, HC=C), 4.18 (q, J = 7.2 Hz, 2H, OŒ2), 3.53 (dd, J = 6.9 and 1.5 Hz, 2H, 
CH2), 1.27 (t, J = 7.2 Hz, 3H, CH3), 1.05 (s, 9H, r-BuSi), 0.32 (s, 6H, Me2Si); 13c 
NMR (CDCI3) S 166.32, 153.31, 146.18, 138.75, 130.60, 129.52, 123.61, 122.93, 
91.09, 60.36, 33.94, 26.42, 18.94, 14.32, -1.49. 
Preparation of compound 19 
To a three neck flask equipped with a H2 gas balloon were added (x,P-unsaturated 
ester 18 (619 mg, 1.36 mmol), ethanol (20 ml), 2N aqueous HCl (0.4 ml) and Pt02 
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(Aldrich, 60 mg). The reaction was flushed with H2 gas using an aspirator, and then stirred 
for 1 h at room tençerature under the H2 balloon pressure. After the reaction was neutralized 
with 3N aqueous NaOH (0.27 ml), it was poured into 100 ml of ethyl acetate. The solution 
was washed with brine (50 ml, 25 ml) and concentrated in vacuo. The residue was purified 
by flash chromatography to give confound Ig: 562 mg, 90% yield; Rf = 0.52 (7:1 
hexane/EtOAc); NMR (CDCI3) 5 7.62 (dd, J = 7.8 and 1.5 Hz, IH, Ar), 7.10 (dd, J = 
7.8 and 1.5 Hz, IH, Ar), 6.64 (t, J = 7.8 Hz, IH, Ar), 4.11 (q, J = 7.2 Hz, 2H, OCH2), 
2.66 (t, J = 7.8 Hz, 2H, CH2), 2.27 (t, J = 7.5 Hz, 2H, CH2), 1.88 (m, 2H, CH2), 1.25 
(t, J = 7.2 Hz, 3H, CH3), 1.04 (s, 9H, f-BuSi), 0.32 (s, 6H, SiMe2). 
Preparation of compound 22 
A solution of cyclopentadiene monoepoxide (1.4 g, 17.1 mmol) in 20 ml of THF was 
added dropwise over 10 min to an ice-cooled solution of Pd(PPh3)4 (Johnson Matthey, Inc., 
173 mg, 0.15 mmol) and compound iâ (3.0 g, 11.5 mmol) in 20 ml of THF. After stirring 
for 30 min at 0 OQ the reaction was allowed to warm to room temperature, and stirring was 
continued for 24 h. After being filtered through a silica gel pad, the reaction mixture was 
concentrated in vacuo and flash chromatographed to give product 22l- 2.5 g, 64% yield; Rf= 
0.38 (2:1 hexane/EtOAc); ^H NMR (CDQs) 6 7.67 (dd, J = 1.2 and 7.8 Hz, IH, Ar), 7.18 
(dd, J = 1.2 and 7.8 Hz, IH, Ar), 6.80 (t, J = 7.8 Hz, IH, Ar), 6.11 (m, 2H, HC=CH), 
5.92 (ddt, J = 16.8 and 10.2 and 6.6 Hz, IH, C=QiCH2), 5.11 (m, 2H, H2C=C), 5.00 
(m, IH, CHOAr), 4.69 (m, IH, CHOH), 3.48 (t, J = 6.0 Hz, 2H, CH2Ar), 2.84 (dt, J = 
14.4 and 7.2 Hz, IH, CH2 in cyclopentane), 2.08 (dt, J = 14.1 and 4.2 Hz, IH, CH2 in 
cyclopentane), 1.89 (br s, IH, OH); 13c NMR (CDCI3) 5 156.22, 130.02,137.78,136.36, 
134.45, 133.96, 130.90, 125.79, 116.59, 92.83, 86.35, 74.84, 41.66, 35.06; IR (neat) 
3464 (OH), 1433,1360,1250 cm"l; HRMS m/z calculated for C14H15O21342.01168, 
found 342.01149. 
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Preparation of y-stannyl allylic alcohol 23^  ^
To a solution of l-octyn-3-ol (Aldrich, 5.0 g, 40 mmol) and AIBN (130 mg, 0.8 
mmol) under N2 atmosphere was added «-Bu3SnH (Aldrich, 16 ml, 60 mmol) by a syringe. 
The reaction mixture was heated at 80 ®C and stirred for 2 h, then cooled to room 
temperature. The reaction mixture was purified by flash chromatography to give compound 
23: 9.6 g, 58% yield; % NMR (€003) 8 6.12 (d, J = 19.2 Hz, IH, HC=C), 5.98 (dd, J = 
19.2 and 5.1 Hz, IH, C=CH), 4.06 (m, IH), 1.52 (m, 12H), 1.30 (m, 13H), 0.97 (m, 
3H), 0.89 (t, J = 7.2 Hz, 12H). 
Preparation of P-stannyl enone 24  ^
To a solution of alcohol 23 (7.2 g, 17 mmol) in 24 ml of CH2CI2 was added PDC 
(Aldrich, 9.7 g, 26 mmol) at room temperature. After being stirred for 8 h, the reaction 
mixture was filtered through Celite, and the flask was rinsed with ether (40 ml x 5). The 
filtrate was concentrated in vacuo and flash chromatographed with 15:1 hexane/EtOAc to give 
enone 24:4.1 g, 57% yield; Rf=0.48 (15:1 hexane/EtOAc); ^ H NMR (CDCI3) 5 7.55 (d, J 
= 19.8 Hz, IH, HC=C), 6.54 (d, J = 19.8 Hz, IH, C=CH), 2.58 (t, J = 7.5 Hz, 2H, CHi), 
1.61 (m, 2H, CH2), 1-54-1.42 (m, 6H), 1.31 (m, 12H), 0.97 (m, 4H), 0.89 (t, J = 7.2 Hz, 
12H). 
Preparation of compound 25 
In a 4 dram vial were placed compound ^  (106 mg, 0.31 mmol), P-stannyl enone 24 
(514 mg, 1.24 mmol) and 3.1 ml of toluene. To this was added AIBN (Aldrich, 5.1 mg, 
0.031 mmol), and then the reaction was stirred for 3 h at 110 ®C. After the reaction mixture 
was allowed to cool to room temperature, it was purified by flash chromatography to give 
product 25: 85 mg, 81% yield; Rf =0.37 (1:1 hexane/EtOAc); ^ H NMR (CDCI3) 5 6.97 (d, 
J = 7.5 Hz, IH, Ar), 6.89 (d, J = 7.5 Hz, IH, Ar), 6.81 (dd, J = 15.6 and 9.6 Hz, IH, 
HC=CHCO), 6.77 (t, J = 7.5 Hz, IH, Ar), 6.19 (d, J = 15.6 Hz, IH, C=CHCO), 6.03-
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5.90 (m, IH, HC=C), 5.41 (dd, J = 7.5 and 6.0 Hz, IH, ŒOAr), 5.06 (m, 2H, HC=CH), 
4.27 (m, m, ŒOH), 3.99 (t, J = 8.4 Hz, IH), 3.32 (d, J = 6.0 Hz, 2H, CH2Ar), 2.86 
(dt, J = 4.2 and 9.6 Hz, IH), 2.55-2.45 (m, 3H), 2.19 (dt, J = 15.3 and 4.8 Hz, IH), 1.74 
(br s, IH, OH), 1.64-1.57 (m, 2H), 1.42-1.25 (m, 4H), 0.89 (m, 3H). 
Compound 26 
1h NMR (CDCI3) 8 7.05 (d, J = 7.5 Hz, IH, Ar), 6.91 (d, J = 7.5 Hz, IH, Ar), 
6.76 (t, J = 7.5 Hz, IH, Ar), 5.75 (m, 2H, HC=CH), 5.45 (t, J = 7.5 Hz, IH, CHOAr), 
4.35 (d, J = 7.8 Hz, IH), 4.11 (q, J = 7.2 Hz, 2H, OŒ2), 2.88 (dd, J = 18.0 and 6.0 Hz, 
IH), 2.75 (d, J = 17.4 Hz, IH), 2.59 (dt, J = 3.3 and 7.5 Hz, 2H), 2.32 (t, J = 7.5 Hz, 
2H), 1.98-1.88 (m, 2H), 1.23 (t, J = 7.2 Hz, 3H, CH3). 
Preparation of compounds 27 and 28 
1). Procedure A (via reduction of compound 11)^  ^
To a solution of LiAlH4 (Aldrich, 0.91 ml, 1.0 M in THF, 0.91 mmol) was added 
ethanol (0.46 ml, 2.0 M in THF, 0.91 mmol) dropwise at room temperature. To this was 
added (S)-binaphthol (Aldrich, 258 mg, 0.91 mmol) in 1.5 ml of TEIF, and the resulting 
mixture was stirred for 30 min. Enone H (126 mg, 0.30 mmole) in 1.2 ml of THF was 
added dropwise over 3 min at -100 ®C. The resulting mixture was stirred for 2 h at -100 ^ C, 
and then another 2 h at -78 OQ Methanol (0.5 ml) was added at -78 to destroy the excess 
reducing agent and the mixture was allowed to warm to room temperature. After the addition 
of water (20 ml) and diethyl ether (25 ml), stirring was continued for 10 min. The solution 
was neutralized with 2N aqueous HCl, and then extracted with ether (3 x 30 ml). The 
organic phase was dried over MgS04 and concentrated in vacuo. The crude product was 
purified by flash chromatography using 1:2 hexane/EtOAc to give compound 27 (11 mg, 9% 
yield) and compound 2Â (52 mg, 41 % yield) as an oil. Starting material li (14 mg, 11% 
yield) was also recovered. Compound 27: Rf=0.17 (1:2 hexane/EtOAc); ^H NMR (CDCI3) 
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5 6.92 (d, J = 7.5 Hz, 2H, Ar), 6.73 (t, J = 7.5 Hz, IH, Ar), 5.69-5.67 (m, 2H, HC=CH), 
5.34 (t, J = 7.2 Hz, IH, CHOAr), 4.20 (m, IH, QiOH), 4.15-4.07 (m, 3H, OCH2 and 
C=CCHOH), 3.90 (t, J = 9.0 Hz, IH, CHAr), 2.79-2.71 (m, IH), 2.66-2.51 (m, 2H), 
2.38 (d, J = 15.0 Hz, IH, CH2 in cyclopentane), 2.27 (dt, J = 1.5 and 7.2 Hz, 2H), 2.15 
(dt, J = 15.0 and 5.4 Hz, IH, CH2 in cyclopentane), 2.04-1.81 (m, 2H), 1.63 (m, 4H), 
1.34 (m, 6H), 1.25 (t, J = 7.2 Hz, 3H, CH3), 0.92 (t, J = 6.0 Hz, 3H, CH3); l^C NMR 
(CDCI3) 8 173.92, 157.81, 136.39, 128.71, 128.19, 127.75, 123.90, 122.960,119.803, 
88.267, 76.920, 72.951, 60.315, 52.213, 49.981, 42.299, 36.982, 33.50, 31.80, 29.06, 
25.23, 24.87,22.69,14.24,13.62; IR (neat) 3396 (OH), 2930,1734 (C=0), 1458 cm'l; 
HRMS m/z calculated for C25H36O5 416.25627, found 416.25574. Compound 28: Rf = 
0.38 (1:2 hexane/EtOAc); ^H NMR (CDQs) 5 6.96 (d, J = 7.5 Hz, IH, Ar), 6.91 (d, J = 
7.5 Hz, IH, Ar), 6.73 (t, J = 7.5 Hz, IH, Ar), 5.69 (m, 2H, HC=CH), 5.32 (t, J = 7.5 Hz, 
IH, CHOAr), 4.14 (m, IH, QiOH), 4.07 (m, 3H), 3.88 (t, J = 9.3 Hz, IH), 2.74 (m, 
IH), 2.57 (m, 2H), 2.35 (d, J = 15.0 Hz, IH, CH2 in cyclopentane), 2.27 (m, 2H), 2.14 
(dt, J = 15.0 and 5.7 Hz, IH, CH2 in cyclopentane), 1.99 (m, IH), 1.91-1.81 (m, 3H), 
1.49 (m, 2H), 1.28 (m, 6H), 1.24 (t, J = 7.5 Hz, 3H, CH3), 0.88 (t, J = 6.6 Hz, 3H, 
CH3); 13c NMR (CDCI3) 5 173.84,157.72, 136.39,128.76, 127.79, 127.20, 124.04, 
123.02, 119.91, 88.27, 77.00, 72.64, 60.28, 52.44, 50.12, 42.59, 37.32, 33.55, 31.82, 
29.09, 25.21, 24.90, 22.66, 14.28, 14.10; IR (neat) 3443 (OH), 2987, 1732 (C=0), 1593, 
1456 cm"l; HRMS m/z calculated for C25H36O5 416.25627, found 416.25591. 
2). Procedure B (via direct conversion from compound IQ) 
In a vial were placed racemic compound 10 (100 mg, 0.24 mmol), optically active y-
stannyl allylic alcohol 30 (401 mg, 0.96 mmol), toluene (2.4 ml) and AIBN (Aldrich, 3.9 
mg, 0.024 mmol). The resulting mixture was cooled to room temperature, and purified by 
flash chromatography using 1:1 to 1:2 hexane/EtOAc to give optically active 27 (22 mg, 21% 
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yield) and 31 (19 mg, 20% yield); The spectral data of this compound is the same as its 
racemic mixture 28. 
Compound 29 
See preparation of confound M- The spectral data of this compound is the same as 
those of compound 34. 
Preparation of optically active 'y-tri-w-butvlstannvl allvlic alcohol 30  ^
To a solution of LiAlH4 (6.0 ml, IM in TEIF, 6.0 mmol) was added ethanol (3.0 ml, 
2M in THF, 6.0 mmol) dropwise at room temperature. To this was added (S)-binaphthol 
(Aldrich, 1.7 g, 6.0 mmol) in 5 ml of THF, and the resulting mixture was stirred for 30 min. 
The enone 24 (830 mg, 2.0 mmol) in 2 ml of THF was added dropwise at -100 °C. The 
reaction mixture was stiired for 2 h at -ICX) ®C, and then another 2 h at -78 OQ The reaction 
was quenched by adding 1 ml of methanol at -78 ®C. After the reaction was warmed to room 
temperature, water (2 ml) and ether (30 ml) were added. Anhydrous MgS04 was added to 
the reaction mixture, and stirring was continued for 30 min at room temperature. The 
solution was filtered through Celite by adding ethyl acetate. The filtrate was concentrated. 
Hexane was added to the residue to remove the binaphthol as a crystalline solid. The filtrate 
was concentrated and flash chromatographed to give conçound 20:677 mg, 82% yield. The 
optical purity of compound 30 was not determined [literature report (98% ee)]20. 
Compound 31 
See preparation of compounds TL and 2&. The spectral data of this compound is the 
same as its racemic mixture 28. 
Preparation of compounds 32 and 33 
In a vial were placed compound 22 (93 mg, 0.27 mmol), alcohol 30 (454 mg, 1.1 
mmol), AIBN (4.5 mg, 0.03 mmol) and 2.7 ml of toluene. The vial was placed in an oil bath 
preheated to 130 OC and the reaction mixture was stirred for 10 h. After the mixture was 
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cooled to room temperature, it was purified by flash column chromatography to give 
compounds 22 and 22- Compound 31:29 mg, 32% yield; Rf = 0.17 (1:1 hexane/EtOAc); 
NMR (CDCI3) 5 6.94 (d, J = 7.2 Hz, IH, Ar), 6.92 (d, J = 7.2 Hz, IH, Ar), 6.75 (t, J = 
7.2 Hz, IH, Ar), 5.94 (m, IH, H2C=CH), 5.68-5.54 (m, 2H, HC=QiCHOH), 5.34 (t, J 
= 6.9 Hz, IH, CHOAr), 5.05-4.99 (m, 2H, H2C=C), 4.15 (m, IH, CHOH), 4.03 (m, IH, 
C=CHCHOH), 3.86 (t, J = 8.7 Hz, IH), 3.31 (d, J = 6.3 Hz, 2H, CH2Ar), 2.76 (m, IH), 
2.36 (d, J = 15.3 Hz, IH, CH2 in cyclopentane), 2.15 (dt, J = 15.3 and 5.7 Hz, IH, CH2 
in cyclopentane), 1.87 (m, IH), 1.64-1.49 (m, 4H), 1.42-1.23 (m, 8 H), 0.90 (t, J = 6.9 
Hz, 3H, CH3). Compound 22- Rf = 0.37 (1:1 hexane/EtOAc): ^H NMR (CDCI3) 8 6.99 (d, 
J = 7.5 Hz, IH, Ar), 6.95 (d, J = 7.5 Hz, IH, Ar), 6.77 (t, J = 7.5 Hz, IH, Ar), 5.97 (m, 
IH, H2C=CH). 5.70 (m, 2H, HC=CHCHOH), 5.36 (t, J = 6.9 Hz, IH, CHOAr), 5.05-
4.99 (m, 2H, H2C=C), 4.16 (m, IH, (MOH), 4.10 (m, IH, C=CHC3iOH), 3.31 (d, J = 
6.3 Hz, 2H, CH2Ar), 2.77 (m, IH), 2.38 (d, J = 15.3 Hz, IH, CH2 in cyclopentane), 2.16 
(ddd, J = 15.3 and 6.0 and 4.8 Hz, IH, CH2 in cyclopentane), 1.72-1.48 (m, 4H), 1.42-
1.25 (m, 8 H), 0.89 (t, J = 6.9 Hz, 3H, CH3). 
Preparation of compound 34 
To a solution of compound 31 (37 mg, 0.09 mmol) in 1.2 ml of THF was added 0.6 
ml of 3N aqueous NaOH. After the reaction mixture was stirred for 4 d at room temperature, 
it was neutralized with 2N aqueous HQ. The organic phase was decanted with EtOAc (3x5 
ml), then dried over MgS04 and concentrated in vacuo. Flash chromatography with 20:1 
EtOAc/MeOH gave compound24:26 mg, 74% yield; Rf=0.29 (20:1 EtOAc/MeOH); ^H 
NMR (CDCI3) S 6.94 (d, J = 7.5 Hz, IH, Ar), 6.91 (d, J = 7.5 Hz, IH, Ar), 6.73 (t, J = 
7.5 Hz, IH, Ar), 5.71 (dd, J = 15.6 and 5.4 Hz, IH, HC=C), 5.64 (dd, J = 15.6 and 7.8 
Hz, IH, C=CH), 5.31 (m, IH, CHOAr), 4.80 (br s, 2H, OH's), 4.18 (m, IH, CMOH), 
4.10 (dd, J = 11.7 and 6.3 Hz, IH, C=CQiOH), 3.88 (t, J = 5.4 Hz, IH, CHAr), 2.77 (m, 
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IH), 2.67 (m, IH), 2.55 (m, IH), 2.35 (d, J = 15.0 Hz, IH, CH2 in cyclopentane), 2.29 
(dt, J = 3.0 and 7.2 Hz, 2H), 2.15 (dt, J = 15.0 and 5.7 Hz, IH, Œ2 in cyclopentane), 
2.06 (m, IH), 1.84 (m, IH), 1.49 (m, 3H), 1.29 (m, 6H), 0.89 (t, J = 6.9 Hz, 3H, CH3); 
13c NMR (CDCI3) 5 178.17, 157.94, 136.42, 128.99, 127.66, 126.78, 124.19, 122.78, 
119.98, 88.03, 76.97, 72.48, 52.31, 49.96, 42.16, 37.27, 33.01, 31.83, 29.02, 25.21, 
24.66, 22.67,14.18; JR (neat) 3362 (OH), 2926, 2851,1701 (C=0), 1593,1454 cm'l; 
HRMS calculated for C23H32O5 388.22497, found 388.22512. Anal. Calcd for 
C23H32O5: C, 71.11; H, 8.30. Found: C, 62.38; H, 7.52. The poor elemental analysis for 
this compound is possibly due to insufficient drying of the sample. 
Preparation of compound 35 
A solution of cyclopentadiene monoepoxide (820 mg, 10.0 mmol) in THF (3 ml) was 
added dropwise over 20 min to an ice-cooled solution of Pd(PPh3)4 (116 mg, 0.1 mmol) and 
2-iodophenol (Lancaster, 2.2 g, 10.0 mmol) in THF (7 ml). The reaction mixture was 
warmed to room temperature and stirred for 15 h. The reaction mixture was passed through a 
silica gel pad, and concentrated. The residue was purified by flash chromatography to give 
the product cis-4-(2-iodophenoxy)-2-cyclopenten-l-ol: 1.88 g, 62% yield; ^H NMR 
(CDCI3) 8 7.78 (dd, J = 7.8 and 1.5 Hz, IH, Ar), 7.29 (dt, J = 1.5 and 7.8 Hz, IH, Ar), 
6.88 (dd, J = 7.8 and 1.2 Hz, IH, Ar), 6.72 (dt, J = 1.2 and 7.1 Hz, IH, Ar), 6.21 (dd, J = 
5.7 and 1.5 Hz, IH, HC=C), 6.17 (dd, J = 5.7 and 1.2 Hz, IH, HC=C), 5.14 (m, IH, 
CHOAr), 4.75 (m, IH, CHOH), 2.83 (dt, J = 14.4 and 6.9 Hz, CH2 in cyclopentane), 1.89 
(m, 2H); NMR (0003) 5 156.13, 139.05, 138.25, 131.34,128.96, 122.09, 113.03, 
86.89, 81.10,73.72,40.87. To a solution of cw-4-(2-iodophenoxy)-2-cyclopenten-l-ol 
(900 mg, 3.0 mmol) and imidazole (507 mg, 7.5 mmol) in Œ2CI2 (10 ml) was added 
dropwise over 10 min at room temperature TBDMSCl (583 mg, 3.6 mmol) dissolved in 5 ml 
of CH2CI2. After being stirred 1 h, the reaction mixture was quenched by adding 5 ml of 
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H20, and extracted with hexane. The organic phase was dried, concentrated and flash 
chromatographed to give compound 35:1.18 g, 95% yield; NMR (CDCI3) Ô 7.77 (dd, J 
= 7.8 and 1.5 Hz, IH, Ar), 7.27 (dt, J = 2.1 and 7.1 Hz, IH, Ar), 6.85 (dd, J = 8.4 and 1.2 
Hz, IH, Ar), 6.70 (dt, J = 1.2 and 7.5 Hz, IH, Ar), 6.07 (m, IH, HC=C), 6.02 (m, IH, 
HC=C), 5.07 (m, IH, CHOPh), 4.78 (m, IH, CHOSi), 2.91 (dt, J = 13.8 and 6.9 Hz, IH, 
CH2), 1.88 (dt, J = 13.5 and 5.1 Hz, IH, CH2), 0.91 (s, 9H, r-BuSi), 0.11 (s, 3H, SiMe), 
0.10 (s, 3H, SiMe); NMR (CDCI3) 5 156.96,139.73, 138.64, 131.26, 129.13, 
122.45, 113.52, 87.54, 81.49, 74.85, 42.05, 25.74, 18.14, -4.69. 
Compound 36 (R = TBDMS) 
1h NMR (CDa3) 5 7.87 (d, J = 16.5 Hz, IH, HC=CHCO), 7.53 (dd, J = 7.8 and 
1.2 Hz, IH, Ar), 7.30 (dt, J = 1.2 and 7.8 Hz, IH, Ar), 6.93 (m, 2H, Ar), 6.74 (d, J = 
16.5 Hz, IH, HC=QiCO), 6.04 (m, 2H, HC=CH), 5.12 (t, J = 6.0 Hz, IH, CHOAr), 
4.78 (t, J = 6.0 Hz, IH, CHOSi), 2.93 (dt, J = 13.8 and 6.9 Hz, IH, CH2 in cyclopentane), 
2.64 (t, J = 7.2 Hz, 2H, CH2CO), 1.81 (dt, J = 13.5 and 5.4 Hz, IH, CH2 in 
cyclopentane), 1.65 (m, 2H), 1.31 (m, 4H), 0.89 (m, 12H, CH3 plus r-BuSi), 0.09 (s, 3H, 
SiMe), 0.08 (s, 3H, SiMe). 
Compound 37 
1h NMR (CDCI3) 8 7.18 (d, J = 7.8 Hz, IH, Ar), 7.07 (t, J = 7.8 Hz, IH, Ar), 
6.81 (t, J = 7.8 Hz, IH, Ar), 6.73 (d, J = 7.8 Hz, IH, Ar), 5.74 (m, 2H, HC=CH), 5.45 (t, 
J = 6.3 Hz, IH, CHOAr), 4.37 (d, J = 7.5 Hz, IH, CHAr), 2.87 (dd, J = 19.2 and 6.3 Hz, 
IH, CH2), 2.75 (d, J = 17.7 Hz, IH, CH2); ^^C NMR (CDCI3) 5 131.23, 129.07, 
128.22, 128.04, 124.43, 124.11, 120.32,109.47, 86.49, 54.37, 40.73; LRMS (relative 
intensity) mjz 115.0 (9), 131.0 (42), 158.3 (M+, 100). 
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Compound 38 
1h NMR (CDOs) 6 7.80 (dd, J = 8.1 and 1.5 Hz, IH, Ar), 7.73 (dd, J = 5.4 and 
2.1 Hz, IH, HC=CHCO), 7.32 (dt, J = 1.5 and 8.1 Hz, IH, Ar), 6.89 (dd, J = 8.1 and 1.2 
Hz, IH, Ar), 6.77 (dt, J = 1.8 and 8.4 Hz, IH, Ar), 6.39 (dd, J = 6.0 and 1.5 Hz, IH, 
C=CHCO), 5.45 (m, IH, CHOAr), 2.90 (dd, J = 18.3 and 6.0 Hz, IH, CH2), 2.54 (dd, J 
= 18.3 and 2.1 Hz, IH, CHi); NMR (CDCI3) 5 204.38, 158.96, 156.27, 139.98, 
136.72, 129.55,123.74, 113.85, 87.62, 76.95,41.81; IR (neat) 1722 (C=0) cm"!. 
Compound 39 
1h NMR (CDCI3) S 7.76 (d, J = 16.5 Hz, IH, PhHC=CHCO), 7.74 (dd, J = 5.7 
and 2.4 Hz, IH, HC=CCO), 7.60 (d, J = 7.8 Hz, IH, Ar), 7.38 (t, J = 7.8 Hz, IH, Ar), 
7.04 (t, J = 7.8 Hz, IH, Ar), 6.86 (d, J = 7.8 Hz, IH, Ar), 6.75 (d, J = 16.5 Hz, IH, 
PhC=CHCO), 6.30 ( d, J = 5.7 Hz, IH), 5.53 (m, IH), 2.96 (dd, J = 18.3 and 6.0 Hz, IH, 
CH2 in cyclopentane), 2.80-2.61 (m, 3H), 1.65 (m, 2H), 1.31 (m, 4H), 0.89 (t, J = 6.9 
Hz, 3H, CH3). 
Preparation of compound 41 
In a vial were placed compound 22 (68 mg, 0.2 mmol), ethyl vinyl ketone (84 mg, 
1.0 mmol), triethylamine (50 mg, 0.5 mmol), n-Bu4NCl (Lancaster, 61 mg, 0.22 mmol), 
Pd(0Ac)2 (2.2 mg, 0.01 mmol) and 0.4 ml of DMF. After the mixture was stirred for 6 h at 
50 ®C, it was poured into 60 ml of ether and the overall solution was washed with saturated 
NH4CI (20 ml) and brine (20 ml). The solution was dried over MgS04 and concentrated in 
vacuo, and the residue was purified by flash chromatography with 2:1 to 1:1 hexane/EtOAc 
to give compound 41:26 mg, 44% yield; ^H NMR (CDCI3) 5 6.97 (d, J = 7.5 Hz, IH, Ar), 
6.90 (d, J = 7.5 Hz, IH, Ar), 6.82 (dd, J = 16.2 and 9.6 Hz, IH, HC=CHCO), 6.79 (t, J = 
7.5 Hz, IH, Ar), 6.21 (d, J = 16.2 Hz, IH, C=CHCO), 5.97 (m, IH, H2C=CH), 5.42 (dd, 
J = 7.8 and 5.7 Hz, IH, CHOAr), 5.02 (m, 2H, H2C=C), 4.28 (m, IH, CHOH), 3.99 (t, J 
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= 8.4 Hz, m, CHAr), 3.32 (d, J = 6.3 Hz, 2H, CHiAr), 2.86 (dt, J = 4.2 and 9.6 Hz, IH, 
CHCH=CHCO), 2.57 (dq, J = 3.0 and 7.5 Hz, 2H, OCCH2CH3), 2.49 (d, J = 15.3 Hz, 
IH, CH2 in cyclopentane), 2.20 (dt, J = 15.3 and 5.4 Hz, IH, CH2 in cyclopentane), 1.64 
(d, J = 7.5 Hz, m, OH), 1.08 (t, J = 7.2 Hz, 3H, Œ3); NMR (CDCI3) 5 201.17, 
157.22, 143.88, 136.23, 132.66, 129.17, 127.07, 123.90, 122.29, 120.53, 115.66, 88.98, 
77.25, 52.60, 50.60,42.87, 38.99, 32.26, 8.18; IR (neat) 3468 (OH), 1668 (C=0) cm'l; 
HRMS m/z calculated for C19H22O3 298.15690, found 298.15741. 
Compound 46 
1h NMR (CDa3) 5 7.65 (dd, J = 1.5 and 7.8 Hz, IH, Ar), 7.17 (dd, J = 1.5 and 
7.8 Hz, IH, Ar), 6.77 (t, J = 7.8 Hz, IH, Ar), 5.99 (m, 2H, HC=CH), 5.02 (m, IH, 
CHOAr), 4.68 (m, IH, CHOSi), 4.11 (q, J = 7.2 Hz, 2H), 2.84 (m, 2H), 2.66 (ddd, J = 
15.3 and 9.6 and 6.0 Hz, IH), 2.29 (t, J = 7.2 Hz, 2H), 2.00 (dt, J = 13.5 and 5.7 Hz, 
IH), 1.90 (t, J = 7.5 Hz, 2H), 1.24 (t, J = 7.5 Hz, 3H, CH3), 0.92 (s, 9H, ï-BuSi), 0.11 
(s, 6H, SiMe2). 
Preparation of compounds 50 and 51 
1). Procedure A (via reduction of compound 12) 
To a solution of LiAIH4 (Aldrich, 2.8 ml, 0.539 M in THF, 1.52 mmol) was added 
ethanol (0.76 ml, 2M in THF, 1.52 mmol) dropwise over 10 min at room temperature. 
Subsequently, a THF solution of (S)-binaphthol (Aldrich, 429 mg, 1.52 mmol in 2.4 ml of 
THF) was added dropwise, and the resulting mixture was stilted for 30 min. Enone 12 (199 
mg, 0.51 mmol) in 2 ml of THF was added dropwise over 3 min at -100 ^C, and stiiring 
was continued for 2 h at -100 and for another 2 h at -78 ^C. The reaction was quenched 
by adding methanol (0.5 ml) at -78 ®C and wanned to room temperature. After addition of 
water (0.5 ml) and ether (15 ml), stirring was continued for an additional 30 min. To this 
was added anhydrous MgS04 and the mixture was filtered through Celite. Concentration, 
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followed by flash chromatography with 1:2 hexane/EtOAc, gave compounds 50 (49 mg, 
25% yield) and 51 (50 mg, 25% yield). Compound 50; Rf = 0.25 (1:2 hexane/EtOAc); 
NMR (CDCI3) 5 6.91 (d, J = 7.5 Hz, 2H, Ar), 6.73 (t, J = 7.5 Hz, IH, Ar), 5.66 (m, 2H, 
HC=CH), 5.33 (t, J = 7.8 Hz, IH, CHOAr), 4.20 (m, IH, CHOH), 4.10 (m, 3H, OŒ2 
and C=CHCHOH), 3.87 (t, J = 8.7 Hz, IH, CHAr), 2.74 (m, IH), 2.64 (dd, J = 12.9 and 
6.6 Hz, IH), 2.55 (dt, J = m, IBQ, 2.38 (d, J = 15.0 Hz, IH, CH2 in cyclopentane), 2.27 
(dt, J = 2.1 and 1.8 Hz, IH), 2.15 (ddd, J = 15.0 and 6.0 and 4,5 Hz, IH, CH2 in 
cyclopentane), 2.04-1.78 (m, 4H), 1.67 (br s, 2H, OH's), 1.54 (m, IH), 1.33 (m, 6H), 
1.25 (t, J = 7.5 Hz, 3H, CH3), 0.92 (t, J = 6.3 Hz, CH3); NMR (CDCI3) 5 173.90, 
157.81, 136.44, 128.73, 128.15, 127.76, 123.91, 122.99, 119.82, 88.28, 76.93, 72.96, 
60.30, 52.28, 50.04, 42.37, 37.04, 33.52, 31.81, 29.06, 25.25, 24.89, 22.69, 14.29, 
14.10; IR (neat) 3486 (OH), 1732 (C=0) cm"l; HRMS m/z calculated for C25H36O5 
416.25628, found 416.25541. Compound 51: Rf = 0.48 (1:2 hexane/EtOAc); % NMR 
(CDCI3) 5 6.97 (d, J = 7.2 Hz, IH, Ar), 6.92 (d, J = 7.5 Hz, IH, Ar), 6.74 (t, J = 7.5 Hz, 
IH, Ar), 5.71 (m, 2H, HC=CH), 5.34 (t, J = 6.9 Hz, IH, CHOAr), 4.19 (m, IH, CHOH), 
4.11 (m, 3H, OCH2 and C=CHCHOH), 3.90 (t, J = 11.7 Hz, IH, CHAr), 2.75 (m, IH), 
2.59 (m, IH), 2.38 (d, J = 15.0 Hz, IH, CH2 in cyclopentane), 2.27 (m, 2H), 2,16 (ddd, J 
= 15,0 and 6.0 and 4.5 Hz, IH, CH2 in cyclopentane), 2.05-1.82 (m, 4H), 1.72 (d, J = 6,0 
Hz, IH), 1.53 (br s, 2H, OH's), 1.29 (m, 6H), 1.25 (t, J = 7.5 Hz, 3H, CH3), 0.88 (m, 
3H, CH3); 13C NMR (CDCI3) 6 173.87, 157.69, 136.34, 128.70, 127,76, 127,08, 
124,04, 122,95, 119,85, 88,23, 77.02, 72,53, 60.27, 52.38, 50.06, 42,52, 37.27, 33,49, 
31.80, 29.04, 25.19, 24.86, 22.63, 14.27, 14.10; IR (neat) 3416 (OH), 3053,2845, 1732 
(C=0), 1599,1447 cm'l; HRMS m/z calculated for C25H36O5 416.25628, found 
416,25711. 
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2). Procedure B (via direct conversion from compound 10) 
In a vial were placed compound 10 (109 mg, 0.26 tnmol), y-staimyl alcohol 30 (164 
mg, 0.39 mmol), i-Pr2NEt (85 mg, 0.66 mmol), «-Bu4NQ (Lancaster, 88 mg, 0.31 mmol), 
Pd(0Ac)2 (2.9 mg, 0.013 mmol) and DMF (0.52 ml) as a solvent After the resulting 
mixture was stirred for 12 h at room temperature, it was passed through a silica gel pad with 
1:2 hexane/EtOAc. The solution was concentrated, and the residue was purified by flash 
chromatography with 1:2 hexane/EtOAc to give compounds 5Q (15 mg, 14% yield) and 52 
(17 mg, 16% yield). 
Compound 52 
See preparation of compound 51. The spectral data of this compound is the same as 
those of compound 51. 
Preparation of 12.15-epi-5.6.7-trinor-4.8-inter-m-phenvlene PGI? (54) 
To a solution of compound 51 (55 mg, 0.14 mmol) in 1.8 ml of THF was added 3N 
aqueous NaOH (0.9 ml) at room temperature. After the reaction was stored for 6 d at room 
temperature, it was neutralized by 2N aqueous HCL The organic phase was decanted with 
ethyl acetate and dried over MgS04. Concentration in vacuo followed by flash 
chromatography with 20:1 EtOAc/MeOH gave compound 47 mg, 92% yield; Rf = 0.37 
(20:1 EtOAc/MeOH); NMR (CDCI3) 5 6.94 (d, J = 7.5 Hz, IH, Ar), 6.90 (d, J = 7.5 
Hz, IH, Ar), 6.74 (t, J = 7.5 Hz, IH, Ar), 5.72 (dd, J = 15.3 and 5.1 Hz, IH, HC=C), 
5.65 (dd, J = 15.3 and 7.8 Hz, IH, C=CH), 5.62 (br s, 2H, OH's), 5.32 (t, J = 6.9 Hz, 
IH, CHOAr), 4.20 (m, IH, CHOH), 4.12 (dd, J = 12.0 and 9.0 Hz, IH, C=CHCHOH), 
3.89 (t, J = 8.7 Hz, IH), 2.80 (dt, J = 4.2 and 9.0 Hz, IH), 2.70 (m, IH), 2.54 (m, IH), 
2.38 (d, J = 15.9 Hz, IH, CH2 in cyclopentane), 2.29 (dd, J = 14.1 and 6.3 Hz, 2H), 2.22-
2.04 (m, 2H), 1.84 (m, IH), 1.49 (m, 3H), 1.29 (m, 6H), 0.89 (t, J = 6.3 Hz, 3H, CH3); 
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13c NMR (CDCI3) 6 178.54, 157.87, 136.26, 128.88, 127.64, 126.73, 124.15, 122.72, 
119.92, 88.00, 76.93, 72.39, 52.27, 49.92, 42.12, 37.19, 33.07, 31.81, 28.97, 25.17, 
24.64,22.64,14.13; IR (neat) 3412 (OH), 3271 (OH), 3063,2924, 2858,1709 (C=0), 
1456,1254 cm'l; HRMS mjz calculated for C23H32O5 388.22497, found 388.22589. 
Anal. Calcd for C23H32O5: C, 71.11; H, 8.30. Found: C, 70.36; H, 8.09. 
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CHARIER EL ORGANOPALLLADIUM APPROACHES TO 
12-EPI-CARBACYCLINS 
I l l  
INTRODUCTION 
Prostacyclin (D, abbreviated PGI2, is the most powerful natural inhibitor of ADP-
induced aggregation of human blood platelets. Due to the inherent chemical instability of the 
enol ether system in the natural PGI2, intensive efforts have been made to prepare chemically 
stable and biologically potent prostacyclin analogues L 
Among the prostacyclin analogues, carbacyclin (2) has attracted special attention, 
because of its potent biological activity^d and satisfactory chemical stability. Carbacyclin 
^^COgH 
OH 
CO2H 
Q) was first synthesized in 1978 independently by Nicolaou et al.,2a Kojima and Sakai^b, 
ShibasaM et al.,2c and Morton and Brokaw^d Since then, several additional syntheses have 
appeared^. In addition, the significant biological activity of carbacyclin led to the synthesis 
of analogues. The therapeutically interesting analogues include ilopost ZK 96 480 (4)5, 
ciprostene (5)^ and OP 41 483 (©6. 
112 
COgH O^COgH 
COoH COgH 
OH 
In our continuing effort to synthesize prostaglandins, compound 2 appeared to be an 
interesting carbacyclin analogue that we might approach using palladium chemistry (Scheme 
I). The cyclization of silyl enol ethers employing palladium acetate has previously been 
Scheme L 
OSiMea O 
m 
2 s 
COoH 
5' '11 
113 
developed^. The coupling of l-octen-3-one and the organopalladium intermediate generated 
by cyclization of compound 2 would give compound&ina single step procedure. 
Subsequent reactions including selective reduction of the ^^-unsaturated ketone and a Wittig 
reaction should provide the novel prostaglandin 9 in very few steps. 
Unlike all of the carbacyclin analogues previously synthesized, compound 9 has an 
a-configuration at carbon 12. Thus, examination of the biological activity of compound 9 
should be interesting. 
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RESULTS AND DISCUSSION 
Compound 7 was prepared by the sequence shown in Scheme E. Compound 11 
Scheme n. 
r-butyldimethylsilyl 
chloride 
imidazole, DMF, rt 
P  
TBDMSO 
12 
96% 
was prepared from cyclopentadiene monoepoxide (10) by previously developed Pd(0) 
chemistry^. The decarboalkoxylation of compound H using Krapcho's method^ provided 
only unidentified product However, protection of the hydroxy group in compound 11. 
followed by Krapcho's thermal decarboalkoxylation^ provided ketone 13 cleanly. 
Subsequent treatment of ketone 1^ with LDA and trimethylsilyl chloride ^ 0 afforded silyl enol 
ether 2. 
The key step was examined using compound 7 and ethyl vinyl ketone as a model 
study. The Pd(II)-mediated cyclization, followed by enone coupling, was conducted under 
various conditions. The results are summarized in Table 1. The desired product 14 was 
a 
o o 
COCH3 
1.2 < ? 
COgEt ^ ^ 
1.7% Pd(PPh3)4 
10 THF, rt, 20 h H 
83% 
^ OSiMes jr / 
DMSO/HP 1.0 LDA 
V"® -78*^ tort \3 165-170 T 
9 h TBDMSÔ'^  THF TBDMSO" ^ 
85% 54% 
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Table 1. Reaction conditions for the synthesis of compound 14 
20^^ '^, 2base 
% Isolated Yield 
Entry Base Solvent 14 15 12 
1 NaOAc - 23 5 20 
2 EtsN - 0 5 52 
3 NaOAc THF 22 44 5 
4 Na2C03 21 30 5 
5 EtgN 9 8 42 
6 K2CO3 acetone 26 33 ? 
7 Li0Ac»2H20 32 38 ? 
sa NaOAc THF 4 0 21 
9b 0 0 21 
10 CH2CI2 7 38 5 
11 CH3CN 4 38 5 
12 DMF 24 38 ? 
^The reaction was conducted with Li2PdCl4, instead of Pd(OAc)2. 
brhe reaction was conducted with 10 PPhg as an additive. 
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Table 1. Continued 
Entry Base Solvent 14_ 
% Isolated Yield 
IS 13 
13 NaOAc DMSO 3 8 64 
14 benzene 18 60 ? 
15 acetone 28 38 7 
16C ŒÎ2C12 19 24 ? 
CThe reaction was conducted with 10 HMPA as an additive. 
produced along with two side-products il and 15. The reaction was examined without any 
solvent in entries 1 and 2. With sodium acetate as a base, product 14 was obtained in 23% 
yield. None of the desired product was obtained with an organic base, such as triethylamine. 
From entries 3 to 7, variations of bases and solvents were examined. Inorganic bases gave 
better results than organic bases. Switching the Pd(II) ^ecies fiom Pd(OAc)2 to Li2PdCl4 
gave worse results (entry 8). Eniployment ofPPhg as an additive gave none of the desired 
product; compound H was obtained as the only product (entry 9). Solvent variations were 
examined in entries 10 to 16. THF, DMF or acetone appeared to give the best results. 
A possible reaction mechanism is proposed in Scheme HI. Reactions with EtgN as a 
base or PPhg as an additive led to the reduction product 13 over the cyclized intermediate 17. 
One might explain this by proposing that EtgN or PPhg is coordinated to the acyl palladium 
intermediate 16, preventing olefin coordination, and thus favoring formation of compound 13 
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Scheme HE. 
a-^PdOAc r\ 
^ _ P d ^  / l  — 5  - M
-TMSOAc ^ '^VPdOAc -HOAc 
TBDMSC?26 TBDMSd ^ _Pd(0) 
HX| ^ I 
+ XPdOAc 
_ + TBDMSOPdOAc 
TBDMSO" 
13 15 
over the competing pathway leading to intermediate 17. With inorganic bases, the desired 
cyclization proceeds well. However, the elimination reaction leading to confound 15 
competes with the formation of the desired enone coupling leading to compound 14. 
To prevent the elimination reaction from occurring in intermediate 17, we decided to 
employ other protecting groups in confound 7. The MOM protecting group was considered 
to be a better choice, because the organopalladium intermediate 17 might be stabilized by the 
coordination of a near-by oxygen as in intermediate 18. Then, the stabilized intermediate 18 
might have sufficient time to undergo intermolecular enone insertion. However, that was not 
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O 
V^-'/PdOAc V-"ÇdOAc 
0^6^ MOMO" PyEt 
IS 12 O 
the case. The oxygen coordination apparently makes olefin coordination to form intermediate 
12 more difficult. As a result, none of the desired product was obtained (eq 1). 
OSiMea O 9 
20'^ \' ,2NaOAc . ^ _ 
O —2 O' • Q 
OCH2OCH3 1-2 PdCOAch. n OCH2OCH3 
20 acetone — 21 
— 37% 10% 
( 1 )  
Compound 20 was prepared following the procedures shown in Scheme IV. 
Scheme IV. 
11 
p O 
MOMQ 
EtgN 
THF.rt 
P 
OMOM 
22 
83% 
2NaOAc^^ 
propylene 
glycol 
85 
0 
OMOM 
21 
21% 
1.0 LDA 
1.7 TMSCl 
-78 tort 
THF 
OSiMeg 
0 
OMOM 
20 
57% 
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We decided to ejq)lore another starting material with which we might accomplish the 
key step more efficiently. a-Iodoketone 24 was considered as a possible starting material. 
No simple literature procedure for the a-iodination of ketones was found. Therefore, a 
procedurel^ for the synthesis of a-iodoesters was ençloyed in the a-iodination of ketone 13 
(eq 2). A compound which looked like product 24 by and NMR spectral analysis 
Ol. 1.0LDA,-78°C 2.12, -789Ctort ^ 
TBDMSC^ TBDMSCf 
12 
( 2 )  
54% ? 
was separated by flash chromatography. However, compound 24 seemed to be unstable. 
Compound 24 was found to decompose when it was subjected to NMR spectroscopic 
examination after overnight storage in a freezer. 
Another compound which might be used to synthesize compound 14 is 
organomercurial 25. When compound 12 was subjected to Stinn's procedure  ^^  for the 
mercuration of an ester, a relatively clean spot was observed upon TLC analysis (eq 3). 
O O 
1. 1.0 LDA, -78 T ^ 
2.2.0 ugci2, -7z\: 
TBDMSCf TBDMSCf 25 
n ( ? )  
However, this confound could not be identified by ^H NMR spectral analysis and high 
resolution mass spectroscopy. 
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While alkoxy palladium elimination in intermediate 17 appeared to be a major problem 
in this project, it was interesting that none of the side-product 22 was observed in the 
synthesis of compound 28 described in Chapter n of this dissertation (eq 4). The difference 
Hp o 
26 ® ^ XT U J Not observed 
between organopalladium intemiediates J2 and 22 lies partly in the ligand on palladium. 
Thus, substitution of an organopalladium iodide for an organopalladium acetate was 
considered to be worth examining. The reaction was conducted simply by adding sodium 
iodide to the reaction mixture. The results are summarized in Table 2. 
As a preliminary experiment, sodium iodide was added to a solution of Pd(OAc)2 
dissolved in THF without any organic substrates. The color of Pd(OAc)2 turned from brown 
to a dark purple as soon as Nal was added. One might suppose that the metathesis reaction 
described in equation 5 is occumng very fast 
Pd(OAc)2 + Nal IPdOAc + NaOAc (5) 
As seen in Table 2, addition of Nal increased the yield of the product to some extent 
(compare entries 1 and 2,9 and 10). The amount of sodium iodide employed didn't make 
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Table 2. Reaction conditions for the synthesis of compound 14 
4  f i  x f  
7 + nNal + 2base 
1.2Pd(0Ac), 
2 h TBDMSC5' ^ Ô 15 TBDMSO 13 
% Isolated Yield 
Entry n Temp. (^C) Base Solvent 14 15 13 
1 0 rt NaOAc THF 22 44 <5 
2 1.2 45 30 20 
3 0.6 43 38 ? 
4 0.2 42 50 <5 
5a 0.2 55 ? ? 
6b 0.2 49 15 14 
7 0.2 KOAc 34 30 30 
8 0.2 KI NaOAc 24 33 22 
9 0 neat 23 15 20 
10 0.2 44 19 34 
11 0.2 0 THF 46 26 25 
12 0.2 10 50 29 11 
^The reaction was conducted employing 1,5 equivalents of Pd(0Ac)2. 
^The reaction was conducted employing 1.5 equivalents of Pd(OAc)2 and 20 
equivalents of isobutylene oxide. 
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much difference in the product yield (entries 2-4). An increase in the amount of Nal afforded 
a slight decrease in the yield of the eliminated product 15. The use of 1.5 equivalents of 
Pd(0Ac)2 increased the yield of the product up to 55% (entry 5). A close look at the reaction 
mechanism in Scheme IE suggests that we might reduce the amount of side-product 13 by 
elimination of acetic acid generated during the reaction. In entry 6, isobutylene oxide which 
has previously been used as a proton scavanger '^^  was added to reduce the side-product 13. 
The attempt, however, proved fruitless. Contrary to Nal, no effect was observed when 
adding KI to this reaction (entry 8). The reaction mixture remained brown upon addition of 
KI implying that no metathesis reaction is occurring. Temperature variations were examined 
in entries 11 and 12. Little effect was observed. 
Based on the results in Tables 1 and 2, l-octen-3-one was employed in place of ethyl 
vinyl ketone to carry through the synthesis of prostaglandin 9. It was observed that the yield 
of the product 8 decreased (eq 6). In addition, compound 30 was observed as a side product. 
^ C5H11 1.5Pd(OAc)2 ? ^ (6) 
7 + 2 0  +  0 . 2 N a l  +  2 N a O A c  ^  
O THF, rt, 3 h 1 
TBDMScf* g J 
32% 
Thus, potassium carbonate was employed as a base to eliminate compound 3Q. Even though 
O 30 
15% 
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compound still remained as a side-product, a slight increase in the product yield was 
observed (entry 1 in Table 3). The reaction was examined with potassium carbonate as a 
base in various solvents. The results were summarized in Table 3. 
Table 3. Reaction conditions for the synthesis of compound & 
2 + 2 0  
O 
CcH 5^11 1.5 Pd(0Ac)2 
+ 0.2 Nal + 2 K2CO3 
rt, 3 h 6 
TBDMSO 8 O 
Entry Solvent % Isolated Yield of ^ Comment 
1 TEÎF 42 -
2 DME 40 -
3 f-BuOH 41 -
4 acetone 38 -
5 neat 30 -
6 CHCI3 48 -
7 45 2 Na2C03 was used as a base 
8 49 0.2 Lil was used in place of Nal 
9 49 0.5 Nal was used in place of 0.2 Nal 
10 CH2CI2 53 0.25 mmol of compound 7 was used 
11 62 0.75 mmol of compound 7 was used 
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Among the solvents examined, CH2CI2 (entries 10 and 11) appeared to be the best. 
By conducting the reaction on a larger scale, the product 8 could be obtained in up to 62% 
yield (entry 11). After this extensive examination of reaction conditions, the desired product 
8 was obtained in good yield utilizing a Pd(II)-mediated cyclization, followed by enone 
coupling. 
To carry through to the prostaglandin 9, we needed to convert compound 8 to 
compound 31 (Scheme IV). From a literature survey, no general method was found for the 
Scheme IV. 
selective reduction of an a,P-unsaturated ketone in the presence of a saturated ketone. One 
promising literature procedure involved the regioselective reduction of compound 32 to 
TBDMSO 
9 OH 
compound 33.15 (eq 7). After a systematic study of various reducing agents, Greene et al.,^^ 
O O 
2Et NaBHgCN 
CH3OH 
-25't:, 36 h . 
pH 3.0-4.6 33 OH 
49% 
isEt 
( 7 )  
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found that sodium cyaaoborohydride was the most efficient reagent for the conversion of 
compound 32 to compound 31, However, this reaction was very sensitive to the reaction 
conditions. The reaction temperature had to be kept at -25 °C for 36 h, and also the pH had 
to be maintained between 3.0 and 4.6 by adding aqueous HQ. Moreover, diastereomeric 
alcohols at carbon-15 were obtained as 1:1 mixtures. 
To overcome the problems in equation 1, we decided to examine Noyori's (S)-
BINAL-H16 as a stereo- and regioselective reducing agent Even though BINAL-H has been 
well documented for the stereoselective reduction of a.P-unsaturated ketones in a predictable 
mannerly, no examples have been reported for the chemoselective reduction of enones in the 
presence of saturated ketones by BINAL-H. 
We were pleased to observe that stereo- and chemoselective reduction of compound 8 
was efficientiy effected by (S)-BINAL-H (Scheme V). When compound 8 was subjected to 
reduction with (S)-BINAL-H, ±e desired product 34 was obtained selectively over 
compound 35 in a ratio of 9:1. The accidental overlapping of compounds M, 35 and (S)-
binaphthol on TLC made isolation of the product difficult However, assignment of the 
olefinic hydrogens of compounds M and 35 in the crude product by ^H NMR spectral 
analysis was possible. The olefinic hydrogens in compounds 34 and 35 were compared to 
those in compounds 31 and 3ô which were isolated cleanly after desilylation. None of the 
TBDMSO 
OH 
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over-reduced product 37 was observed upon NMR spectral analysis. Even though an 
excess of the reducing agent was employed, some of the starting material 8 was left upon 
NMR spectral analysis. Since the Rf value of compound ^was also close to (S)-binaphthol, 
no attempt was made to recover the starting material & 
Scheme V. 
J 
^ 2.5 (S)-BINAL-H 
-10b (2 h) 1 \1 
to-78 9C(2h) TBDMSd ^4 5h ^BDIVISd" ^ J 
« 34:35 = 9:1 by NMR spectral analysis 
• 14-25% of starting material & left upon NMR spectral analysis 
without purification of compound 34 ^ o: 0.5N HCl, rt, 38 h 
21 5H 
(50% from ^ 
s 3°g)-BINAL-H _ 3 , ^ 2 5 , 8  
-100 T (2 h) rt,36h 
to-78%: (2 h) 
• 34:35 = 10:1 by NMR spectral analysis 
• 16% of starting material 8 left upon NMR spectral analysis 
(42% from S) 
Deprotection of the silyl group in compound 34 was effected using aqueous 
hydrochloric acid to yield compound 31. which was then separable from (S)-binaphthol and 
compound 36. None of the Ci5-(R) isomer 2S was observed. Since only one stereoisomer 
127 
ê 
M OH 
at Ci5 was obtained, we assigned it as the desired Ci5-(S) isomer based on the previous 
report using (S)-BINAL-HI^. Therefore, compound & was reduced chemo- and 
stereoselectively to give crude product 21 which was, without further purification, subjected 
to hydrolysis to provide compound 21 in 50% yield from compound 
A subsequent Wittig reaction on conpound 21 provided the 12-epi-carbacyclin (2) 
along with its C5-Z isomer 22 (eq 8). The E and Z configurational assignments at C-5 of 
"COgH 
f : 
6 [Ph3P(Œ2)4CO^Br 
/V COgH 
o 12KN(TMS)2 
THF,rt,3h g OH 22 OH 
(3:2) ^ 
47% 
the final products has not been definitively established. The stereochemistry was tentatively 
assigned based on the polarity and product ratio of corrçounds 9 and 39. A literature survey 
revealed that the more polar isomers are generally those with the desired stereochemistry at C-
5 (Scheme VI). The configuration of the trisubstituted olefin at C-5 in carbacyclin (2)2 or its 
analogues, such as compounds 4^ and 4420. have been assigned by comparison of biological 
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Scheme VL 
/v„^C02H 
y—H (5.23 ppm) 
(5.21 ppm) 
H, ^ COgH 
HO 2 OH 
(more polar) 
H(f _ =L. 
41 OH 
Ref. 
• product ratio via Wittig reaction 2:41 = 7:2 2c 
= 10:3 17 
C6 
.COgH 
(5.17 ppm) 
(5.42 ppm) 
H 
= 7:3 18 
COgH 
HO 
-C5H11 
^ OH 
(more polar) 
ÇX^js^^CgHii 
HÙ _ Aw 43 OH 
Ref. 
COgH 
• product ratio via Wittig reaction ^ : 43 = 2:1 19 
= 9:1 18 
Hcf k.. 44 OH 
(more polar) 
HO 45 OH Ref. 
20 
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activities. The inhibitory activity of compound 2 toward human platelet aggregation was 
reported to be a hundred times stronger than 4l2c^. The E and Z configurations in 
compounds 44 and 4^ were also assigned based on polarities and biological activities. When 
tested in vitro against ADP-induced human platelet aggregation, compound 45 was found 
inactive (ED50 > 1000 ng/ml), whereas compound 44 showed slight activity (500 < ED50 
<1500 ng/ml)20. On the other hand, the configuration of the C5 double bond in compounds 
42 and 4^ was determined based on the difference in the chemical shift of the C6 protons 
Due to the steric interaction with the upper side chain, the Cg protons show a broad AB 
system (J = 12.5 Hz) in compound ^ whereas the corresponding signals in compound 43 
are magnetically equivalent 
In the case of 12-epi-carbacyclin (9) and its isomer 39. however, the C7 protons did 
not show up cleanly in the NMR spectra. Thus, unambiguous assignment of the 
configuration at C-5 was diffîculL The olefin protons appeared cleanly, and their chemical 
shifts were assigned as indicated below. 
/v^COaH (5.19) 
(516) 
H (5.66) H (5.69) 
HO 
(5.', 
9 39 
It is also noteworthy that the formation of compounds 2 and ^ over their isomers 41 
and 43 respectively was found in the Wittig reaction (Scheme VI). We can explain this by 
proposing that the steric congestion in compounds 41 and M is larger than that present in 
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confounds 2 and Upon the Wittig reaction of confound 2L compound 9 was obtained 
in larger quantity than compound 22. The spot of the more polar component 2 was much 
larger than that of the less polar component upon TLC analysis. Even though some 
difficulties were met in separation due to their close Rf values, compounds 9 and 39 were 
isolated in a 3 to 2 ratio. This product ratio also supports die assignment of the more polar 
component â as having the Cg-E configuration. Compounds 9 and 39 were characterized by 
1h NMR, 13c NMR and IR spectroscopy, plus high resolution mass spectrometry. 
It is desirable to synthesize a confound in an enantiomerically pure form. In 
connection with the asymmetric synthesis of the prostaglandin analogue 9, it is worth noting 
that our key intermediate, compound U, should be readily available in optically active 
formal (Scheme VII). The optically pure compound 46, which is available by enzymatic 
hydrolysis22 of the diacetate, should be cleanly converted to confound 11 through jc-
aHylpalladium chemistry^l. Subsequent reactions described above should provide optically 
active 12-epi-carbacyclin (9). 
Scheme Vn. 
Hcf 
46 
>99% ee 
Ref. 21 
OSiMe 
Scheme n 
TBDMSO HO 11 1 9 OH 
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CONCLUSION 
A short synthesis of a novel prostanoid, 12-epi-carbacyclin (2), was accomplished 
using palladium chemistry as a key step. The silyl enol ether 7 prepared through 
organopalladium chemistry was treated with l-octen-3-one in the presence of Pd(OAc)2 to 
give compound 8 in a single step. The unusual chemo- and stereoselective reduction of the 
a,|3-unsaturated ketone 8 was effected with (S)-BINAL-H. Subsequent desilylation and 
Wittig reaction have provided the PGl2 analogue 9. 
132 
EXPERIMENTAL SECTION 
Equipment 
NMR spectra were recorded on a Nicolet NT-300 spectrometer ( NMR, 300 
MHz; 13(2 nmR, 75 MHz), and chemical shifts are reported in ppm relative to TMS (8 0.00) 
as an internal standard. ÏR spectra were obtained on an IBM IR 98. High-Resolution mass 
spectra were recorded on a Kratos MS-50 spectrometer. 
Reagents 
AU chemicals were used direcdy as obtained commercially unless otherwise noted. 
Tetrahydrofuran was distilled over sodium benzophenone ketal and used immediately. 
Methylene chloride was distilled over phosphorous pentoxide and stored over 4Â molecular 
sieves. DMF was distilled over calcium hydride and stored over 4Â molecular sieves. 
Acetone was distilled over calcium hydride and stored over 4Â molecular sieves. 
Preparation of compound 7^0 
To a solution of diisopropylamine (2.93 ml, 21.0 mmol) in 44 ml of THF was added 
n-BuLi (Aldrich, 2.5 M in hexane, 6.99 ml, 17.5 mmol) at -78 ^C. The resulting mixture 
was stirred for 2 min at that temperature. To this was added ketone 10 (4.42 g, 17.5 mmol) 
over 10 min under N2 at -78 ®C. The solution was stirred for 1 h; then fteshly distilled 
trimethylsilyl chloride (3.78 ml, 29.7 mmol) was added over 10 min. The solution was 
allowed to warm to room temperature and stirring was continued for an additional 1 h. The 
reaction mixture was concentrated under vacuum pressure, then hexane was added and the 
LiCl solid which precipitated was filtered off. After concentration, the residue was purified 
by vacuum distillation (110 ^C/ 0.6 mm Hg) to give compound 7 as a light yellow oil: 3.1 g, 
54% yield; Rf = 0.48 (15:1 hexane/EtOAc); IhNMR (CDCI3) 5 5.83 (m, IH, HC=C), 5.69 
(m, IH, HC=C), 4.82 (m, IH, CHOSi), 4.06 (m, 2H, C=CH2), 2.74 (m, IH), 2.37 (dt, J 
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= 13.2 and 7.5 Hz, IH), 2.18 (dd, J = 13.8 and 6.9 Hz, IH), 2.03 (dd, J = 13.8 and 8.1 
Hz, IH), 1.32 (dt, J = 13.2 and 6.3 Hz, IH), 0.90 (s, 9H, r-BuSi), 0.21 (s, 9H, SiMe3), 
0.08 (s, 6H, SiMe2); NMR (0003) 5 158.11, 136.80, 133.99, 90.86, 77.55, 43.47, 
41.68,40.67,26.05, 18.33, 0.23, -4.47; IR (neat) 2957,2930, 1252 cm"!; HRMS 
calculated for Ci7Hi302Si2 326.20974, found 326.20917. 
Preparation of compound 8 
In a vial were placed compound 7 (256 mg, 0.78 mmol), l-octen-3-one (2.3 ml, 16 
mmol), K2CO3 (216 mg, 1.6 mmol), Nal ( 23 mg, 0.16 mmol) and CH2CI2 (2.3 ml). The 
resulting mixture was stirred for 2 min at room temperature. To this was added Pd(OAc)2 
(263 mg, 1.2 mmol); then stirring was continued for 2 h at room temperature. After the 
reaction mixture was filtered through a silica gel pad using 1:1 hexane/EtOAc, it was 
concentrated under reduced pressure. The residue was purified by flash chromatography 
with 3:1 hexane/EtOAc to give conçound 8 as a yellow oil: 179 mg, 62% yield; Rf=0.21 
(3:1 hexane/EtOAc); ^H NMR (CDa3) 5 6.96 (dd, J = 16.2 and 8.7 Hz, IH, HC=CHCO), 
6.11 (d, J = 16.2 Hz, IH, HC=QiCO), 4.29 (t, J = 3.9 Hz, IH, CHOSi), 2.94 (m, 2H), 
2.70 (m, IH), 2.61 (m, IH), 2.53 (dt, J = 2.4 and 7.2 Hz, 2H), 2.30-2.20 (m, 3H), 1.67-
1.55 (m, 3H), 1.34-1.22 (m, 5H), 0.88 (t, J = 6.3 Hz, 3H, CH3), 0.85 (s, 9H, f-BuSi), 
0.01 (s, 6H, SiMe2); NMR (CDCI3) 5 219.42, 200.47,145.08, 132.23,78.36, 60.30, 
51.84, 46.23, 43.67, 40.05, 39.38, 36.10, 31.45, 25.66, 23.93, 22.41, 17.96, 13.90, -
4.74; IR (neat) 2957,2930,1740 (C=0), 1672 (C=0), 1464,1364 cm'l; HRMS m/z 
377.25070 [calculated for C22H3703Si CM-H)+, m/z 377.25119]; Ammonia CI Mass, m/z 
396.3 for M++ NH4. 
Preparation of 12-epi-carbacvclin ( 9 )  
To a solution of (4-carboxybutyl)triphenylphosphonium bromide (Aldrich, dried for 
12 h at 100 ®C under reduced pressure, 1.15 g, 2.66 mmol) in 9 ml of fi-eshly distilled THF 
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was added KHMDS (Aldrich, 0.5 M in THF, 10.7 ml, 5.32 mmol) at room temperature 
under N2atmoq)here. At this point, the reaction mixture turned a deep red color. The 
reaction mixture was stirred for 15 min at room temperature. To this was added slowly 
ketone ^(118 mg, 0.44 mmol) in 2 ml of THF. The reaction mixture turned a brown color. 
After stirring for 3 h at room temperature, the reaction was quenched by adding H2O (25 ml). 
The reaction mixture was washed with ethyl acetate (25 ml) to remove any organic soluble 
side-product The aqueous layer was acidified by adding 2N aqueous HCl (2.4 ml). The 
solution was extracted with CH2CI2 (20 ml x 3). The organic phase was washed with water 
(15 ml), then dried over anhydrous MgS04 and concentrated. The cmde product was 
purified by flash chromatography with 500:1 EtOAc/acetic acid to give compounds 9 (44 mg) 
and 39 (29 mg) as oils in an overall 47% yield. Compound 9: Rf = 0.31 (500:1 
EtOAc/AcOH); ^H NMR (CDQs) 8 5.66 (dd, J = 15.3 and 9.0 Hz, IH, HC=C), 5.52 (dd, 
J = 15.3 and 6.6 Hz, IH, HC=C), 5.16 (t, J = 6.9 Hz, IH, HC5=C), 4.63 (br s, 2H, 
OH's), 4.09 (m, 2H), 2.71-2.45 (m, 3H), 2.45-2.23 (m, 5H), 2.23-2.08 (m, 2H), 2.08-
1.95 (m, 2H), 1.78-1.63 (m, 2H), 1.63-1.42 (m, 3H), 1.42-1.18 (m, 7H), 0.89 (t, J = 6.9 
Hz, 3H, CH3); 13c NMR (CDCI3) 6 177.87, 144.71, 136.69,129.18, 119.96, 76.92, 
73.18, 51.33, 44.50, 41.49, 40.54, 37.07, 36.04, 35.80, 33.50, 31.80, 28.79, 25.26, 
24.74,22.71,14.12; IR (neat) 3414 (OH), 2930,2858,1709 (C=0), 1437 cm'l; HRMS 
m/z 332.23463 [calculated for C21H32O3 (M-H20)+, m/z 332.23515]; Ammonia CI Mass, 
m/z 368.2 for M++ NH4. Anal. Calcd for C21H34O4: C, 71.96; H, 9.78. Found: C, 70.19; 
H, 8.77. The poor elemental analysis is possibly due to insufficient diying of compound 9. 
Compound 39: Rf=0.38 (500:1 EtOAc/AcOH); ^H NMR (CDCI3) 5 6.00 (br s, 2H, 
OH's), 5.69 (dd, J = 15.3 and 7.8 Hz, IH, HC=C), 5.57 (dd, J = 15.3 and 6.3 Hz, IH, 
HC=C), 5.19 (t, J = 7.2 Hz, IH, HC5=C), 4.12 (m, 2H), 2.64-1.95 (m, 12H), 1.78-1.25 
(m, IIH), 0.88 (t, J = 6.6 Hz, 3H, CH3); l^C NMR (CDCI3) 5 178.90, 144.57, 136.22, 
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129.69, 119.96, 76.47, 73.26, 51.28, 45.83, 41.45, 40.32, 37.05, 33.27, 31.81, 30.29, 
28.55,26.42,25.25,24.54,22.69, 14.15; IR (neat) 3425 (OH), 1710 (C=0) cm'l; HRMS 
m/z 332.23470 [calculated for C21H32O3 (M-H20)+, 332.23515]; Ammonia CI Mass, nVz 
368.4 for M++ NH4. Anal. Calcd for C21H34O4: C, 71.96; H, 9.78. Found: C, 67.63; H, 
9.93. The poor elemental analysis is possibly due to insufficient drying of compound 39. 
Preparation of compound 11^ 
To a solution of Pd(PPh3)4 (1.18 g, 1.0 mmol) and ethyl acetoacetate (9.4 g, 72 
mmol) in 50 ml of THF was added dropwise over 20 min at 0 ^ C cyclopentadiene 
monoepoxide (4.9 g, 60 mmol) dissolved in 10 ml of THF. After stirring for 40 min at 0 
OC, the mixture was allowed to warm to room temperature, then stirring was continued for 
24 h at room temperature. The reaction mixture was concentrated in vacuo, and the crude 
product was purified by flash chromatography with 1:1 hexan^tOAc to give compound 11 
as an inseparable mixture of diastereomers: 10.6 g, 83% yield; Rf = 0.25 (1:1 
hexane/EtOAc); % NMR (CDCI3) S 5.82 (m, 2H, HC=CH), 4.72 (m, IH), 4.19 (dq, J = 
1.8 and 7.2 Hz, 2H), 3.53 (dd, J = 8.1 and 6.0 Hz, IH), 3.26 (m, IH), 2.52 (dt, J = 17.1 
and 7.8 Hz, IH), 2.23 (ddt, J = 42.3 and 14.1 and 3.9 Hz, IH), 2.24 (s, 3H), 1.44 (dd, J = 
4.8 and 7.8 Hz, IH), 1.26 (t, J = 6.9 Hz, 3H, CH3); NMR (CDa3) 5 202.36, 169.08, 
168.72, 135.62, 135.29, 134.80, 134.31, 76.49, 64.59, 64.43, 61.52, 43.43, 43.22, 
38.02, 37.28, 30.08, 29.72, 14.13; IR (neat) 3423 (OH), 1715 (C=0) cm-1. 
Preparation of compound 12 
To a solution of alcohol H (2.90 g, 13.7 mmol) and imidazole (2.33 g, 34.3 mmol) 
in 20 ml of DMF was added with stirring at room tençerature r-butyldimethylsilyl chloride 
(2.27 g, 15.1 mmol) dissolved in 16 ml of DMF. After stirring for 14 h at room temperature, 
the reaction was quenched by adding 20 ml of H2O. The mixture was extracted with hexane 
(50 ml X 3), and the organic phase was washed with brine (50 ml), then dried and 
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concentrated. The residue was purified by flash chromatography using 4:1 hexane/EtOAc to 
give compound 12:4.27 g, 96% yield; Rf = 0.53 (4:1 hexane/EtOAc); NMR (QDCI3) 6 
5.79 (m, 2H, HC=CH), 4.79 (m, IH), 4.20 (q, J = 7.2 Hz, 2H), 3.48 (dd, J = 10.5 and 
3.6 Hz, IH), 3.24 (m, IH), 2.40 (m, IH), 2.24 (s, 3H), 1.27 (m, 4H), 0.88 (s, 9H, t-
BuSi), 0.06 (s, 6H, SiMe2). 
Preparation of compound 13 
To a round bottomed flask attached with a reflux condenser were placed compound 
12 (6.7 g, 20.6 mmol), DMSO (20.6 ml), H2O (1.1 ml) and NaCl (1.8 g, 31.0 mmol). The 
reaction was placed in a hot oil bath (165-170 ®C), and stirring was continued for 9 h. The 
mixture was cooled to room temperature, then poured into 150 ml of diethyl ether. The 
phases were separated, and the organic phase was washed with water (3 x 30 ml) and brine 
(30 ml). After being dried and concentrated in vacuo, the reaction mixture was purified by 
flash chromatography to give compound 13 as a colorless oil: 4.44 g, 85% yield; Rf = 0.50 
(4:1 hexane/EtOAc); Ir NMR (CDCI3) S 5.74 (m, 2H, HC=CH), 4.81 (m, IH, CHOSi), 
2.95 (m, IH), 2.55 (m, 3H), 2.18 (s, 3H, 0=CCH3), 1.23 (ddd, J = 13.2 and 6.0 and 5.4 
Hz, IH), 0.89 (s, 9H, /-BuSi), 0.06 (s, 6H, SiMe2); NMR (CDCI3) 5 207.79, 135.83, 
134.41, 76.43, 50.15, 40.71, 39.04, 30.22, 25.78, 18.02, -4.75; IR (neat) 1718 (C=0) 
cm"l; HRMS m/z calculated for Ci4H2502Si 253.16238, found 253.16260. 
Typical procedure for the reactions in Table 1 
In a vial were placed compound 7 (98 mg, 0.30 mmol), ethyl vinyl ketone (504 mg, 
6.0 mmol), NaOAc (49 mg, 0.6 mmol), Pd(0Ac)2 (81 mg, 0.36 mmol) and THF (0.9 ml) as 
a solvent After the resulting mixture was stirred for 2 h at room tençerature, it was filtered 
through a silica gel pad. Concentration and flash chromatography with 3:1 hexane/EtOAc 
provided compounds 14,15 and 12. 
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Typical procedure for the reactions in Table 2 
In a vial were placed compound 7 (98 mg, 0.30 mmol), ethyl vinyl ketone (504 mg, 
6.0 mmol), NaOAc (82 mg, 0.6 mmol), Nal (9 mg, 0.06 mmol) and THF (1.8 ml). The 
resulting mixture was stirred for 5 min at room temperature, then Pd(0Ac)2 (81 mg, 0.36 
mmol) was added. After stirring for 2 h at room temperature, the reaction mixture was 
filtered through a silica gel pad. Concentration, followed by flash chromatography, gave 
compounds 14,1^, and 13. 
Compound 14 
Rf = 0.27 (3:1 hexane/EtOAc); % NMR (CDCI3) 5 6.95 (dd, J = 16.2 and 8.7 Hz, 
IH, HC=CHCO), 6.12 (d, J = 16.2 Hz, IH, HC=CHCO), 4.29 (m, IH, CHOSi), 2.94 (m, 
2H), 2.69 (m, IH), 2.59 (m, 4H), 2.25 (m, 3H), 1.65 (m, IH), 1.10 (t, J = 7.2 Hz, 3H, 
CH3), 0.85 (s, 9H, f-BuSi), 0.02 (s, 6H, SiMe2); l^C NMR (CDCI3) S 219.57, 200.794 
145.02, 132.05, 78.43, 51.94, 46.32, 44.15, 43.74, 40.16, 38.18, 32.58, 25.74, 18.04, 
8.22, -4.63; IR (neat) 2955,1748 (C=0), 1674 (C=0), 1256 cm'l; HRMS m/z 321.18885 
[calculated for Ci8H2903Si (M-CH3)+, 321.18860]. 
Compound 15 
Rf = 0.46 (3:1 hexane/EtOAc); ^H NMR (CDCI3) 8 5.82 (m, IH, HC=C), 5.72 (m, 
IH, C=CH), 3.40 (m, IH), 2.95 (m, IH), 2.69 (ddt, J = 16.5 and 5.1 and 2.4 Hz, IH), 
2.47 (m, 2H), 2.21 (m, 2H), 1.98 (dd, J = 18.9 and 6.9 Hz, IH); NMR (CDCI3) 5 
220.49, 134,07, 130.43, 46.31, 44.93, 42.67, 40.15, 37.12; IR (neat) 2928, 2903, 1742 
(C=0), 1402,1159 cm-1. 
Preparation of compound 20 
To a solution of LDA (0.65 mmol) was added compound 23 (120 mg, 0.65 mmol) at 
-78 OC. After stirring for 1 hat that temperature, TMSCl was added at -78 OC. The reaction 
mixture was warmed to room temperature, and stirring was continued for an additional 2 h. 
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The reaction mixture was concentrated, and then hexane was added and the LiCl solid which 
precipitated was filtered off. After concentration and flash chromatography using 4:1 
hexane/EtOAc, compound 20 was obtained: 96 mg, 57% yield; Rf = 0.52 (4:1 
hexane/EtOAc); NMR (CDCI3) 5 5.93 (m, IH, C=CH), 5.80 (m, IH, HC=C), 4.69 (m, 
3H), 4.06 (s, 2H), 3.37 (s, 3H), 2.78 (m, IH), 2.42 (dt, J = 13.8 and 7.5 Hz, IH), 2.18 
(dd, J = 13.2 and 6.9 Hz, IH), 2.04 (m, IH), 1.44 (dt, J = 13.5 and 5.1 Hz, IH), 0.22 (s, 
9H, SiMe3). 
Preparation of compound 22 
To a solution of alcohol H (1.0 g, 4.7 mmol) and triethylamine (2.0 ml, 14.1 mmol) 
in 10 ml of TEiF was added MOMCl (Aldrich, 0.72 ml, 9.4 mmol) dropwise over 5 min. 
After stirring for 9 h at room temperature, the mixture was filtered, and then concentrated. 
The residue was purified by flash chromatography to give compound 22:1.04 g, 83% yield; 
Rf = 0.52 (1:1 hexane/EtOAc); ^H NMR (CDCI3) 6 5.90 (m, 2H), 4.85 (m, 3H), 4.20 (q, J 
= 7.2 Hz, 2H), 3.45 (dd, J = 10.5 and 5.4 Hz, IH), 3.35 (d, J = 2.1 Hz, 3H), 3.30 (m, 
IH), 2.47 (m, IH), 2.24 (s, 3H), 1.41 (m, IH), 1.27 (t, J = 7.2 Hz, 3H). 
Preparation of compound 23^^ 
A mixture of anhydrous propane-l,2-diol (16 ml) and sodium methoxide (343 mg, 
6.4 mmol) was heated at 85 ®C for 15 min. To this was added compound 22 (812 mg, 3.2 
mmol) and heating was continued for 40 min. The reaction mixture was cooled to room 
temperature and H2O (5 ml) was added, and then the reaction mixture was extracted with 
ether (30 ml x 3). The organic phase was washed with saturated NEI4CI (20 ml) and brine 
(20 ml). Concentration, followed by flash chromatography, gave product 23:122 mg, 21% 
yield; % NMR (CDCI3) S 5.86 (m, 2H), 4.67 (m, 3H), 3.36 (s, 3H), 2.99 (s, IH), 2.55 
(s, 3H), 2.13 (s, 3H), 1.35 (dt, J = 13.8 and 7.5 Hz, IH). 
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Preparation of compound 31^^ 
To a solution of LiAlH4 (Aldrich, 1.0 M in THF, 0.6 ml, 0.6 mmol) was added 
ethanol (2.0 M in THF, 0.3 ml, 0.6 mmol) dropwise over 10 min at room temperature. 
Subsequently a THF solution of (S)-binaphthol (Aldrich, 170 mg, in 1 ml of THF, 0.60 
mmol) was added dropwise, and the resulting mixture was stirred for 30 min at room 
temperature. Enone 8 (91 mg, 0.24 mmol) in 1 ml of THF was added dropwise over 3 min 
at -100 (liquid N2 and methanol bath). The reaction mixture was stirred for 2 h at -100 
OC, and then another 2 h at -78 ^C. Methanol (1 ml) was added at -78 to destroy the 
excess reducing agent, and the reaction mixture was allowed to warm to room temperature. 
After the addition of water (25 ml) and diethyl ether (30 ml), stirring was continued for 10 
min. The reaction solution was neutralized with 2N HCl, and then extracted with ether (30 
ml X 3). The organic phase was dried over anhydrous MgS04 and concentrated in vacuo. 
Grade product (247 mg) was obtained. The relative product ratio was calculated using ^H 
NMR spectroscopy by integration of the following characteristic peaks: compound 8,6.09 
ppm (d, J = 15.9 Hz, C=CH-C=0); compound 34. 5.77 ppm (dd, J = 15.6 and 8.1 Hz, 
HC=C); compound 25» 6.06 ppm (d, J = 15.6 Hz, C=CH-C=0). The product ratio of 
confounds 2â and 25 was calculated to be 9 :1. The crade product was dissolved in 3 ml of 
THF. To this was added 3 ml of 0.5 N aqueous HCl at room temperature. After stirring for 
38 h at room temperature, the mixture was neutralized with 3N aqueous NaOH. Water (7 ml) 
was added to the mixture. After extraction with CH2CI2, the organic phase was dried and 
concentrated. The residue was purified by flash chromatography to give compound 31: 32 
mg, 50% overall yield; Rf=0.19 (1:2 hexane/EtOAc); ^H NMR (CDCI3) 5 5.72 (dd, J = 
15.3 and 7.5 Hz, IH, HC=C), 5.61 (dd, J = 15.3 and 6.3 Hz, IH, C=CH), 4.29 (m, IH, 
CHOH), 4.09 (q, J = 6.3 Hz, IH, CHOH), 2.88 (m, 2H), 2.68 (dt, J = 4.5 and 7.5 Hz, 
IH), 2.61-2.51 (m, 2H), 2.32-2.20 (m, 3H), 2.03 (br s, 2H, OH's), 1.61 (dt, J = 14.4 and 
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3.0 Hz, IH), 1.50 (m, 2H), 1.29 (m, 6H), 0.88 (t, J = 6.6 Hz, 3H, CHg); NMR 
(CDCI3) 8 221.40, 136.80, 128.41, 76.83, 72.91, 51.17, 46.38, 42.20, 40.49, 37.33, 
36.97, 31.73,25.15,22.60,14.05, one aliphatic carbon is overlapped; IR (neat) 3404 (OH), 
2930,1734 (C=0), 1458 cm'l; HRMS m/z calculated for C16H26O3 266.18819, found 
266.18851. 
Compound 36 
Rf = 0.31 (1:2 hexane/EtOAc); ^H NMR (CDCI3) Ô 7.14 (dd, J = 16.2 and 7.8 Hz, 
IH, HC=CHCO), 6.69 (d, J = 16.2 Hz, IH, C=CH-C=0), 4.32 (m, IH, CHOH), 4.25 (m, 
IH, CaiOH), 3.20 (br s, IH, OH), 2.72 (m, 4H), 2.59 (t, J = 7.8 Hz, 2H, 0=CCH2), 2.25 
(ddd, J = 15.0 and 7.5 and 5.7 Hz, IH), 2.14 (ddd, J = 13.8 and 8.4 and 5.7 Hz, IH), 1.98 
(m, IH), 1.88-1.79 (m, 2H), 1.62 (m, 2H), 1.31 (m, 5H), 0.89 (t, J = 6.6 Hz, 3H, CH3). 
Compound 39 
See preparation of compound 9. 
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CHAFEERIV. PREPARATION OF ALLYLIC ARYL ETHERS 
VIA tu-ALLYLPALLADIUM CHEMISTRY 
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INTRODUCTION 
As a part of our synthetic work directed toward the synthesis of optically pure 
benzoprostacyclins described in Chapter n of this dissertation, we found the need for 
optically pure allyl aryl ether 3 (eq 1). Thus, we decided to follow the procedure recently 
AcO 
o 
TBDMSC? ^  
developed by Deardorff etal.^. It was reported that cyclopentanoid 5 was obtained 
stereoselectively via nucleophilic attack of phenoxide on a Ji-allylpalladiiun complex 
generated from allylic acetate 4 (eq 2). Unfortunately, none of the desired product 7 was 
o 
AcS 
4 
TBDMSO 3 
OH < 
THF, 50 °C, 1 h 
°ro 
90% 
obtained when 2-allyl-6-iodophenol (6) was subjected to Deardorff s reaction conditions (eq 
3). Several variations in the reaction conditions, including solvent and Pd(0) species, led to 
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AcO 
Q 3% P(i(PPh3)4 
+ 2NaH ^ /-^l I) 
THF, 50't,24h (3) 
HO ^ (major) 
4 + 2 6  . 2 N a H  •  2  , , ,  
DMSO, 50 °C, 24 h 0% 
i  +  2 &  4 . 2 N a H  3%Pd(dba)a ^ j 
THF, 50 T. 24 h 
the same results (eqs 4 and 5). Failure to effect the desired phenoxide attack on the tc-
allylpalladium complex is probably due to steric hindrance around the phenoxide anion. In 
addition, product 2 may actually revert to starting material 4 in the presence of NaOAc 
through palladium chemistry (eq 6). 
AcO 
Pd(0) 
^ ^ ^  N a O A c  ( 6 )  
•5 
HO 7 
The above observations led us to survey literature procedures involving oxygen 
nucleophiles and re-aUylpalladium complexes. Intramolecular attack of oxygen nucleophUes 
on 7t-allylpalladium complexes have proven useful in OTganic synthesis^. However, few 
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oxygen nucleophiles have proven useful for intennolecular attack on Tc-allylpalladium 
intermediates. 
Takahashi and co-workers^ reported that the phenoxy grog) in allyl phenyl ethers 
may be replaced by other phenoxy groups, such as p-methylphenoxy, employing 
PdQ2(PPh3)2-NaOPh as the catalyst Allyl acetate was also converted to allyl phenyl ether 
by phenoxide attack on 7t-allylpalladium complexes (eqs 7 and 8). Unfortunately, the yields 
are low to moderate in most cases, with formation of aUylic isomers. Thus, the synthetic 
value of this reaction is not high. 
phenoxy-2-cyclopenten-l-ol (5) based on the reaction of phenol with cyclopentadiene 
monoepoxide (§) (eq 9). Later they^ extended this chemistry to the synthesis of 
1.0 HO 
1.0% PhONa 
17 h, 85 °C 
1.0% PhONa 
3 h , 8 5 ^  41' 
HO 
Deaidorff and co-workers previously described'^  a palladium-catalyzed route to 4-
OH o 
+ 
THF, 0 T, lOmin 
0.5% Pd(PPh3)4 
( 9 )  
8 
82% 
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unsymmetricàlly protected diol IQ using silyl-protected phenols 9 (eq 10). Even though a 
good example of the intennolecular attack of the phenoxide nucleophile in 7C-allylpalladium 
chemistry was presented, this reaction is limited to only cyclopentadiene monoepoxide 
and sterically less congested phenols. 
a 
OSiMe 
MegSiCJ 
1.0% Pd(PPh3)4 
THF, rt (5 
(10) 
R = H 23% 
R = NO2 87% 
Larock and Stolz-Dunn recently reported^ that mixtures of regio- and stereoisomers 
were obtained upon Pd(0)-catalyzed reaction of phenol and vinylic oxetanes (eqs 11 and 12). 
OH 
/\-0 THF 
Cj + 1.2||^ +2%Pd(PPh3)4^ + ^^^(11) 
OH 
2.5 h 11 — 
84% 16% 
THF 
9% Pd(PPh3)4 s- 23% + 58% ( 12 ) 
40% (87:13 E/Z) 
3.5 h 
With a low amount of the palladium catalyst and a low reaction temperature, the kinetic 
product li was obtained as the major product With a higher amount of palladium catalyst 
and a higher reaction temperature, the thermodynamic product 12 was observed as the major 
product. 
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Larock and Lu also observed^ the selective attack of phenoxide on 7t-allylpalladium 
complexes generated through palladium hydride migration (eq 13). 
T DMSO, 100 °C 60% 
COgEt 
Thus far, no truly general, broadly useful synthetic method to prepare aryl allylic 
ethers from phenols and Jt-allylpalladium complexes has appeared. Since aUyl aryl ethers are 
very important in organic synthesis as starting materials for thermal^ or Lewis acid-
catalyzed^ Claisen rearrangements, we have attempted to develop just such a process. 
149 
RESULTS AND DISCUSSION 
To overcome the problems described in equations 3-6, we decided to carry out the 
reaction employing a unimolecular process. AUylic carbonates appeared to be appropriate as 
starting materials in this reaction. AUylic carbonates are known to be more reactive than 
allylic acetates in %-allylpalladium chemistry, generally reacting with nucleophiles under mild 
conditions^®. Since no examples have been found of oxygen nucleopMes being generated 
from allylic carbonates in R-allylpalladium chemistry, we simply examined the reaction with 
allyl alcohol (eq 14). Carbonate 13 was prepared quantitatively using commercially available 
O 
^\yOH 1.2 ClCOPh 
_ 1.5% Pd(PPh3)4 
1.5p^dine ' 
benzene, rt — 
100% 87% 
phenyl chloroformate and allyl alcohol. The desired decarboxylation, followed by phenoxide 
attack on the intermediate :c-allylpalladium complex was cleanly effected using Pd(PPh3)4 to 
give allyl phenyl ether (14) in 87% yield. 
Cyclopentenyl carbonate 16 was also prepared and subjected to the same reaction 
conditions (eqs 15 and 16). The starting material 16 was recovered in 21% yield after 3 d 
stirring at room temperature (eq 15). However, the reaction could be completed by a slight 
increase of the reaction temperature to give phenyl ether 17 in 75% yield (eq 16). 
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TBDMSd 
HO 
o 
o 
1.2 ClCOPh 
1.5 pyridine 
benzene, rt • 
1.5% Pd(PPh3)4 
+ 16 
.2  
15 TBDMSd TBDMS(? 16 
89% • rt, 3 d 44% 
• 47*^,2 h 75% 
17 
21% ( 15 ) 
( 1 6 )  
The product 17 was obtained as a single isomer. The stereochemistry of the product 
was assigned by comparing the NMR spectra to analogous compounds 16 and 18 shown 
below. 
Ha 6 2.89 (dt, J=14.3, 7.0 Hz) 5 2.93 (dt, J=13.8, 7.2 Hz) 6 3.08 (dt, J=13.5, 7.2 Hz) 
HfeS 1.78 (dt, J=14.3, 3.8 Hz) 5 1.83 (dd, J=13.8, 4.8 Hz) 5 1.95 (dd, J=13.5, 5.1 Hz) 
Since good results were obtained with simple phenyl carbonates, we decided to 
extend this chemistry to more complex carbonates, such as compound 12 (see equations 18 
and 19). Since compound 12 has additional functional groups in the phenyl ring, we needed 
to develop a synthetic procedure to prepare compound 12 from the funtionalized phenol 6-
TBDMSO TBDMSO 
1& m 17 
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From a literature survey ^  1, no general method was found for the synthesis of 
unsymmetrical carbonates. However, we envisioned the step-by-step addition of two 
different alcohols to phosgene as an one-pot procedure (eq 17). Since phosgene is difficult to 
O 
J1 
CI^C! 
ROH 
-HCl 
O 
X RO^CI 
R'OH 
-HCl 
O 
RO^OR* ( 17 ) 
handle, we considered instead the use of ttiphosgene which has been reported to generate 
three equivalents of phosgene upon reacting with bases^^. We were pleased to find that 
consecutive addition of phenol é and alcohol 15 provided carbonate 12 in 71% yield in a one-
pot procedure. With carbonate 12 in hand, we carried out the palladium reaction under the 
same conditions used in the reaction illustrated in equation 14 (eq 18). The desired product 
 ^ 9 
1.2/5 ClsCOCOCas 
1.0 pyridine 
2. 1.0 li 
1.0 pyridine JBDMSC? — 
19 
71% TBDMSa 2Q 
1.5% Pd(PPh3)4 
THF, 50 ®C, 20 h 
5% Pd(0Ac)2 
20% PPhj 
rt,THF, 1 d 
5% 50% 
55% 10% 
( 1 8 )  
( 1 9 )  
20 was obtained in only a 5% yield, acconçanied by the starting material 12 in 50% yield. A 
literature report^^ that a tetrakis Pd(0) species generated in situ ôom Pd(OAc)2 and PPhg 
gave better results than Pd(PPh3)4 in jc-allylpalladium chemistry led us to try the reaction 
enoploying Pd(OAc)2 and PPhg as a catalyst Pleasantiy, it was found that Pd(0Ac)2 and 
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PPh3 were better than Pd^Ph3)4 in this reaction and gave compound 2Q in 55% yield as a 
single isomer (eq 19). In addition, this reaction is operationally simpler, because Pd(0Ac)2 
and PPhg can be handled with less difficulty than Pd(PPh3)4. 
Since a better result was obtained using Pd(0Ac)2 and PPhg, we re-examined the 
reaction of allylic acetate 4 and phenol 6 using this catalyst system (eq 20). However, none 
of the desired product was obtained 
+ 1.5 NaH 
5% Pd(0Ac)2 
20% PPhg 
THF, 50 °C, 12 h 
(20) 
HO 0% 
We also examined the reaction of methyl carbonate 21 and o-iodophenol under neutral 
conditions (eqs 21 and 22). Neither reaction gave any of the desired product 22. Only a 
o OH 
Q^OCHa^ 
.fV' X) 
1.5 pyridine 1.5% Pd(PPh3)4 (' n— 
TBDMS(5  ^ TBDMS<5 . THE, SO °C, 12 h 
11 21 
91% 
21 
TBDMSO 
OH 
1.2 (V' 
5% Pd(0Ac)2 
20% PPhg 
THF, 50 2 d 
22 
0% 
0% ( ) 
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volatile product which seemed to be a low molecular weight cyclopentanoid was obtained as a 
side product. 
With the results above, a number of carbonates were synthesized and subjected to the 
reaction conditions employed in equation 18. The results were summarized in Table 1. 
Phenyl carbonates were prepared from commercially available phenyl chloroformate 
and allylic alcohols usually in quantitative yield. Functionalized aryl carbonates, such as 19 
and 43, were prepared efficiently from triphosgene and the corresponding alcohols in a one-
pot procedure (eq 23). 
However, more sterically bulky phenols, such as compounds 2 and 48, failed to give 
carbonates, probably due to steric hindrance around the hydroxy group (eqs 24 and 25). 
1.0 pyridine, CH2CI2 1.0 pyridine 
O 42 
90% 
rt, 2h 
(24) 
1 TBDMS(Î 0% 
( 2 5 )  
0% 
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Table 1. Palladium-mediated synthesis of allyl aryl ethers^ 
Entry Substrate Temp. (OQ Time Solvent Product(s) % Isolated Yield 
lb 
13 
2b 
OPh 
O X O^OPh 
Ô 
TBDMSO lé 
O 
,A, o o 
0 
TBDMS(f 12 
rt Ih THF 
47 2 h THF 
I  I t  I d  THF 
OPh 
14 
PhO 
.0 
TBDMSO 17 
o 
TBDMSO 20 
87 
75 
55 (61)c 
Ô OPh 50 1 h THF 
22. 
24 
OPh 
/^/^OPh 
25 
04:25 = 86:14) 
74 
^AU reactions were performed employing 5 mol % of Pd(0Ac)2,20 mol % of PPhg, 
1.0 mmol of substrate and 20 ml of solvent under N2 unless otherwise stated. 
bThe reactions were conducted using 1.5 mol % of Pd(PPh3)4. 
^Yields based on recovered starting material. 
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Table 1. Continued 
Entry Substrate Temp. (OQ Time Solvent Product(s) % Isolated Yield 
23 rt 12 h THF 24:25 = 87:13 62 
rt 2 h THF 24:21 = 86:14 80 
O OPh 
2 â l  
rt 5h THF 
O OPh OPh 
27 J 28 
10 CH2CI2 I 31 / bPh 22 
30 ° V ^ .OPh 
60 
8 / ^ O OPh 55 10 h THF 28 27 
22 
9d 22 rt Id CH2CI2 28 42 
I ' O
(21:52 = 86:14) 
^In this reaction, an additional portion of catalyst [5% Pd(0Ac)2 and 20% PPhg] was 
added after 12 h to attain complete conversion to products. 
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Table 1. Continued 
Entry Substrate Temp. (OQ Time Solvent Product(s) % Isolated Yield 
l ie  
O 
II 
PhOCO VW I 
AÀ 
22 
50 2d THF 
12 OCOPh rt 5h THF 
26 
34 OPh 
ruw I 
AÀ 
25 
(34:35 = 60:40) 
38 OPh 
(22:28 = 89:11) 
43 (53)C 
89 
13 
O 
II 
•OCOPh rt 30 h THF 
\ 22 
65 
®This reaction was conducted using 5 % Pd(PPh3)4. 
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Table 1. Continued 
Entry Substrate Temp. (^C) Time Solvent Product(s) % Isolated Yield 
14 22 rt 3 d CH2CI2 40 70 
O 
JJ 
O OPh OPh 
15 JL 50 12 h THF JL 62 
ci) 
16 A JL II rt 3d CH2CI2 74 A? 
17 "^y^O^OPh rt 4 h THF 81 
Although changing various reaction conditions, including solvent, reaction temperature and 
base, we were still unable to obtain any of the desired products 47 and 49. 
As seen in Table 1, this reaction provides a general method for the preparation of 
allylic aryl ethers from allylic alcohols and phenols via carbonates. As described earlier, a 
high degree of regio- and stereoselectivity was observed with cyclopentenyl carbonates 16 
and 19 to give compounds 12 and 20 with retention of stereochemistry (entries 2 and 3). The 
regioselectivity was examined in entries 2-14, and found to be excellent to good. The 
regioselectivity between primary and secondary centers was examined in entries 4-6. When 
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compounds 23 and 26 were subjected to the reaction conditions, regioisomers 24 and 25 
were obtained in an 86:14 or 87:13 ratio. This shows that the regioselectivity is dependent on 
the charge distribution in the jc-allylpalladium intermediate. Nucleophilic attack is favored at 
the more substituted allyl terminus. The reaction temperature didn't affect the regioselectivity 
(entries 4 and 5). The results in entries 4-6 show that the same 7t-allylpalladium complex was 
generated independent of the original position of the leaving group. Even though attempts 
were made to improve the regioselectivity in the reaction of carbonate 26, no improvement 
was observed. These efforts will be described later. 
The regioselectivity between primary and tertiary centers was found to be excellent 
(entries 7-9). Only a single product 28 was obtained from carbonates 27 and 29 as indicated 
by NMR analysis, independent of the position of the leaving group. With compound 29, 
a slightly better yield was obtained using Œ2CI2 as the solvent 
Ethers, such as 1,1-dimethyl allyl phenyl ether (28) have been reported to be 
important substrates for Claisen rearrangement to o-isopentenyl phenols which are abundant 
in nature The compound 28 has been previously prepared by a partial hydrogénation 
of 1,1-dimethyl propargyl ether (51) which was prepared firom phenol and 3-chloro-3-
methylbut-l-yne (50) (eq 26). The method developed here can be an alternative route to 
H2 
cat Pd/C (26)  
acetone 51 
70-90% 
28 
>90% 
compound 2S from more readily available allylic alcohols. Moreover, our approach is 
advantageous in that we can obtain compound 2& from either starting material 22 or 22. 
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In the reaction of carbonate 30 derived from geraniol, the selectivity between the 
primary and tertiary positions was not as good, giving a 86:14 ratio of compounds 21 and 32 
(entry 10). Comparing the results with those of substrates 27 and 29, we might expect that 
carbonate 30 would generate a more stoically congested tertiary center, thus giving less 
selectivity due to a competitive steric effect As an altemative explanation, we might assume 
that some stabilization of the palladium in intermediate SZ by olefin coordination, which is not 
available in compounds 22 and 29, might favor formation of regioisomer 22 (Scheme I). 
Scheme 1. 
H 
L^Pd(+) 
5^2 
PhO' Sn2' 
OPh 
H 
C! 
53 
PhO" Sn2' 
/ 
21 OPh 
We also examined the regioselectivities between secondary and tertiary carbons in the 
TC-allylpalladium intermediates (entry 11). Even though nucleophilic attack favors the tertiary 
product over the secondary product, the selectivity is poor. Iq this reaction, the use of 
Pd(PPh3)4 as a catalyst provided a better result than Pd(0 Ac)2-PPh3. Since the starting 
material 21 is probably unstable to acidic conditions, the acetic acid generated by reduction of 
Pd(OAc)2 might be destroying compound 33 when using the Pd(OAc)2-PPh3 catalyst 
system. 
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In entry 12, the reaction of carbonate 36 prepared from cinnamyl alcohol was 
examined. Due to the thermodynamic stability of conjugated carbon-carbon double bonds, 
phenoxide was found to attack the less hindered terminus of the 7t-allylpalladium intermediate 
54 favoring formation of compound 3? as the major product in an 89:11 isomeric ratio. 
» A" 
In entry 13, carbonate 32 was prepared from (-)-myrtenol. It was considered to be of 
interest to examine the regio- and stereoselectivity of this reaction. Since 7c-allylpalladium 
complexes are reported to be generated via the intermediacy of an olefin-PdL2 complex, such 
as 55 it was expected that the palladium should be directed toward the bottom of 
intermediate 56. Thus, we would expect regioisomers 4Q and SI in which the phenoxy 
group has attached itself to the upper face of the molecule, since the overall reaction has 
Scheme H. 
O OPh 40 
PPh 
57 
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already been shown to proceed with retention of stereochemistry (entries 2 and 3). However, 
subjection of carbonate 39 to the reaction conditions yielded compound 40 as the sole 
product, which shows that steric effects override the electronic effects in this reaction. 
In entry 16, sterically bulky 2,6-dimethylphenoxide was employed as the nucleophile. 
Upon reaction, compound 43 gave the product 44 in 74% yield. This result shows that this 
methodology provides a useful route to introduce sterically congested phenols into an allylic 
position. 
In entry 17, we examined carbonate 45 which has a methyl group at the C2 position 
of the resulting 7C-allylpalladium complex Nucleophilic attack of phenoxide proceeds well 
to give ether 46 in 81% yield. 
As mentioned earlier, we tried to improve the regioselectivity of the reaction 
represented by entry 6 in Table 1. The results were presented in Table 2. 
different regioselectivities, implying that the resulting allylic phenyl ethers undergo Pd-
assisted isomerization under the reaction conditions. Thus, we tried less Pd(0Ac)2 in entry 
2. Although the reaction took longer, the yield remained high and there was no change in the 
regioselectivity observed. This indicates that isomerization doesn't occur under these reaction 
conditions. The effect of solvent was examined in entry 3. No effect on the regioselectivity 
ÇH3 
Pd(+) ^ 
ir L 
Larock and Stolz-Dunn^ reported that employing different amounts of Pd(0) provided 
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Table 2. Attempts to improve the regioselectivity of the reaction of compound 26 
M O T solvent,!! 242Ï 
Entry % Pd(OAc)2 % PPhg Solvent Time Additive 24:25^ % Isolated Yield 
1 5 20 THF 2h 86:14 80 
2 2 8 TEÎF 12 h 86:14 81 
3 5 20 CH2Cl2 20 h 86:14 68 
4 5 10% dppe THF 2d 82:18 53 
5 3 12% Tz-BugP THF 3d - ? 
6b 5 20 DMF 3d 1.0NaN02 - 0 
^ Isomeric ratio was determined by NMR spectral analysis. 
'^This reaction was conducted at 33 OQ 
was observed. Different phosphous ligands wCTe examined in entries 4 and 5. With dppe, 
the regioselectivity and product yield decreased slightiy. W^th M-BugP, the reaction was 
found to be very slow. After stirring 3 days, only a very small product spot was observed 
upon TLC analysis. Tamura and co-workers^^ have recentiy reported that Pd(0)-assisted 
isomerization can be suppressed by adding sodium nitrite. This led us to try the reaction with 
addition of NaN02. Even though the starting material disappeared as indicated by TLC 
analysis, the reaction provided none of the desired product 
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A reaction mechanism for our overall process is proposed in Scheme HI with the 
compound lé illustrated as the starting materiaL The palladium catalyst displaces the 
carbonate group in allylic carbonate lé with inversion to give the 7C-allylpalladium complex 
Scheme HE. 
Pd(0) 
OTBDMS PhOCO OTBDMS PhO _ L 
o 
PhO" OTBDMS 
Pd(+) "OCO^h 
OTBDMS 
/ 
Pd(+) 
60 CO2 59 
59. which undergoes decarboxylation to complex 60 and phenoxide ion. The phenoxide ion, 
thus, attacks the anti face of the jc-allylpalladium intermediate to form the allylic phenyl ether 
17 with regeneration of the Pd(0) species, making the whole reaction catalytic in palladium. 
Allylic aryl ethers have previously been synthesized firom allylic halides or allylic 
alcohols 1^. However, these reactions are limited to sterically less congested primary or 
secondary allylic species or less bulky phenolic species. The method developed here exhibits 
a unique feature, that is, the sterically more congested product is obtained as the major 
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product. Due to the high regio- and stereoselectivity, along with the mild reaction conditions, 
this synthetic method should find considerable use in organic synthesis. 
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CONCLUSION 
A simple 2-step method for the synthesis of allyl aryl ethers fixjm allylic alcohols via 
allylic carbonates has been developed using Pd(0) chemistry. The allylic carbonates have 
been prepared either by using phenyl chloroformate or by ençloying triphosgene and 
substituted phenols. The palladium-mediated reaction of allylic carbonates gives high yields 
of allylic aryl ethers with high regio- and stereoselectivity. 
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EXPERIMENTAL SECTION 
Equipment 
NMR spectra were recorded on a Nicolet NT-300 spectrometer ( NMR, 300 
MHz; 13c NMR, 75 MHz), and chemical shifts are reported in ppm relative to TMS (5 0.00) 
as an internal standard. IR spectra were obtained on an IBM IR 98. High-resolution mass 
spectra were recorded on a Kratos MS-50 spectrometer. 
Reagents 
All chemicals were used direcdy as obtained commercially unless otherwise noted. 
AU starting materials were purchased ôom Aldrich (Triphosgene, phenyl chloroformate, 3-
methyl-2-buten-l-ol, 2,6-dimethylphenol, 2-methyl-2-propen-l-ol, crotyl alcohol, geraniol, 
2-cyclohexenol, allyl alcohol, 3-buten-2-ol, 2-methyl-3-buten-2-ol) and Pfaltz & Bauer, Inc. 
(4-methyl-3-penten-2-ol). Palladium acetate and Pd(PPh3)4 were generously supplied by 
Johnson Mattey, Inc. Tetrahydrofuran was distilled over sodium benzophenone ketal and 
used immediately. Methylene chloride was distilled over phosphorous pentoxide and stored 
over 4Â molecular sieves. Benzene was distilled azeotropically by adding a small amount 
ethanol. 
General procedure for the preparation of carbonates: Allvl phenyl carbonate (131 
To a solution of allyl alcohol (1.2 g, 20 mmol) and pyridine (2.4 g, 30 mmol) in 40 
ml of benzene was added phenyl chloroformate (3.8 g, 24 mmol) dropwise over 10 min at 
room temperature. After the reaction mixture was stirred for 30 min at room temperature, it 
was filtered and concentrated. The residue was purified by flash chromatography using 4:1 
hexane/EtOAc to give the title product as a colorless oil: 3.6 g, 100% yield; Rf=0.50 (4:1 
hexane/EtOAc); % NMR (CDCI3) 5 7.41-7.16 (m, 5H, phenyl), 6.07-5.93 (m, IH, 
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HC=C), 5.43 (d, J = 17.4 Hz, IH, HC=C), 5.33 (d, J = 5.4 Hz, IH, HC=C), 4.74 (d, J = 
6.0 Hz, 2H, CH2); IR (neat) 3090, 1759 (C=0), 1593,1493,1209 cm'l. 
Compound 16 
This compound was obtained in 89% yield: Rf = 0.58 (4:1 hexane/EtOAc); ^H NMR 
(CDCI3) 5 7.47-7.20 (m, 5H, phenyl), 6.09-6.02 (m, 2H, HC=CH), 5.51 (m, IH, 
CH0C=0), 4.77 (m, IH, CHOSi), 2.92 (dt, J = 13.8 and 7.2 Hz, IH, CH2), 1.83 (dt, J = 
13.8 and 4.8 Hz, IH, CH2), 0.94 (s, 9H, r-BuSi), 0.14 (s, 6H, SiMe2); IR (neat) 2948, 
1763 (C=0), 1211 cm-1. 
Compound 23 
This compound was obtained in 76% yield: Rf = 0.54 (5:1 hexane/EtOAc); ^H NMR 
(CDCI3) S 7.40-7.16 (m, 5H, phenyl), 5.89 (m, IH, HC=C), 5.68 (m, IH, HC=C), 4.66 
(dt, J = 6.6 and 0.9 Hz, 2H, OCH2), 1.76 (d, J = 6.6 Hz, 3H, CH3); IR (neat) 2947, 1763 
(C=0), 1495,1238 cm'l. 
Compound 26 
This compound was obtained in 86% yield: Rf = 0.50 (5:1 hexane/EtOAc); ^H NMR 
(CDCI3) 6 7.40-7.16 (m, 5H, phenyl), 5.93 (ddd, J = 17.4 and 10.5 and 6.3 Hz, IH, 
HC=C), 5.39-5.22 (m, 3H, HC=CH and HC0C=0), 1.46 (d, J = 6.6 Hz, 3H, CH3); IR 
(neat) 1761 (C=0), 1495,1269,1211 cm" I. 
Compound 27 
This compound was obtained in 90% yield: Rf = 0.54 (5:1 hexane/EtOAc); % NMR 
(CDCI3) 5 7.39-7.14 (m, 5H, phenyl), 6.15 (dd, J = 17.4 and 10.8 Hz, IH, HC=C), 5.29 
(d, J = 17.4 Hz, HC=C), 5.18 (d, J = 10.8 Hz, IH, HC=C), 1.63 (s, 6H, 2 CH3); IR (neat) 
2996,1755 (C=0), 1593,1269 cm-1. 
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Compound 29 
This compound was obtained in 100% yield: Rf = 0.50 (7:1 hexane/EtOAc); 
NMR (CDCI3) Ô 7.40-7.16 (m, 5H, phenyl), 5.45 (m, IH, HC=C), 4.74 (d, J = 7.5 Hz, 
2H, OCH2), 1.79 (s, 3H, CH3), 1.76 (s, 3H, CH3); IR (neat) 2874, 2937, 1763 (C=0), 
1495,1234 cm-1. 
Compound 30 
This compound was obtained in 85% yield: Rf = 0.54 (5:1 hexane/EtOAc); ^H NMR 
(CDCI3) 5 7.40-7.16 (m, 5H, phenyl), 5.44 (m, IH, HC=C), 5.09 (m, IH, HC=C), 4.77 
(d, J = 7.2 Hz, 2H. OCH2), 2.09 (m, 4H, CH2CH2), 1.75 (s, 3H, CH3), 1.69 (s, 3H, 
CH3), 1.61 (s, 3H, CH3); IR (neat) 2968, 2922, 1763 (C=0), 1495,1236,1211 cm'l. 
Compound 33 
This compound was obtained in 50% yield. This product slowly decomposed during 
flash chromatography: Rf =0.44 (7:1 hexane/EtOAc); ^H NMR (CDCI3) 5 7.40-7.16 (m, 
5H, phenyl), 5.55 (dq, J = 9.0 and 7.2 Hz, IH, OCH), 5.25 (m, IH, HC=C), 1.75 (s, 6H, 
2 CH3), 1.40 (d, J = 6.6 Hz, 3H, OCHCH3); IR (neat) 2936,1763 (C=0), 1495, 1220 
cm-1. 
Compound 36 
This compound was obtained in 92% yield: Rf = 0.34 (7:1 hexane/EtOAc); ^H NMR 
(CDCI3) 8 7.43-7.18 (m, lOH, phenyl), 6.75 (d, J = 15.9 Hz, IH, ArCH=C), 6.35 (dt, J = 
15.9 and 6.3 Hz, IH, ArC=CH), 4.89 (dd, J = 6.3 and 0.9 Hz, 2H, OCH2); IR (neat) 
3061, 3029,1763 (C=0), 1593,1495, 1263 cm'^ . 
Compound 39 
This compound was obtained in 93% yield: Rf = 0.31 (15:1 hexan^tOAc); ^H 
NMR (CDCI3) S 7.40-7.14 (m, 5H, phenyl), 5.68 (m, IH, HC=C), 4.61 (m, 2H, OCH2), 
2.44 (dt, J = 8.7 and 5.7 Hz, IH), 2.30 (m, 2H), 2.23 (dt, J = 1.5 and 5.4 Hz, IH), 2.12 
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(m, IH), 1.31 (s, 3H, CH3), 2.22 (d, J = 8.4 Hz, IH), 0.85 (s, 3H, CH3); m (neat) 2928, 
1763 (C=0), 1495,1211 cm'l. 
Compound 41 
This compound was obtained in 80% yield: Rf = 0.58 (5:1 hexane/EtOAc); NMR 
(CDCI3) S 7.40-7.17 (m, 5H, phenyl), 6.03 (m, IH, HC=C), 5.85 (m, IH, HC=C), 5.21 
(m, IH), 2.16-1.64 (m, 6H); IR (neat) 2947,1763 (C=0), 1236 cm'l. 
Compound 45 
This compound was obtained in 100% yield: Rf=0.46 (7:1 hexane/EtOAc); ^H 
NMR (CDCI3) 6 7.41-7.17 (m, 5H, phenyl), 5.09 (m, IH, HC=C), 5.01 (m, IH, HC=C), 
4.66 (s, 2H, OCH2). 1.83 (s, 3H, CH3); IR (neat) 2973, 2945,1763 (C=0), 1493,1242 
cm"^. 
Preparation of compound 19 
To a solution of 2-allyl-6-iodophenol (260 mg, 1.0 mmol) and triphosgene (119 mg, 
0.4 mmol) in 10 ml of CH2CI2 was added pyridine (79 mg, 1.0 mmol) dropwise at room 
temperature. The resulting mixture was stirred for 20 h at that temperature. To this was 
added allylic alcohol 15 (214 mg, 1.0 mmol), followed by pyridine (79 mg, 1.0 mmol). 
After the reaction mixture was stirred for 5 h at room temperature, it was quenched by adding 
20 ml of H2O. The reaction mixture was extracted with CH2CI2 (25 ml x 2), then dried and 
concentrated. The residue was purified by flash chromatography using 15:1 hexane/EtOAc to 
give compound 19: 355 mg, 71% yield; ^H NMR (CDCI3) S 7.69 (dd, J = 7.8 and 1.5 Hz, 
IH, aryl), 7.21 (dd, J = 7.8 and 1.5, IH, aryl), 6.94 (t, J = 7.8 Hz, IH, aryl), 6.04 (m, 2H, 
HC=CH), 5.89 (m, IH, C=QiCH2), 5.50 (t, J = 6.3 Hz, IH, CH0C=0), 5.14-5.09 (m, 
2H, H2C=C), 4.75 (t, J = 5.4 Hz, IH, CHOSi), 3.37 (d, J = 6.6 Hz, 2H, CH2Ar), 2.91 
(dt, J = 14.1 and 7.2 Hz, IH, CH2 in cyclopentane), 1.84 (dt, J = 14.1 and 5.1, IH, CH2 
in cyclopentane), 0.91 (s, 9H, f-BuSi), 0.11 (s, 3H, SiMe), 0.11 (s, 3H, SiMe); NMR 
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(CDC13) 5 151.80, 149.41, 140.01, 137.57, 135.04, 134.07, 130.49, 130.15, 128.00, 
116.98, 91.33, 81.84, 74.66, 40.91, 35.31, 25.91, 18.18, -4.53; IR (neat) 2955, 2930, 
1761 (C=0), 1244,1213 cnrh HRMS m/z calculated for C2lH2804SiI (M-H)+ 
499.08016, found 499.07886. 
Preparation of compound 43 
To a solution of 2,6-dimethylphenol (2.4 g, 20 mmol) and triphosgene (2.3 g, 7.2 
mmni) in 40 ml of CH2CI2 was added pyridine (1.6 g, 20 mmol) diopwise at room 
temperature. The resulting mixture was stirred for 30 min at that temperature. To this was 
added 2-cyclohexenol (2.0 g, 20 mmol), followed by pyridine (2.0 g, 25 mmol), at room 
temperature. After the reaction was stirred for 2 h, it was quenched by adding 20 ml of H2O, 
and the organic phase was separated, dried and concentrated. The residue was purified by 
flash chromatography with 7:1 hexan^tOAc to give compound ^ as a colorless oil: 4.4 g, 
90% yield; Rf = 0.48 (7:1 hexane/EtOAc); NMR (CDCI3) 8 7.05 (m, 3H, aryl), 6.05-
5.99 (m, IH, HC=C), 5.86-5.81 (m, IH, C=CH), 5.23 (m, IH, CH0C=0), 2.21 (s, 6H, 2 
CH3), 2.10 (m, IH), 2.04 (m, IH), 1.99-1.89 (m, 2H), 1.83-1.77 (m, IH), 1.70-1.65 (m, 
IH); 13C NMR (CDCI3) 8 152.67, 148.42, 133.75, 130.17, 128.63, 125.92, 124.59, 
72.72, 28.17, 24.87, 18.59, 16.10; IR (neat) 3034, 2947, 2870,1755 (C=0), 1479, 1259 
cm'l; HRMS m/z calculated for C15H18O3 246.12559, found 246.12555. 
General procedure for the preparation of allylic arvl ethers: 1.1-dimethvlalIvl phenyl ether 
(28). 
To a flask were added 1,1-dimethylaIlyl phenyl carbonate (27) (206 mg, 1.0 mmol), 
PPh3 (52.4 mg, 0.2 mmol), Pd(OAc)2 (11.2 mg, 0.05 mmol) and THF (20 ml). The 
resulting mixture was stirred until the reaction was judged complete (5 h) by TLC analysis. 
Next, the reaction mixture was concentrated using a rotaiy evaporator and purified by flash 
chromatography to give compound 2&asa colorless oil: 98 mg, 60 % yield; Rf = 0.58 (8:1 
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hexane/EtOAc); NMR (CDCI3) 5 7.23-7.18 (m, 2H, phenyl), 6.99-6.95 (m, 3H, 
phenyl), 6.13 (dd, J = 17.7 and 10.5 Hz, IH, HC=C), 5.25 (dd, J = 17.7 and 0.9 Hz, IH, 
HC=C), 5.11 (dd, J = 10.5 and 0.9 Hz, HC=C), 1.44 (s, 6H, 2 CH3); NMR (CDCI3) 
5 155.97, 144.44, 128.76, 122.21, 121.72, 113.35, 79.42, 27.07; IR (neat) 3089, 2983, 
1595,1491,1379 cm~l; HRMS m/z calculated for C11H14O 162.10447, found 162.10430. 
Anal. Calcd for C11H14O: C, 81.44; H, 8.70. Found C, 81.11; H, 8.88. 
AIM phenyl ether (14') 
This compound was obtained in 87% yield: Rf = 0.65 (4:1 hexane/EtOAc); ^H NMR 
(CDCI3) 6 7.32-7.22 (m, 2H, phenyl), 6.96-6.89 (m, 3H, phenyl), 6.04 (m, IH, HC=C), 
5.40 (d, J = 17.4 Hz, IH, HC=C), 5.27 (d, J = 10.5 Hz, IH, HC=C), 4.52 (d, J = 4.8 Hz, 
2H, CH2); NMR (CDCI3) 5 158.52, 133.32, 129.41, 120.80, 117.57, 114.69, 68.68; 
IR (neat) 3065,3040,1599,1597,1497 cm"l; HRMS m/z calculated for C9H10O 
134.07317, found 134.07345. Anal. Calcd for C9H10O: C, 80.56; H, 7.51. Found C, 
80.29; H, 7.83. 
cf5-4-f-butyldimethvIsilvloxv-2-cvclpentenvl phenyl ether (17) 
This compound was obtained in 75% yield: Rf=0.60 (6:1 hexane/EtOAc); ^H NMR 
(CDCI3) 5 7.48-7.43 (m, 2H, phenyl), 7.14-7.08 (m, 3H, phenyl), 6.23-6.18 (m, 2H, 
HC=CH), 5.27 (m, IH, CHOPh), 4.96 (m, IH, CHOSi), 3.07 (dt, J = 13.5 and 7.2 Hz, 
IH, CH2), 1.95 (dt, J = 13.5 and 5.1 Hz, IH, Œ2), 1.09 (s, 9H, r-BuSi), 0.28 (s, 3H, 
SiMe), 0.27 (s, 3H, SiMe); NMR (CDCI3) S 158.04, 138.50, 131.67, 129.48, 120.67, 
115.42, 79.71, 75.06, 42.04, 25.95, 18.25, -4.59; IR (neat) 2955, 1599, 1495, 1371, 1240 
cm'l; HRMS m/z calculated for Ci7H2502Si (M-H) 289.16238, found 289.16163; 
Ammonia CI Mass m/z 308.2 (M++ NH4). Anal. Calcd for Ci7H2602Si: C, 70.29; H, 
9.02. Found: C, 70.35; H, 9.14. 
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cf5-4-f-Butyldiniethvlsilvloxv-2-cvclopentenvl ('2-allvl-6-iodo')phenvl ether QO) 
This compound was obtained in 55% yield: Rf =0.54 (15:1 hexane/EtOAc); 
NMR (CDas) 5 7.67 (dd, J = 7.8 and 1.5 Hz, IH, aryl), 7.17 (dd, J = 7.5 and 1.5 Hz, 
IH, aryl), 6.78 (t, J = 7.8 Hz, IH, aryl), 6.04-5.85 (m, 3H), 5.10-4.99 (m, 3H), 4.69 (t, J 
= 5.4 Hz, IH), 3.52-3.46 (m, 2H, CH2Ar), 2.82 (dt, J = 13.5 and 7.2 Hz, IH, CH2 in 
cyclopentane), 2.03 (dt, J = 13.5 and 5.4 Hz, IH, CH2 in cyclopentane), 0.92 (s, 9H, t-
BuSi), 0.11 (s, 6H, Me2Si); NMR (CDCI3) 6 156.26,138.07, 137.99,136.55, 
134.94, 132.56, 130.67, 125.69, 116.41, 92.49, 86.09, 74.66, 42.09, 35.07, 25.99, 
18.28, -4.44, -4.49; IR (neat) 2955,2930,1472,1462,1369,1252 cm'l; HRMS m/z 
calculated for C2()H2802SiI (M-H) 455.09033, found 455.08915. Anal. Calcd for 
C20H29O2Sn: C, 52.63; H, 6.40. Found: C, 53.13; H, 6.65. 
Compounds 24 and 25 
These compounds were obtained as an inseparable 86:14 mixture of isomers: 62-80% 
yield; Rf = 0.65 (5:1 hexane/EtOAc); ^H NMR (CDCI3) 5 7.28-7.22 (m, 2H, phenyl), 6.94-
6.89 (m, 3H, phenyl), 5.91 (ddd, J = 16.5 and 10.5 and 5.7 Hz, IH, HC=C in compound 
24), 5.26 (dd, J = 16.5 and 1.2 Hz, IH, HC=C in compound 24), 5.16 (dd, J = 10.5 and 
1.2 Hz, IH, HC=C in compound 24), 4.80 (t, J = 6.6 Hz, IH, CHOPh in compound 24), 
4.45 (d, J = 4.5 Hz, 0.3 H, CH20Ph in compound 25), 1.43 (d, J = 6.6 Hz, 3H, CHg in 
compound 24); 13c NMR (CDCI3) S 157.94,139.20, 129.30, 120.67,115.98, 115.52, 
74.48,21.39. Small peaks corresponding to compound 25 were not always evident; IR 
(neat) 2932,1599,1495 cm"!. 
Compounds 31 and 32 
These compounds were obtained as an inseparable 86:14 mixture of isomers; 22% 
yield; Rf = 0.54 (15:1 hexane/EtOAc); ^H NMR (CDCI3) ô 7.27-7.17 (m, 2H, phenyl), 
6.99-6.90 (m, 3H, phenyl), 6.08 (dd, J = 17.4 and 11.1 Hz, IH, HC=C in compound 31), 
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5.19-5.13 (m, 3H). 4.53 (d, J = 6.6 Hz, 0.3 H, CHzOPh in compound 32), 2.15-2.07 (m, 
2H, CH2), 1.83-1.73 (m, 3H), 1.68 (s, 3H, CH3 in compound 3D, 159 (s, 3H, CH3 in 
compound 31), 1.39 (s, 3H, CHg in compound 31); NMR (CDCI3) 5 156.07,148.68, 
131.67, 128.79, 124.19, 121.90, 121.30, 114.14, 81.44, 64.77, 41.64, 25.75, 22.58, 
17.68. Small peaks corresponding to compound 32 were not always evident; IR (neat) 2978, 
2916,1599,1491 cm'l. 
Compounds 34 and 35 
These compounds were obtained as an inseparable 60:40 mixture of isomers: 44% 
yield; Rf = 0.63 (7:1 hexane/EtOAc); NMR (CDCI3) 5 7.26-7.17 (m, 3.8 H, phenyl), 
7.02-6.92 (m, 3.3H, phenyl), 5.74 (dd, J = 15.6 and 1.2 Hz, IH, HC=C in compound 34). 
5.56 (dq, J = 15.6 and 6.3 Hz, IH, Œ3CH=C in compound 34), 5.52 (m, 0.7H, HC=C in 
compound 35), 4.98 (m, 0.7H, CHOPh in compound M), 1.71 (m, 6.5H), 1.41 (s, 6H, 2 
CH3 in compound M), 137 (d, J = 6.3 Hz, 2.3H, CH3 in compound 35); NMR 
(CDCI3) 8 158.09, 156.02, 137.28, 134.23, 129.30, 128.69, 127.08, 124.32, 122.11, 
122.02, 120.43, 115.90, 79.19, 71.16, 27.46, 25.70, 21.48, 17.86; IR (neat) 3028, 2970, 
1597,1491 cm-1. 
Compounds 37 and 38 
These compounds were obtained as an inseparable 89:11 mixture of isomers: 89% 
yield; % NMR (CDCI3) 5 7.59-6.90 (m, lOH, phenyl), 6.69 (d, J = 16.2 Hz, IH, 
ArHC=C in compound 22), 6.37 (dt, J = 16.2 and 6.0 Hz, IH, HC=CHAr in compound 
37), 6.07 (m, 0.16 H, HC=C in compound 38), 5.60 (d, J = 6.0 Hz, 0.11 H, CHOPh in 
compound 38), 5.32 (d, J = 17.4 Hz, 0.12H, HC=C in compound 38), 5.21 (d, J = 10.5 
Hz, 0.13H, HC=C in compound 38), 4.63 (dd, J = 5.7 and 1.5 Hz, 2H, CH20Ph in 
compound 37); 13c NMR (CDCI3) S 158.56, 136.38,132.85, 129.45, 128.52, 127.83, 
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126.54,124.16,120.85,114.71, 68.46. Small peaks corresponding to compound 38 were 
not always evident; IR (neat) 3028,2903,1599,1495 cm-1. 
Compound 40 
This compound was obtained in a 65% yield; Rf =0.40 (15:1 hexane/EtOAc); 
NMR (CDCI3) Ô 7.32-7.22 (m, 2H, phenyl), 6.93-6.88 (m, 3H, phenyl), 5.59 (m, IH, 
HC=C), 4.37 (m, 2H, CH20Ph), 2.41 (dt, J = 8.8 and 5.7 Hz, IH), 2.31-2.26 (m, 2H), 
2.21 (dt, J = 1.2 and 8.7 Hz, IH), 2.11 (m, IH), 1.29 (s, 3H, CH3), 1.20 (d, J = 8.4 Hz, 
IH), 0.84 (s, 3H, CH3); NMR (CDCI3) 5 158.95, 144.00, 129.27, 120.53, 120.08, 
114.87, 70.58, 43.29, 40.91, 38.12, 31.55, 31.31, 26.22, 21.09; IR (neat) 2910, 1599, 
1497,1242 cm"l; HRMS m/z calculated for C16H20O 228.15142, found 228.15126. Anal. 
Calcd for C16H20O: C, 84.16; H, 8.83. Found: C, 83.88; H, 8.94. 
2-Cvclohexenvl phenyl ether (42) 
This compound was obtained in 62% yield: Rf = 0.67 (5:1 hexane/EtOAc); ^H NMR 
(CDCI3) 5 7.29-7.23 (m, 2H, phenyl), 6.94-6.89 (m, 3H, phenyl), 5.98-5.84 (m, 2H, 
HC=CH), 4.79 (m, IH, ŒOPh), 2.16-2.02 (m, 2H), 1.96-1.80 (m, 3H), 1.68-1.59 (m, 
IH); 13c NMR (CDCI3) 5 157.83, 132.06, 129.47, 126.41, 120.62, 115.69, 70.83, 
28.36,25.17,19.08; IR (neat) 3030,2939,2868, 1599,1493,1240 cm'l; HRMS m/z 
calculated for C12H14O 174.10447, found 174.10453. Anal. Calcd for C12H14O: C, 
82.72; H, 8.10. Found: C, 82.77; H, 8.33. 
Compound 44 
This compound was obtained in 74% yield: Rf=0.50 (10:1 hexane/EtOAc); ^H 
NMR (CDCI3) 5 7.03 (d, J = 7.5 Hz, 2H, aryl), 6.93 (dd, J = 7.5 and 7.5 Hz, IH, aryl), 
5.97-5.86 (m, 2H, HC=CH), 4.40 (m, IH, CHOPh), 2.32 (s, 6H, 2 CH3), 2.21-1.86 (m, 
5H), 1.65 (m, IH); 13C NMR (CDCI3) 5 155.12, 131.38, 131.28, 128.81, 127.37, 
123.25, 75.32,29.31, 25.31, 19.22, 17.32; IR (neat) 3029, 2932, 2864, 1474, 1261 cm-1; 
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HRMS m/z calculated for C14H18O 202.13577, found 202.13557. Anal. Calcd for 
C14H18O: C, 83.12; H, 8.97. Found: C, 83.24; H, 8.61. 
Compound 46 
This compound was obtained in 81% yield: Rf = 0.62 (7:1 hexane/EtOAc); NMR 
(CDCI3) 5 7.32-7.23 (m, 2H, phenyl), 6.95-6.90 (m, 3H, phenyl), 5.08 (s, IH, HC=C), 
4.92 (s, IH, HC=C), 4.41 (s, 2H, Œ20Ph), 1.82 (s, 3H, CH3); 13c NMR (CDCI3) 5 
158.74, 140.95, 129.37, 120.72, 114.76, 112.67, 71.62, 19.47; IR (neat) 3072, 2916, 
1601,1495 cm"l; HRMS m/z calculated for C10H12O 148.08882, found 148.08895. Anal. 
Calcd for C10H12O: C, 81.04; H, 8.16. Found C, 81.13; H, 8.33. 
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GENERAL SUMMARY 
In this dissertation, the synthesis of prostaglandins has been accomplished using 
organopalladium chemistry in the key step. In addition, a method for the synthesis of allylic 
aryl ethers was developed. 
In the first chapter of this dissertation, the formal synthesis of PGF2a and the total 
synthesis of 12-epi-PGF2a has been accomplished &om optically active cis-4-t-
butyldimethylsilyloxy-2-cyclopenten-l-ol. A Pd(II)-assisted three-component coupling 
reaction was employed as the key step. 
In the second chapter of this dissertation, an efficient synthesis of the PGI2 analogue 
(+)-5,6,7-trinor-4,8-inter-/7j-phenylene PGI2 was accomplished. Radical chemistry was 
employed for the cyclization, followed by subsequent trapping by a tri-«-butylstannyl allylic 
alcohol in a one-step procedure. The epimer, 12-epi-5,6,7-trinor-4,8-inter-m-phenylene 
PGI2, was also synthesized by a one-step Pd(0)-mediated cyclization and subsequent enone 
coupling. 
In the third chapter of this dissertation, a short synthesis of a novel prostanoid, 12-
epi-carbacyclin, was accomplished. The Pd(II)-mediated cyclization of a silyl enol ether, 
followed by enone trapping, was used as a single step procedure. 
In the last chapter of this dissertation, a Pd(0)-catalyzed synthetic approach to allylic 
aryl ethers was developed. Palladium-mediated reaction of allylic aryl carbonates gave allylic 
aryl ethers with high regio- and stereoselectivity. Allylic aryl carbonates were prepared from 
allylic alcohols either using phenyl chloroformate or triphosgene and functionalized phenols. 
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